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Prelude 
 
The first aim of this PhD project was to verify the neuropathological finding of increased 
apoptosis in the brainstem of SIDS victims as previously observed in a Canadian population by 
my supervisor (Waters et al., 1999). Subsequent investigations were planned to test for any 
correlations between the above finding and known SIDS risk factors. Having achieved this, the 
aim was to proceed with studies to evaluate mechanistic hypotheses regarding such neuronal cell 
death in SIDS, possibly via an animal model.  
 
To date, most of neuropathological findings in SIDS are based on small infant datasets (20-80 
cases in total). In addition, very few studies have correlated the neuropathological abnormalities 
that have been identified with known clinical or epidemiological risks for SIDS, mostly because 
this information is often not available.  
 
Here in NSW, Australia, every sudden infant death is investigated by the State Coroner. For 
infants 1 month to 1 year of age, a death scene investigation is routinely performed, clinical data 
collected using a standard questionnaire, and an autopsy conducted. Thus, correlations between 
pathological research and clinical data should be feasible.  
 
The first phase of the current project was the characterization of a large dataset of human infants 
and subsequent collection of the relevant brainstem tissue from remaining diagnostic blocks. 
During this time, research on human tissue was suspended for the review of the Human Tissue 
Act. Since the use of an animal model had always been feasible and contemplated in the 
planning phase of the project, focus shifted from the infant dataset to an animal model.  
 
A piglet model of intermittent hypercapnic hypoxia (IHH) was being developed in my residing 
laboratory and so, I moved on to study neuropathological outcomes of this model. The IHH 
model was designed to mimic the clinical situations of the prone sleeping position with the face 
down or obstructive sleep apnoea, both of which are risk factors for SIDS. Thus, the aim of my 
project now was to determine how well this model of IHH was in reproducing the same 
neuropathological findings sought in SIDS infants, particularly increased neuronal apoptosis.  
 
This shift in focus of my research from the infant dataset to the piglet dataset provided a number 
of advantages. First, it showed that IHH did induce apoptosis in the brainstem of these piglets, 
thus supporting the relevance of the model to SIDS. Second, it allowed me to refine new 
  
xii
experimental techniques aimed at determining the mechanism of this increased apoptosis, which 
would not have been possible in the limited number of human tissue samples that were available. 
Finally, it provided me with a much broader range of positive studies, three of which have been 
published in peer reviewed journals. 
 
As I was nearing the end of my studies with the piglet dataset, the original infant tissue dataset 
became available, with ethics approval to finish studies in the 25 cases for which I had already 
collected the brain tissue. The results published in this thesis are therefore considered 
preliminary, but also provide verification of the importance and urgency of undertaking further 
analysis in larger datasets to definitively conclude the specificity of these findings to SIDS.  
 
The lay out of this thesis reflects the sequence in which my projects were performed. Part I 
concerns the neuropathology of the piglet model of IHH while Part II concerns the 
neuropathology of SIDS infants compared to non-SIDS infants, with each part containing several 
chapters. The final chapter of the thesis highlights the comparative findings of this project 
between Parts I and Parts II; that is, the findings that are consistent between the piglet model of 
IHH and SIDS infants, and discusses future research directions.  
 
  
xiii
Abstract 
This thesis tests the hypothesis that increased neuronal cell death in SIDS infants is related to the 
ability of risk factors, such as prone sleeping, to expose infants to intermittent hypercapnic 
hypoxia (IHH). Based on the hypothesis that the NMDA system is linked to neuronal death, by 
way of excitotoxicity, correlations were also sought between cell death and changes in NMDA 
receptor (NR1) expression in brainstem nuclei controlling cardiorespiratory function.  
 
The first aim of this study was to verify that increased neuronal cell death occurs in SIDS infants. 
To verify a piglet model of SIDS risk factors, brainstem changes were examined in piglets 
exposed to IHH, and comparisons were made to changes seen in SIDS infants. The NMDA 
receptor was characterised in controls for both the human infant and the piglet groups. 
Comparisons of neuronal changes were made with SIDS infants, and piglets exposed to IHH.  
 
Non-radioactive in-situ hybridisation and immunohistochemistry were performed on formalin 
fixed and paraffin embedded brainstem tissue to identify markers of cell death (caspase-3, active 
caspase-3, and TUNEL), and to examine NR1 mRNA and protein expressions. Staining was 
quantified using computerised image analysis software. Eight nuclei from the brainstem medulla 
(caudal in piglets, and mid in infants), and two nuclei from the rostral pons (infants) were studied. 
 
The first dataset included human infants aged 1-6 months with a diagnosis of SIDS (n=15) or 
non-SIDS (n=10). The second dataset comprised developing piglets aged 13-14 days, with 
controls (n=6), against those exposed to IHH for 2 (n=6) or 4 (n=5) days. Increased neuronal cell 
death was not verified in the SIDS infants, but abnormalities in NR1 expression were present in 
selected nuclei of the medulla. Piglets exposed to IHH had increased neuronal cell death and 
changes in NR1 in selected nuclei of the medulla. There was also a positive correlation between 
increased cell death and high NR1 levels. Preliminary data showed that SIDS infants who usually 
slept prone had some differences in NR1 compared to those who did not usually sleep prone.  
 
From these findings, it was concluded that IHH may underlie the abnormalities in NMDA 
receptor expression that are present in the brainstem of SIDS infants. Although IHH can induce 
an increase in neuronal cell death, its significance in the aetiology of SIDS is not known. In 
piglets, IHH induced cell death correlated with high NMDA expression in some brainstem nuclei, 
supporting the hypothesis that excitotoxicity may be involved in the mechanism for cell death. 
Moreover, this thesis presents for the first time, ‘preliminary pathological proof’ of an association 
between prone sleeping and abnormal NMDA receptor expression in SIDS infants. 
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Chapter 1 
Literature Review  
1.1 Summary 
Sudden Infant Death Syndrome (SIDS) is a major cause of postneonatal mortality (i.e. deaths 
between 28 days and one year of age) in developed countries. The incidence peak lies between 
the second and fourth month of life. Victims of SIDS die suddenly during a period of sleep, the 
cause of which remains unknown, although many hypotheses implicating hypoxic mechanisms 
exist and are under investigation.  
 
The Sudden Infant Death Syndrome is associated with many risk factors that can be categorised 
under four headings: cultural, environmental, obstetric and socio-economic. The epidemiological 
evidence for the major risk factors and proposed mechanism(s) of action will be discussed in the 
first part of this literature review. 
 
It has long been suspected that SIDS results from a brain abnormality, but the precise nature of 
this abnormality has been elusive. Light microscopy examination of the brains of SIDS victims 
has revealed slight abnormalities that in themselves are not sufficient to explain the death and are 
not useful as diagnostic markers of SIDS, so the diagnosis remains one of exclusion. These 
neuropathological findings will be discussed in the second part of this literature review. 
 
Determining possible mechanisms for these neuropathological findings has relied upon animal 
studies mimicking SIDS risk factors. The third part of this literature review will present 
pathophysiological and brainstem pathological findings from animal models relevant to SIDS, 
with particular reference to the piglet as the most suitable species for neuropathological studies.  
 
The most compelling and comprehensive hypothesis in the aetiology of SIDS is that a brainstem 
abnormality or maturational delay exists in relation to neuroregulation of cardiorespiratory 
control. Such an abnormality could then lead to repeated episodes of hypoxia (lack of oxygen) or 
may be due to the hypoxia. This thesis tests the hypothesis that following an hypoxic insult, 
apoptosis (a physiological process of cell death) is exacerbated in certain brain areas. Therefore, 
the cause of death in SIDS may be due to repeated episodes of hypoxia first leading to neuronal 
apoptosis in vulnerable brain regions and then, through loss of a significant number of cells, to 
impaired function in those regions. This neuronal apoptosis is believed to be due to, at least in 
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part, excitotoxicity (a phenomenon induced by overstimulation of glutamate receptors). The 
background behind this phenomenon will be discussed in the fourth part of this literature review, 
with particular focus on the N-methyl-D-aspartate (NMDA) glutamatergic receptor and its 
involvement in neuronal apoptosis.  
 
Finally, the study aims and global hypothesis of this PhD project will be presented.  
 
1.2 Introduction 
Sudden Infant Death Syndrome (SIDS) is currently the second cause of postneonatal mortality, 
after congenital anomalies in developed countries. SIDS is related to periods of sleep with the 
highest number of SIDS deaths occurring around 2-4 months of age, and with males 1.5 times 
more affected than females (Mitchell and Stewart, 1997; Adams et al., 1998). Several important 
advances in SIDS research have been made in the past decade. Epidemiologically, it was found 
that a prone sleeping position substantially increases the risk for SIDS (reviewed in Dwyer et al., 
1995). Exposure to cigarette smoke has also been implicated, both prenatally from maternal 
smoking and postnatally from passive smoke exposure (reviewed in Anderson and Cook, 1997 & 
Henderson-Smart et al., 1998). Physiologically, infants who later succumbed to SIDS have been 
found to exhibit a variety of cardiac, respiratory and sleep state abnormalities (Sturner et al., 
1980; Harper et al., 1981; Southall et al., 1988; Kahn et al., 1997). Pathologically, particularly in 
post-mortem studies of the brainstem, findings have provided evidence of neurochemical deficits 
in SIDS infants (reviewed in Kinney et al., 2001). 
 
Despite ever increasing epidemiological, physiological and pathological findings in SIDS, a 
precise and specific cause of SIDS has yet to be identified. As a result, there are no criteria that 
can reliably identify an individual infant who is at risk to die from SIDS, nor is there a specific 
post-mortem marker for diagnosing SIDS, so the diagnosis continues to be one of exclusion. 
Thus, SIDS research is designed with the aim of achieving the following two main objectives:  
1- to identify the mechanism resulting in SIDS with sufficient specificity that it will lead to 
development of a screening test capable of accurately and economically identifying 
infants at high risk for death from SIDS and  
2- to identify post-mortem changes that are specific in infants who died of SIDS so that a 
positive diagnosis can be made.  
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A triple-risk model has been proposed for the pathogenesis of SIDS (Filiano and Kinney, 1994), 
and takes into account epidemiologic, physiologic and autopsy findings. This model proposes 
that an infant will die of SIDS when the following three overlapping factors occur 
simultaneously:  
1- underlying vulnerability in the infant,  
2- a critical developmental period in homeostatic control, and  
3- an exogenous stressor(s) (Fig. 1.1).  
Thus, SIDS may well represent a common end point or response to a diversity of stressors. 
 
Although many general hypotheses have been proposed concerning the potential causes of SIDS 
(Valdes-Dapena, 1986), the most compelling continues to be that SIDS is related to a brainstem 
abnormality affecting neuroregulation of cardiorespiratory control (Hunt and Brouillette, 1987). 
Research has extended this general hypothesis to implicate hypoxia as a major contributor in 
producing this abnormality in SIDS (Hunt, 1992). The abnormality is also thought to involve 
changes in neurotransmitter and receptor systems (Kinney et al., 1995), with the final result 
being increased neuronal cell death (apoptosis) in selected vulnerable brainstem nuclei (Waters 
et al., 1999; Sawaguchi et al., 2002).  
 
 
 
 
 
 
 
 
 
 
Fig. 1.1: SIDS triple-risk model.  
The triple-risk model proposed by Filliano and Kinney, (1994), stating that an infant will die of SIDS 
only when the following three factors, represented by each circle, overlap simultaneously: 1) underlying 
vulnerability in the infant, 2) a critical developmental period in homeostatic control and 3) an exogenous 
stressor(s). 
 
1.3 Definition of SIDS 
The term ‘Sudden Infant Death Syndrome (SIDS)’ was first proposed in 1969 (Beckwith, 1970) 
to define a subgroup of infants who died unexpectedly during the postneonatal period with 
relatively consistent clinical, epidemiological and pathological features. In 1991 this definition 
was revised to state that SIDS is “The sudden death of an infant under one year of age which 
remains unexplained after a thorough case investigation, including performance of a complete 
Vulnerable  
infant 
Critical 
developmental 
period 
Exogenous 
stressor(s) 
SIDS
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autopsy, examination of the death scene, and review of the clinical history” (Willinger et al., 
1991). This definition contrasts with the 1969 definition in that the limitation of age to the first 
year of life is now included, and review of the history and examination of the death scene is now 
made explicit. However, there is still no positive criteria for diagnosing SIDS, and so it 
continues to be a diagnosis of exclusion. 
 
Although the 1991 definition is currently accepted and applied internationally, its validity has 
been the subject of much recent debate (Guntheroth and Spiers, 2002; Beckwith, 2003). Many 
suggest the definition should be revised again but this time, include sub-classifications based on 
epidemiological findings of typical characteristics present amongst most SIDS cases.  
 
1.4 Epidemiology of SIDS 
A number of characteristic features have been identified and still remain typical for cases that 
fulfil the requirements of the 1991 definition. Although all of these characteristics were 
identified prior to 1991 when “Back to sleep” campaigns were introduced, recent studies such as 
the confidential enquiry into stillbirths and deaths in infancy (CESDI) conducted in the United 
Kingdom (UK) (Leach et al., 1999; Fleming et al., 2003), show they still remain the same. These 
predominant characteristics include: an incidence peak between 2 and 4 months of age, more 
males than females (male:female ratio 1.5:1) (Mitchell and Stewart, 1997; Adams et al., 1998; 
Australian Institute of Health and Welfare (AIHW), 2002) and death during a sleep period with 
more reports in the winter months (Dwyer et al., 1995). Other characteristic features include: an 
increased incidence in indigenous and African-American populations (Mitchell et al., 1993; 
Alessandri et al., 1996; Pollack, 2001; Pollack and Frohna, 2001), in premature infants, and 
infants of a high birth order whose mothers had short inter-pregnancy intervals (Hoffman and 
Hillman, 1992; Leach et al., 1999; Mitchell and Becroft, 1997).,. 
 
1.4.1 Risk Factors for SIDS  
In addition to identifying characteristic features typical to most SIDS cases, epidemiological 
studies over the last 30 years have also helped to identify factors considered to increase the risk 
for SIDS (Table 1.1). However, it is important to note that even though these factors are 
associated with an increased risk for SIDS, many infants experience one or more of these factors 
and remain alive. Therefore, the question why SIDS infants are more sensitive to these 
influences compared to other infants remains unanswered. 
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Identifying these risk factors led to the initiation of campaigns such as those run by the National 
SIDS Council of Australia: “Back to sleep” (1991) and then updated to “Reducing the Risk” 
(1997). Appendix 1 shows when such campaigns were introduced internationally. These 
campaigns aimed to decrease the incidence of SIDS by raising public awareness of the risk 
factors associated with SIDS, in particular the prone sleeping position and cigarette smoke 
exposure. Most recent data in Australia (AIHW, 2002) shows that this campaign was successful 
and that the SIDS death rate decreased by 62% (from 2.7/1000 in 1991 to 1.0/1000 in 2000). 
Despite such decreases in SIDS death rates, SIDS still remains the main cause of death among 
infants aged 1 month to 1 year in western countries, especially in certain groups of the 
community where it has been difficult to implement public health campaigns either due to low 
socioeconomic and educational status (Fleming et al., 2003), or to cultural and language barriers 
(Byard and Krous, 2003).  
 
Table 1.1: Risk factors for SIDS 
Cultural sleep position, bedding, feeding method 
Environmental parental smoking, substance abuse  
Obstetric maternal age, low birth weight, preterm delivery, multiple births, sibling of SIDS 
Socio-economic social class, ethnicity, income 
 
1.4.1.1 Cultural 
1.4.1.1.1 Sleep position 
Evidence that the sleep position of an infant is related to the risk of SIDS has been accumulating 
over the past three decades. Thus, by 1991, consensus had been reached in many countries 
[Appendix 1] that parents should be advised not to place healthy infants in the prone position for 
sleep.  
 
Prospective and retrospective case-control studies conducted to determine the effects of this 
intervention have shown there to be a dramatic reduction in the rate of SIDS cases. As the 
prevalence of prone sleeping in Tasmania, Australia decreased from 31% in 1988 to 3% in 1992, 
the SIDS rate decreased from 1.8/1000 in 1988 to 1.0/1000 in 1992. A concomitant decline in 
infant mortality rate was also observed, 3.4/1000 to 2.5/1000, with the reduction in SIDS being 
the primary contributor (Dwyer et al., 1995). Similar trends were observed in other countries 
(Table 1.2 and Fig. 1.2). 
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The reduction in SIDS rate also predominated in winter. However, a winter peak still occurs 
suggesting an interaction with a seasonal factor, perhaps thermal environment or infection 
(Dwyer et al., 1995). 
 
         Table 1.2: Prevalence (%) of infants sleeping prone in selected countries 
Country 1988 1990 1991 1992 
Tasmania, Australia 31 31 13 3 
Avon, England 59 27 2  
Netherlands 27 16  10 
New Zealand  35 30 5  
Norway    54 31 31   
   (Adapted from Willinger et al., 1994). 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
Fig. 1. 2: SIDS rate in selected countries 1988-1992.  
These rates are calculated as the number of SIDS deaths, between 27 days and 1 year of age, per 1000 
live births. Dashed vertical line represents the year campaigns were introduced. (Adapted from Willinger 
et al., 1994). 
  
The pathophysiological mechanisms by which the prone position could increase the risk of SIDS 
include:  
1-  rebreathing of expired gases and suffocation from facial proximity to bedding (Kemp and 
Thach, 1993),  
2-  elevated core or brain temperature due to the face being in close proximity to insulated 
bedding where the face is the major site of heat loss (Fleming et al., 1992),  
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3-  upper airway obstruction, either by retropositioning the mandible and occluding the pharynx 
or by direct compression of the nose (Chiodini and Thach, 1993), and  
4-  elevated arousal thresholds in the prone position which could reduce efforts to move or 
overcome suffocation challenges (as hypothesised by Harper et al., 2000). 
 
1.4.1.1.2 Bedding  
1.4.1.1.2.1 Type of bedding 
One proposed explanation for death in the prone position among susceptible infants is 
rebreathing of exhaled gases trapped in bedding (Kemp et al., 1993). Items of bedding such as 
sheepskins and natural fibre mattresses (Ponsonby et al., 1993) as well as conventional bedding 
such as comforters, have been associated with SIDS (Kemp and Thach, 1993). These appear to 
share certain physical properties that enhance the risk for rebreathing, including increased 
softness (limiting the infants ability to turn the head) and increased capacity to limit carbon 
dioxide (CO2) dispersal.  
 
1.4.1.1.2.2 Amount of bedding/ thermal stress 
The possible role of thermal stress in the aetiology of SIDS has been suggested by a number of 
authors. Two analytical case-control studies, conducted when prone sleeping was more common, 
have found overheating to be related to SIDS (Fleming et al., 1990; Ponsonby et al., 1992). 
 
An examination of insulation in room heating for 72 SIDS infants and 144 matched control 
infants found that infants who died from SIDS were slightly more heavily wrapped and likely to 
have been sleeping in rooms where heating was left on all night, compared to control cases 
(P<0.01) (Fleming et al., 1990). Similarly, SIDS cases were found to have had more excess 
thermal insulation (togs) for the measured room temperature at the death scene (2.3 togs) than 
control infants at home visits (0.6 togs) (P=0.009) (Ponsonby et al., 1992). 
 
These two studies point to a small added risk for SIDS from high insulation and high ambient 
temperature. Currently, no studies have shown conflicting results. The mechanism(s) by which 
thermal imbalance might lead to death is not clear, although heat stress is known to affect 
breathing control (Fleming et al., 1993) and animal studies indicate potentially lethal rises in 
brain temperature as a result of head covering (Galland et al., 1994) [see section 1.8.2 ANIMAL 
STUDIES- piglet models of SIDS physiology]. 
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1.4.1.1.2.3 Bed sharing 
Data regarding an association between bed sharing and SIDS are inconclusive. In 1992, a report 
from the New-Zealand (NZ) Cot Death study identified bed sharing as a modifiable risk factor 
for SIDS (Scragg et al., 1993). This risk factor was dependent on the place of sleep, smoking and 
alcohol consumption where: 
1- bed sharing, free of confounding factors, had a relative risk factor (RR) of 1.64,  
2- the relative risk for bed sharing increased the risk for SIDS when the mother smoked 
(RR= 3.82), 
3- usual maternal alcohol consumption did not interact with bed sharing and the risk of 
SIDS (RR= 1.95), 
4- room sharing, as opposed to bed sharing, with one or more adults decreased the relative 
risk of SIDS (RR=0.92). 
 
In contrast, Farooqi et al., (1994) showed that bed sharing, even in the presence of maternal 
smoking, did not increase the risk for SIDS. In this study, 3 times as many Asian infants as 
Caucasian infants slept in the parental bed. A random sample of this population showed that 36% 
of Caucasian mothers smoked compared with 2.8% of Asian mothers. Thus, Caucasian mothers 
are more likely to smoke but less likely to share their infants bed. Nevertheless, Caucasian 
infants have twice the mortality from SIDS than Asian infants. 
 
Therefore, whilst there is some data indicating that bed sharing increases the risk of SIDS 
amongst smokers, the data is currently not sufficient to provide complete reassurance that bed 
sharing with non smoking parents is safe. 
 
1.4.1.1.3 Breast-feeding 
While breast-feeding has many important beneficial effects, it is not evident that it is protective 
against SIDS. Retrospective case-control studies in the USA with 757 SIDS cases and 1514 
controls (Hoffman et al., 1988), and in NZ with 356 cases and 1529 controls (Ford et al., 1993), 
found that breast feeding appeared to be protective for SIDS. However, a prospective cohort 
study in the USA with 193 SIDS and 1930 controls, found that the protective effect of breast-
feeding was reduced to non-significant after adjusting the data for maternal education and birth 
weight (Kraus et al., 1989).  
 
Given the inconsistency of evidence, breast-feeding is not promoted as a factor reducing the risk 
for SIDS. However, there is consensus that it should be supported on other grounds. 
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1.4.1.2 Environmental 
1.4.1.2.1 Smoking 
Both pre- and postnatal exposures to cigarette smoking, i.e. active maternal smoking and passive 
environmental smoke, increase the risk for SIDS with strong suggestions that maternal smoking 
during pregnancy is an independent risk factor for SIDS (RR 1.6 - 4.4) (Bulterys et al., 1990; 
Slotkin, 1998).  
 
Parental smoking is currently considered to be the second most significant risk factor for SIDS; 
the first being prone sleeping. Prior to the reduction of prone sleeping, the population 
attributable risk for SIDS from smoking was 33%. After the reduction in rates of prone sleeping, 
the population attributable risk from smoking is reported to have risen to 61% (Henderson-Smart 
et al., 1998). 
 
A highly significant effect of both maternal and paternal smoking on SIDS risk has been shown 
in two case control studies. A study in the UK, carried out between 1993 and 1995 when the 
change in sleeping position was promoted, found that the incidence of smoking during 
pregnancy was greater in mothers of 195 SIDS cases (63%) than in mothers of 780 controls 
(25%). An additive increase in the risk for SIDS was observed if fathers were smokers (Blair, 
1996). A study in Sheffield reported odds ratios (OR) of 1.68 for maternal smoking and 1.39 for 
paternal smoking. Where both parents smoked, the OR increased to 3.46 compared to the 
reference value of 1.0 for families where neither parent smoked (Nicholl and O’Cathain, 1992). 
Evidence of a dose-response trend was provided by a case-control study in Southern California 
where it was found that increasing exposure to tobacco smoke was associated with increasing 
risk for SIDS (Klonoff-Cohen et al., 1995).  
 
Our understanding of maternal smoking during pregnancy as a risk factor for SIDS has been 
enhanced by a study that showed in women with low hematocrit, smoking was a strong risk 
factor. While hematocrit was not a risk factor for SIDS among non-smokers, it became an 
important predictor among heavy smokers. This suggests that hematocrit and smoking may 
interact through exposing the foetus to chronic hypoxia (Bulterys et al., 1990). Thus, the reduced 
oxygen supply during pregnancy may act by impairing normal development of fetal central 
nervous system. 
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1.4.1.2.2 Substance abuse 
Published epidemiological data suggests the association between SIDS and maternal opiate or 
cocaine use is weak compared with smoking when considering other confounding risk factors.  
Since most drug users also smoke cigarettes, it is unclear whether the data reflects the effects of 
the substance abuse itself or whether it is marred by the smoke exposure (Slotkin, 1998). 
 
In New York between 1979 and 1989, the SIDS rate in drug exposed infants was 5.83/1000 
compared with 1.39/1000 in those not exposed to drugs, controlling other known risk variables. 
When divided into individual drug groups, higher rates of SIDS were found in infants exposed to 
opiates alone (3.6/1000 methadone, 2.3/1000 heroine) than in the cocaine exposed infants 
(1.6/1000) (Kandal et al., 1993).  
 
A meta analysis of 10 published studies on the incidence of SIDS amongst infants exposed to 
prenatal cocaine showed that the combined OR for SIDS in cocaine exposed versus all 
comparison groups is 3.9. When compared to the polydrug comparison group of infants, it was 
2.7 but not statistically significant. It was thus concluded that the increase in risk for SIDS was 
not specific to cocaine, but instead, due to intrauterine exposure to illicit drugs in general (Fares 
et al., 1997).  
 
1.4.1.3 Obstetric 
1.4.1.3.1 SIDS siblings 
The SIDS risk in subsequent siblings of SIDS victims remains uncertain. An original study in the 
USA by Peterson et al., (1980), reported a 10 fold increase in SIDS rates in subsequent siblings. 
In a later study, it was concluded that this 10 fold increase estimate was biased towards over 
reporting and the actual estimate was a 4 times increase. However, this difference disappeared 
after adjusting for birth rank and maternal age (Peterson et al., 1986). Therefore, with statistical 
methodological improvements, their data did not indicate an increased SIDS risk amongst 
siblings of SIDS victims. 
 
In contrast, Guntheroth et al., (1990) showed that there was a statistically greater incidence of 
SIDS in subsequent siblings. The researchers examined all Oregon birth and death certificates 
from 1975-84 and observed a SIDS incidence of 13/1000 amongst subsequent siblings with a RR 
of 6.0. After adjusting for birth order, maternal age and marital status, the RR was reduced to 
4.8, 5.3 and 5.4 respectively. The findings of this study were supported by Oyen et al., (1996) 
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who showed that the recurrence rate of SIDS in Norway from 1967-1988 was 11/1000 live births 
with a RR of 5.9 in all subsequent siblings. 
 
It should be noted that these studies of SIDS siblings were conducted prior to the intervention of 
the sleep position and no studies on SIDS siblings have been conducted after those campaigns. 
The current actual risk for SIDS siblings is therefore unknown.   
 
1.4.1.3.2 Prematurity, gestational age  & birth weight 
The incidence of SIDS deaths amongst infants who were born prematurely varies between 
studies. Southall et al., (1982) found a SIDS rate of 4/1000 in one population and 9/1000 in a 
second population of premature infants. In premature infants who needed admission to an 
intensive care unit, the rate of subsequent SIDS deaths was 6/1000 (Kulkarni et al., 1978) and 
10/1000 (Hoppenbrouwers et al., 1993). However, in these studies, the premature group was not 
categorised by gestational age. Malloy et al., (1995) conducted a study to determine the SIDS 
rate by gestational age categories (24-28, 29-32, 33-36 and 37+ weeks) and showed the rate was 
3.52, 3.01, 2.27 and 1.06 deaths/1000 live births respectively. Thus, the earlier the gestational 
age of the infant, the greater the risk for SIDS. 
 
Rather than gestational age alone, the infants’ birth weight may better reflect their risk for death 
since birth weight is the most common indicator of prematurity. For the premature infant of very 
low birth weight (<1500g) or low birth weight (1500-2499g), the SIDS rate was 3.7/1000 and 
3.5/1000 respectively, while for normal birth weight infants (≥ 2500g), the SIDS rate was 1/1000  
(Bigger et al.,1998). However, Black et al., (1986) showed that although the incidence of SIDS 
among low birth weight infants is much higher than normal birth weight infants, most SIDS 
cases (76%) occurred among babies whose birth weights are normal. This has recently been 
confirmed by Pollack and Frohna (2001), further adding to the difficulty of predicting which 
infants are at risk for SIDS.  
 
Chapter 1: Literature Review            12
1.4.1.4 Socio-economic 
1.4.1.4.1 Ethnicity 
All studies of SIDS incidence have shown significantly higher rates in Indigenous than in non- 
Indigenous infants. In NZ, Maori infants had 3.81 times the risk of SIDS compared with non-
Maori infants (Mitchell et al., 1993). In Cook County, USA, the SIDS rate in Indigenous, 
Hispanics and Caucasians, from 1975-1980 was 5.1, 1.2 and 1.3/1000 respectively (Black et al., 
1986). In Australia, the average SIDS death rates for Aboriginal and Torres Strait Islander 
infants, from 1998-2000, were 5 times those for other Australian Infants (253.2 compared with 
51.9) (AIHW, 2002). These studies concluded that the high rate of SIDS amongst Indigenous 
infants is based largely on the high prevalence of the major risk factors in this population. 
 
1.5 Physiology of SIDS 
Early and most recent prospective studies concerning the physiology of SIDS showed that 
infants who latter succumbed to SIDS demonstrated alterations in their cardiorespiratory and 
sleep-waking patterns. Cardiorespiratory alterations include a mild increase in heart rate (Sturner 
et al., 1980; Kahn et al., 1983; Southall et al., 1988), reduced heart rate variation (Schechtman et 
al., 1989 and 1992; Schwartz et al., 1998), heart rhythm disturbance, in particular prolongation 
of QT intervals (Schwartz et al., 1998) and changes in the R-R interval (Schechtman et al., 
1992), and reduced mean breath-to-breath changes in respiratory rate (Schechtman et al., 1996).  
 
Some published alterations with respect to sleep and arousal in SIDS infants include failure to 
arouse from sleep (Harper et al., 1981; Kahn et al., 1997), increased frequency of respiratory 
pauses (apnoea) during sleep (Schulte et al., 1982; Kato et al., 2000), and altered sleep patterns 
(Schechtman and Harper, 1992). 
 
1.6 Neuropathology of SIDS 
It is believed that SIDS results from a brain abnormality or maturational delay particularly in 
regions responsible for cardiorespiratory control. However, it has been very difficult to prove 
because SIDS brains look “normal” or contain non-specific lesions when conventional 
histopathological criteria are used (Kinney et al., 1992). One of the major challenges in SIDS 
brain research is to locate and identify specific brain lesions. If a brain abnormality exists to 
explain (is directly responsible or reflects) the cause for sudden death, more refined analysis with 
quantitative cellular, neurochemical and/or molecular tools appear to be necessary for it to be 
detected.  
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The focus on brain abnormalities in SIDS is strong for two major reasons. First, physiological 
studies of infants who subsequently died of SIDS indicate abnormalities in cardiopulmonary and 
sleep waking function. A common pathway to explain the origin of these abnormalities would be 
altered control of these functions, at the level of brainstem nuclei. Second, a number of studies 
have now reported neuropathological findings in SIDS victims using non-standard histological 
techniques, and which taken together, suggest that brain abnormalities are present in SIDS 
victims.  
 
The brainstem medulla oblongata is a strong candidate for the location of abnormalities, because 
it contains nuclei and pathways that control ventilation, cardiac activity, as well as initiating 
pathways for sleep and arousal control. Defective, dysfunctional or degenerating neuronal 
circuitry in this region could cause the sudden death of an infant, who was outwardly “normal” 
(Sparks and Hunsaker, 2002). The pathophysiological changes that have been observed in future 
SIDS infants could also be explained by abnormalities in these brainstem structures.  
 
1.6.1 Brainstem nuclei of interest 
The specific brainstem regions and nuclei implicated in failure of cardiovascular, respiratory, 
sleep, and arousal control in SIDS are discussed below, and their locations are colour coded and 
represented in Fig. 1.3. 
 
The final common pathways for respiration, cardiac activity, and blood pressure control are 
located in the brainstem reticular formation     , which is a diffusely organised area that forms the 
central core of the brainstem (Nolte, 1993). The reticular formation is classically subdivided into 
two zones, the lateral reticular zone (LRZ)    and the medial reticular zone (MRZ)     (Fig. 1.3a). 
The LRZ is confined primarily to the pons and medulla, while the MRZ begins in the central part 
of the medulla and extends rostrally into the midbrain and thalamic regions (Heimer, 1995).  
 
1.6.1.1. Cardiovascular control 
The reticular formation of the ventrolateral medulla (VLM), the nucleus of the tractus solitarus 
(NTS)    , and the nucleus ambiguus (NA)     are crucial components in the central pathways 
mediating cardiovascular functions and reflexes, including the baroreceptor and chemoreceptor 
reflexes. Each of these regions contributes to cardiovascular regulation by receiving multiple 
excitatory and inhibitory inputs, either from each other or externally (from other central or 
peripheral regions) (reviewed in Sapru, 2002).  
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Two different cell populations have been identified in the VLM and are termed the rostral 
ventrolateral medulla (RVLM), and the caudal ventral lateral medulla (CVLM) (Fig. 1.3 b,f & 
g). The RVLM is known as a pressor area since activation of the RVLM cells produces an 
increase in blood pressure and heart rate (McAllen and Dampney, 1989). The CVLM on the 
other hand, is a depressor area since activation of the CVLM cells elicits a fall in blood pressure 
(Kubo and Kihara, 1988). The RVLM receives inputs from many peripheral and central sources 
including the CVLM, NTS, and the midbrain periaqueductal gray nucleus (PAG) (reviewed in 
Dampney, 1994), while the CVLM to date, is known to receive inputs from only the NTS 
(Sapru, 2002). 
 
The NTS is the first central site where cardiovascular reflexes regulating blood pressure and 
fluid balance are coordinated (Spyer, 1990). The NTS is the primary site of termination of 
afferent fibres arising from many cardiovascular receptors, including those in the aortic nerve, 
carotid sinuses and bodies, and is also a major site of termination for second-order neurons 
receiving inputs from many other visceral and somatic receptors (as reviewed in Dampney, 
1994). Centrally, the NTS receives afferent inputs from many brain regions including the cortex, 
hypothalamus, parabrachial complex (PBC)    , PAG, nuclei of the pons and VLM, and the area 
postrema (AP), and inturn, send efferent outputs back to the same regions or various other ones.  
 
Projection from the NTS to the NA and dorsal motor nucleus of the vagus (DMNV)   , are of 
particular interest. NTS projections to the NA seem to be the predominant pathway mediating 
bradycardia (i.e. baroreceptor-mediated excitation of cardiac vagal neurons) (Loewy, 1990), 
while projections to the DMNV, innervate the preganglionic spinal neurons of the sympathetic 
system involved in blood pressure regulation (Willis et al., 1996). 
 
The arcuate nucleus (AN)      ,  is located near the surface of the ventrolateral, ventral and 
ventromedial medulla and believed to have a role in cardiovascular control. It is a well defined 
area in the human brainstem but not in experimental animals. In some animal species, like the cat 
and rat, neurons which occupy locations homologous to the human AN have been called nucleus 
paragigantocellularis lateralis, ventral raphe pallidus or other names depending on the species (as 
noted by Filliano and Kinney, 1992). In the cat brainstem, the region homologous to the human 
AN has been shown to be involved in protective responses to hypercapnia (excess CO2 in blood) 
and asphyxia (suffocation), and projects to nuclei of the medullary raphe, including the NTS and 
NA, thus evoking hypotension often accompanied by bradycardia (Lawing et al., 1987; McAllen 
et al., 1982). Although this homology seems reasonable and suggests the AN to play a role in 
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cardiovascular, as well as respiratory control, more research is required before the argument for 
a definite link can be sustained. 
 
The vestibular (Vest) nuclei     , which include the inferior, superior, medial and lateral 
vestibular nuclei, are part of the vestibular system which is important in mediating postural 
reflexes and information concerning the orientation of the head (Nolte, 1993). A change in 
posture is associated with a change in blood pressure, and the vestibular system has been shown 
to participate in making the necessary adjustments in blood pressure during these postural 
changes (reviewed in Yates et al., 2000). 
 
1.6.1.2 Respiratory control 
Respiratory neurons are concentrated in two distinct regions of the medulla, the dorsal 
respiratory group (DRG), and ventral respiratory group (VRG) (Fig 1.3 c). The DRG is 
homologous to the ventrolateral division of the NTS and contains multipolar, morphologically 
homogeneous cells (Bianchi and Pasaro, 1997). Almost all DRG neurons posses inspiratory-
modulated discharge patterns. In contrast, VRG neurons are more heterogeneous and composed 
of various classes of respiratory neurons. The VRG is a bilateral longitudinal column of neurons 
extending from the cervical spinal cord to the facial nucleus     , and includes the NA. The VRG 
is subdivided into three parts, the caudal (cVRG), intermediate (iVRG), and rostral (rVRG), each 
with different anatomical and functional characteristics (reviewed in Bianchi et al., 1995). 
Within the rVRG is a Bötzinger complex, a functional entity of much research in respiratory 
control.  
 
Numerous respiratory-related neurons have also been identified in the pons, especially in the 
PBC and the Kölliker-fuse (KF) nucleus    . These regions are often referred to as the pontine 
respiratory group (PRG), and considered the site of the “pneumotaxic centre” controlling 
inspiratory duration, i.e. they influence respiratory pattern by contributing to the termination of 
inspiration and switching to expiration. Thus, compared to the medullary DRG and VRG, the 
PRG are not essential for respiratory rhythm generation but rather, stabilization of respiratory 
pattern (as reviewed in Bianchi and Pasaro, 1997).   
 
Other nuclei not part of the above mentioned respiratory groups, but have a role in respiratory 
control include the hypoglossal nucleus (XII)     and the vestibular nuclei. The XII is not directly 
involved in respiration, but because it innervates the intrinsic and extrinsic muscles of the 
tongue, it is important in airway patency and swallowing (O’Kusky, 1992). Of the vestibular 
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nuclei, the medial and inferior vestibular nuclei of the rostral medulla, are essential for relaying 
vestibular input to the VRG and DRG (Bianchi and Pasaro, 1997).  
 
1.6.1.3 Sleep and Arousal 
The need for a functioning arousal system during potentially fatal respiratory or cardiac 
challenges during sleep in SIDS has focused attention to the mechanisms that regulate arousal. 
Arousal is mediated by several neurotransmitter systems, which together comprise the 
“ascending reticular activating system (ARAS)” (Kinney et al., 1992). This arousal system is a 
portion of the reticular formation, defined by physiological criteria (Nolte, 1993). Neuronal 
populations included in this system and play a role in arousal control are the pontine nuclei     via 
cholinergic projections, the rostral raphe complex (RR)    via serotonergic projections, and the 
locus coeruleus (LC)      via noradrenergic projections.  
 
Sleep in humans is divided into two states, non-rapid eye movement (NREM) and rapid eye 
movement (REM) sleep. NREM sleep involves depression of the ARAS through inhibitory 
neuronal populations in the NTS, area postrema and reticular formation of the lower medulla 
(Vertes, 1990; Messier et al., 2002). REM sleep on the other hand, is controlled by the pontine 
neurons, where it has been shown that inhibition of these neurons resulted in an enhanced active 
REM sleep state in the rat (Ahnaou et al., 2000; Xi et al., 1999). 
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Fig. 1.3: The human brainstem and representative sections at 4 different levels  
a) Dorsal view of the brainstem showing the reticular formation (shaded grey), and 3 divisions; midbrain, pons and 
medulla. b) Lateral view of the brainstem showing the predominant cardiovascular (adapted from Dampney, 1994) 
and c) respiratory centres (adapted from Bianchi and Pasaro, 1997). Representative coronal sections at the level of 
d) rostral pons, e) caudal pons, f) rostral medulla (open medulla) and g) caudal medulla (obex or closed medulla). 
Abbreviations in alphabetical order: Abd, abducens nucleus; Acc olv, accessory olivary nucleus; AN, arcuate 
nucleus; AP, area postrema; CC, central canal; Cun, cuneate nucleus; CVLM, caudal ventral lateral medulla; DLF, 
dorsal longitudinal fasciculus; DMNV, dorsal motor nucleus of the vagus; DRG, dorsal respiratory group; Fac, 
facial nucleus; Gr, gracile nucleus; ICP, inferior superior peduncle; ION, inferior olivary nucleus; iVest, inferior 
vestibular nucleus; KF, Kölliker Fuse; Lat cun, lateral cuneate; LRt, lateral reticular nucleus; LC, locus coeruleus; 
ML, medial lemniscus; MLF, medial longitudinal fasciculus; mVest, medial vestibular nucleus; NA, nucleus 
ambiguus; NSTT, nucleus of the spinal trigeminal tract; NTS, nucleus of the tractus solitarus; PAG, periaqueductal 
gray nucleus; PBC, parabrachial complex; Pon, pontine nuclei; Pyr, pyramids; pyr T, pyramidal tract; RR, rostral 
raphe complex; RVLM, rostral ventral lateral medulla; SCP, superior cerebellar peduncle; Vest, vestibular nucleus; 
VRG, ventral respiratory group; XII, hypoglossal nucleus. 
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1.6.2 Cerebral Anatomic Neuropathology 
1.6.2.1 Brain weight 
The question of whether brain weight is greater in SIDS victims has been controversial with 
evidence both for and against this. Studies report that SIDS victims have heavier brain weights at 
autopsy compared with control infants (Shaw et al., 1989, Kinney et al., 1991). However, it is 
also possible that SIDS brain weight may represent the true normal weight spectrum. SIDS 
victims are not clinically ill prior to death, whereas infants dying of known causes, even without 
neurological disease, may have other factors which could affect brain growth and thereby give 
inaccurate “standards” for comparison (Shaw et al., 1989).  
 
It remains possible that brain weight is disproportionately increased in SIDS victims at death 
(Kinney et al., 1992). This is supported by data comparing brain weight amongst groups and 
accounting for the head circumference, body weight and body length at death. This analysis 
showed that brain weight was significantly heavier in SIDS than controls when adjusted for body 
length, suggesting that there is a true development disorder of brain size in SIDS victims (ie. 
megalencephaly). 
 
In contrast, a recent study specifically comparing brain weights between SIDS infants (n=125) 
and previously healthy infants who had died abruptly, or without warning, of known causes 
(non-SIDS, n=38), found no evidence of greater brain weight among the SIDS infants (Falck and 
Rajs, 1995). A similar observation was reported by Sparks et al., (1996). It seems that with 
improved dataset selections, increased brain weight is not a true abnormality in SIDS. 
 
1.6.2.2 Delayed CNS myelination 
An original study by Kinney et al., (1991) reported significantly delayed myelination in 25 of 62 
white matter sites examined in SIDS cases. This delayed myelination preferentially affected 
pyramidal and cerebellar (somatomotor) systems, and prefrontal-temporal-limbic (viceromotor) 
regions, in particular, the temporal lobe at the level of the lateral geniculate nucleus, the 
cingulum and the anterior commisure. The involvement of the somatomotor system is of 
particular interest considering its control of motility (i.e. body movement), whilst the 
visceromotor system is integrated with the state- modulation of cardiac and ventilatory function 
(Kinney et al., 1991). These investigators state that although their data supports the concept of 
delayed maturation in SIDS, their findings are more likely to be an effect, rather than cause, of 
the disorder; taking into consideration that the changes may be non-specific or secondary to 
hypoxia-ischemia.  
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1.6.2.3 Hippocampal damage  
The hippocampus is an hypoxia sensitive region in the brain (Pokorny and Trojan, 1986). Thus, 
changes within the hippocampus would suggest the involvement of hypoxia induced 
mechanisms. The first study of the hippocampus in SIDS infants was conducted in 1991, where 
it was reported that there was an increase in neurons immunoreactive for Alz-50 (a marker of 
neurodegeneration) in the SIDS infant hippocampus compared to non-SIDS controls (Sparks and 
Hunsaker, 1991). This finding was later confirmed by the same investigators in a dataset three 
times larger (Sparks et al., 1996). Further confirmation of increased Alz-50 in the hippocampus 
of SIDS infants was reported later by an independent group (Oehmichen et al., 1998).   
 
In line with these observations, a study conducted on a Canadian population of infants consisting 
of 29 SIDS cases and 9 controls, found apoptosis, marked by terminal 
deoxynucleotidyltransferase-mediated dUTP-biotin nick end labelling (TUNEL), was 
significantly increased in the SIDS hippocampus (Waters et al., 1999).  The interesting finding 
from this study was that the distribution of apoptosis in the hippocampus was in hypoxia-
sensitive subregions, which is consistent with the hypothesis that SIDS victims have had prior 
exposure to hypoxia.   
 
1.6.3 Brainstem Anatomic Neuropathology 
1.6.3.1 Gliosis 
Interest in the brainstem of SIDS infants began with Naeye’s 1976 report of astrogliosis in 50% 
of all SIDS cases. Although this gliosis was found in the medullary and pontine reticular 
formation that controls respiration, Naeye concluded that these changes were not the cause of 
SIDS but rather were secondary to chronic hypoxia or to repeated episodes of acute hypoxia. 
This finding of gliosis has since been confirmed in the reticular formation by other researchers 
(Kinney et al., 1983; Yamanouchi et al., 1993; Sparks et al., 1996) who have also reported 
gliosis in NTS, DMNV and ION as well.  
 
1.6.3.2 Dendritic spines 
Normally, the density of dendritic spines in the infant brain decreases with age (Valdes-Dapena, 
1992). However, an increased number of dendritic spines in respiratory brainstem centres has 
been reported in SIDS victims (Quattrochi et al., 1980 and 1985). This elevated level has been 
interpreted as evidence for delayed brainstem maturation (Becker, 1990). The elevated spine 
density was notable in neurons in the XII nucleus, DMNV, the cervical anterior horn, the 
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ventrolateral medulla and the reticular formation. This suggests that these findings not only 
reflect a delay in neuronal maturation but may also be related to developmental disorders of 
respiratory, circulatory or sleep wake regulation given the nuclei in which this abnormality was 
observed (Takashima and Becker, 1985). 
 
1.6.3.3 Degenerative changes  
No definitive conclusions have been made as to whether degenerative changes, observed by 
measuring the volume, length, cell number, density and hyperplasia of nuclei, are present in the 
SIDS medulla when compared to non-SIDS controls. One group of researchers found that in 
SIDS, the total volume of the XII nucleus increased faster with age, and was translated into a 
decrease in neuron density of the XII nucleus without any change in the total number of neurons 
(O'Kusky and Norman, 1992). In a follow up study, the same group demonstrated an increase in 
the absolute number of synapses in the XII nucleus of SIDS infants although the density of 
synapses did not differ (O'Kusky and Norman, 1995).  
 
In contrast, a different group of researchers found that there was no difference in the length, 
volume or number of neurons in the XII nucleus and DMNV (Konrat et al., 1992), nor in any 
other nuclei (Lamont et al., 1995) when comparing SIDS to non-SIDS infants. In direct 
opposition, this group found neuron density to be decreased in the XII and DMNV of their SIDS 
cases (Konrat et al., 1992), but astrocyte number and size were unchanged (Pamphlett and 
Treloar, 1996). A similar finding of unchanged number and density of astrocytes has recently 
been reported in the ION of SIDS infants when compared to age-matched controls (Kinney et 
al., 2002).  
 
Hypoplasia of the arcuate nucleus (AN) has been reported in some SIDS infants. A study of 41 
SIDS cases found AN hypoplasia in two of these cases (Filliano and Kinney, 1992) while a study 
of 14 SIDS cases reported AN hypoplasia in one of their cases (Mallard et al., 1999). Because of 
the small number of cases in which AN hypoplasia has been reported in SIDS infants, its 
significance and specificity in the neuropathogenesis of SIDS is unclear. It has been argued that 
a finding of hypoplasia in the three cases mentioned above should have resulted in a diagnosis of 
a congenital defect rather than SIDS, since an anatomical anomaly such as this is known to cause 
death in itself (Guntheroth and Spiers, 2002). This was demonstrated by Matturri et al., (2002) 
who found hypoplasia in nine stillbirth cases for which they described the anomaly as a “primary 
developmental defect”. 
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1.6.3.4 Neuronal cell death - Apoptosis 
To date, 4 studies have looked for changes in neuronal cell death markers in the brainstem of 
SIDS infants (Sparks et al., 1996; Oehmichen et al., 1998; Waters et al., 1999; Sawaguchi et al., 
2002). Using Alz-50 as a marker, Sparks et al., (1996) found an increase in Alz-50 
immunoreactive neurons in regions of the dorsal medulla (mid medulla level) in SIDS infants 
when compared to the controls. They proposed that this increase in Alz-50 reflected an increase 
in apoptotic neurodegeneration in SIDS. These findings were later confirmed independently by 
Oehmichen et al., (1998) who also found increased Alz-50 in the medulla of a different SIDS 
dataset.  
 
Using TUNEL as a specific marker for apoptosis, Waters et al., (1999) were the first to report 
that apoptosis was increased in SIDS infants compared to non-SIDS cases, in both the medulla of 
the brainstem, and the hippocampus. Of the 29 SIDS cases, 96% showed an increase in TUNEL 
positive neurons. The distribution of this increase was mostly in dorsal nuclei of the medulla 
(NSTT and vestibular nuclei) at both the caudal and rostral levels, and CA1 and CA4 hypoxia 
sensitive regions of the hippocampus. Due to the particular distribution of the apoptosis, the 
authors interpreted the data as providing a link between apoptosis and hypoxia, and possibly the 
prone sleeping position (given that the NSTT and vestibular nuclei are involved in sensory relay 
of body movement and sensation), as a significant risk factor for SIDS.  
 
A recent quantitative analysis of TUNEL staining in glial cells of the periaqueductal gray matter 
at the midbrain level (Sawaguchi et al., 2002) showed that SIDS infants had a greater number of 
TUNEL positive glial cells compared to controls. This increase was associated with a high 
frequency of obstructive apneas documented in the same infants during life. Given that the 
midbrain periaqueductal gray matter is associated with the “visceral alerting response”, this 
group concluded that their findings indicated a possibility of disfunction within the arousal 
pathway. 
 
1.6.4 Brainstem Chemical Neuropathology 
Studies for neurochemical abnormalities in the brainstem of SIDS infants were initiated in the 
1980’s. The rationale is that functional deficits may be present without gross anatomical 
neuropathology. The neurotransmitters selected for study had their functional role in the 
brainstem established in prior animal studies. For example, serotonin (5HT) and acetylecholine 
(Ach) were found to facilitate respiration (Dev and Loeschcke, 1979; Millhorn et al., 1980) 
whereas epinephrine (Epi), otherwise known as adrenaline, and norepinephrine (NE), also 
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known as noradrenaline, depressed respiration (Champagnat et al., 1979). For blood pressure 
and cardiac control, 5HT/Ach and Epi/NE interacted in opposition to one another (Telang and 
Ng'ang'a, 1975; Dev and Loeschcke, 1979). Furthermore, it was shown that 5HT, Epi and NE 
were also involved in sleep organization (Masserano and King, 1982; Gaillard, 1983). Dopamine 
was found to be involved in stimulating respiration while the peptide neuromodulators substance 
P (SP) and endogenous opioids (endorphins and enkephalins) were found to be involved in 
central control of respiration (Henry and Sessle, 1985; Moss et al., 1986). More specific roles for 
these neurotransmitters and modulators according to their particular brain stem location have 
since been identified and can be found in many recent neuroanatomy text books, but because this 
is still an evolving field, many more roles are yet to be determined. 
 
The first report on the neurochemical abnormalities in the SIDS brainstem was in 1983. All 
neurochemical findings since then have been summarised in Table 1.3. The enzymes, 
transmitters or ligands analysed have been tabulated under one of the following 5 categories: 
catecholamine, neuropeptide, acetylcholine, indole amine and amino acid. The order in which 
they are presented represents the trend and time sequence in which the neurotransmitters were 
studied over the last 25 years. The specific neurotransmitter and/or receptor analysed has been 
specified, as has its general functional significance. The experimental methods employed are 
restricted to one of the following three:  
1- biochemical analysis using a radioimmunological assays (RIA) which involves 
homogenizing tissue to determine protein content,  
2- immunohistochemistry (IHC) where tissue sections are stained and either qualitatively or 
quantitatively analysed and  
3- radioactive ligand binding (RLB) which involves studying a radioactively labelled 
receptor ligand binding to the receptor of interest. The level of binding is determined by 
the amount of radioactivity emitted.  
Earlier studies mainly employed the RIA method, whereas recent studies have moved to employ 
IHC and RLB methods (Table 1.3). Although many of the studies were conducted at the level of 
the medulla, other parts of the brainstem have been studied.  
 
Early studies compared SIDS infants to all infants who had died from a known cause and who 
were denoted as controls. Recent studies have now separated this control group into two; one 
comprising infants who died of a known cause and who had experienced acute hypoxia (acute 
controls) while the other comprising infants who had experienced chronic hypoxia (chronic 
controls) prior to death. The purpose for this separation of the control group is to rule out chronic 
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hypoxia prior to death as a contributing factor for the neuropathological changes observed in 
SIDS infants.  
 
Changes in each of the five neurotransmitter categories have been found in the SIDS brainstem 
but no definitive conclusion can be made with regards to these findings since most of them have 
not yet been verified or the results have been inconsistent amongst studies, mostly due to 
differences in experimental methodologies. An important emerging distinction is whether the 
abnormalities reflect aetiological factors for SIDS or whether they are also a consequence of the 
risk factors associated with SIDS. Thus, it seems likely that the changes, which in most of the 
studies have actually been stated as being present in “some” and not all of the SIDS infants, are 
caused by associated risk factors. Regardless, there is now a body of evidence to support the 
contention that neurochemical pathologies exist in the SIDS brainstem, and that these affect 
regions known to be involved in respiratory, cardiac, sleep and arousal control (Table 1.3). Some 
of the more convincing findings in the SIDS brainstem compared to non-SIDS (based on the 
reproducibility of the results and moderate number of cases studied) include: 
• Of the catecholamines, a decrease in tyrosine hydroxylase (TH). Although two 
studies showed no changes in TH (Ozand and Tildon, 1983; Kopp et al., 1993), 
two other independent studies found it to be decreased in several nuclei of the 
medulla including the DMNV and NTS (Obonai et al., 1998; Ozawa et al., 1999).  
• Of the neuropeptides, an increase in substance P (SP). Three out of four studies 
showed an increase in SP in the medulla (Bergstrom et al., 1994; Obonai et al., 
1996) and pons (Yamanouchi et al., 1993). This increase seemed to be specific to 
nuclei of the trigeminal system (Yamanouchi et al., 1993; Obonai et al., 1996). 
• Of the acetylcholinergic system, a decrease in muscarinic receptor binding 
(Kinney et al., 1995) and number (Kubo et al., 1998), specifically in the AN. A 
third study (Mallard et al., 1999) showed there to be no differences but was 
restricted in that they only studied for one receptor subtype. 
• Of the amino acids, a decrease in kainite receptor binding specifically in the AN 
(Panigrahy et al., 1997). This is the only study to date, concerning the amino 
acids. 
• Of the indole amines, a decrease in serotonin receptor binding (Panigrahy et al., 
2000a) and expression (Ozawa and Okado, 2002) in the medulla and pons.  
 
Table 1.3: Summary of all neurochemical pathologies identified in the SIDS brainstem to date. 
Enzyme, transmitter or ligand 
analysed  
Specific neurotransmitter 
and receptor system  
General Functional 
significance 
Method & level of 
brain stem 
# of cases 
SIDS:Controls 
Results: SIDS vs Controls References 
Catecholamines       
     COMT (catechol-o-  
      methyl transferase) 
Catabolises catacholamines Respiratory control RIA; whole 
brainstem 
30:20 No difference Ozand and 
Tildon 1983 
     Dopa  decarboxylase Converts l-dopa to dopamine; 
dopaminergic 
Respiratory control 
 
RIA; whole 
brainstem 
30:20 No difference Ozand and 
Tildon 1983 
     DBH (Dopamine-beta-  
     hydroxylase) 
Converts dopamine to 
norepinephrine;  
Respiratory control RIA; whole 
brainstem 
30:20 No difference Ozand and 
Tildon 1983 
 dopaminergic  RIA; medulla & 
pons 
28:9 ↓ in NA & medullary C2 (area of 
NTS & DMNV)  
Denoroy et al., 
1987 
    TH (tyrosine hydroxylase) Converts tyrosine to l-dopa: 
the rate limiting step in  
Respiratory control 
 
RIA; whole 
brainstem 
30:20 No difference Ozand and 
Tildon 1983 
 dopamine synthesis; 
dopaminergic 
 IHC; medulla &  
pons 
9:5 No difference Kopp et al., 
1993 
   IHC; midbrain, 
pons & medulla 
22:13 ↓ in DMNV, area reticularis 
superficialis ventrolateralis, NTS  
Obonai et al., 
1998 
   IHC; midbrain, 
pons & medulla 
37:20 ↓ in DMNV & area reticularis 
superficialis ventrolateralis  
Ozawa et al., 
1999 
     PNMT (phenethalolamine- 
     N-methyl transferase) 
Converts norepinephrine to 
epinephrine; adrenergic 
Respiratory control RIA; medulla & 
pons 
28:9 ↓ in medullary C2 (area of NTS & 
DMNV), NA & nucleus centralis  
Denoroy et al., 
1987 
         IHC; medulla & 
pons 
9:5 Absent in the dorsal part of NTS  Kopp et al., 
1993 
      3H-PAC 
     (Para-amino-clonidine) 
norepinephrine and 
epinephrine; adrenergic 
Respiratory control RLB; medulla  10:10 No difference Mansouri et al., 
2001 
Neuropeptides       
    NPY (Neuropeptide Y) Co-transported with other 
neurotransmitters; No 
particular receptor 
Respiratory control RIA; medulla & 
pons 
12:9 No difference  Bergstrom et 
al., 1984 
     ME (met enkephalin) opioid Respiratory & 
autonomic control 
RIA; medulla unknown No difference Kuich et al., 
1983 (abstract) 
   RIA; medulla & 
pons 
12:9 No difference Bergstrom et 
al., 1984 
C
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Enzyme, transmitter or ligand 
analysed  
Specific neurotransmitter 
and receptor system  
General Functional 
significance  
Method & level of 
brain stem 
# of cases 
SIDS:Controls 
Results: SIDS vs Controls References 
Neuropeptides continued       
     SP (substance-P) Co-transported with other 
neurotransmitters; No  
Respiratory control & 
chemoreception 
RIA; medulla & 
pons 
12:9 ↑ in medulla Bergstrom et 
al., 1984 
 particular receptor  IHC; pons 20:7 ↑ in trigeminal fibres of the pons Yamanouchi et 
al., 1993 
   IHC, medulla 15:8 ↑ in NTS and NSTT Obonai et al., 
1996 
   RLB; medulla 9:24 No difference Jordan et al., 
1997 
      3H-Naloxone opioid Respiratory & 
autonomic control, 
opioids as a risk factor 
RLB; medulla and 
pons 
45: 14 Acute 
& 15 Chronic 
Controls 
No difference  Kinney et al., 
1998 
      125I-Tyr3 Neurotensin Respiratory control RLB; medulla 7:6 ↑ in NTS Chigr et al., 
1992 
      125I-Somatostatin Somatostatin Respiratory & blood 
pressure control 
RLB; medulla 7:6 No difference Chigr et al., 
1992 
 [125I-Tyr0,D-Trp8] 
  somatostatine-14 
Somatostatin Respiratory & blood 
pressure control 
RLB; medulla and 
pons 
11:6 ↑ in Medial and lateral 
parabrachial nuclei 
Carpentier et 
al., 1998 
Acetylcholine       
     3H-QNB 
    (Quinuclidinyl benzilate) 
muscarininc chemoreception RLB; medulla and 
pons 
45: 14 Acute 
& 18 Chronic 
Controls 
↓ in AN compared to both control 
groups 
Kinney et al., 
1995 
     mAchR (mucarinic acetyl  
     choline receptor) 
muscarininc chemoreception Quantitative IHC; 
medulla 
unknown ↓ number of positive neurons in 
AN 
Kubo et al., 
1998 (abstract) 
     mAchR2 muscarininc receptor 2 chemoreception Quantitative IHC; 
medulla 
14:9 No difference Mallard et al., 
1999 
     3H-Nicotine nicotinic Autonomic control, 
nicotine as risk factor  
RLB; medulla and 
pons 
45: 14 Acute 
& 15 Chronic 
Controls 
No difference compared to both 
control groups 
Nachmanoff et 
al., 1998 
     CHAT (choline acetyl  
      transferase) 
Catalyzes acetylcholine chemoreception Quantitative IHC; 
medulla 
14:9 ↓ number of positive neurons in 
XII & DMNV, ↓ optical density 
in XII 
Mallard et al., 
1999 
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Enzyme, transmitter or ligand 
analysed  
Specific neurotransmitter 
and receptor system  
General Functional 
significance  
Method & level of 
brain stem 
# of cases 
SIDS:Controls 
Results: SIDS vs Controls References 
 Amino acid       
     3H-Kainate Glutamate; kainate chemoreception RLB; medulla and 
pons 
47: 14 Acute 
& 17 Chronic 
Controls 
↓ in AN Panigrahy et 
al., 1997 
Indole amine       
      3H-LSD (lysergic acid  
     diethylamide) 
Serotonin; serotonergic 
receptors (5-HT1A-D & 5-HT2) 
Respiratory, sleep & 
arousal control 
RLB; medulla and 
pons 
52: 14 Acute 
& 17 Chronic 
Controls 
↓ in AN, ION, nucleus 
giantocellularis, nucleus raphe 
obscurus & IRZ 
Panigrahy et 
al., 2000a 
     5-HT1A Serotonin; serotonergic  Respiratory, sleep & 
arousal control 
IHC; midbrain, 
pons & medulla  
31:25 ↓ in DMNV, NTS and VLM, ↑ in 
PAG 
Ozawa and 
Okado 2002 
     5-HT2A Serotonin; serotonergic  Respiratory, sleep & 
arousal control 
IHC; midbrain, 
pons & medulla  
31:25 ↓ in DMNV, NTS and VLM, ↑ in 
PAG 
Ozawa and 
Okado 2002 
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Abbreviations: AN, arcuate nucleus; DMNV, dorsal motor nucleus of the vagus; IHC, immunohistochemistry; ION, inferior olivary nucleus; IRZ, intermediate 
reticular zone; NA, nucleus ambiguus; NSTT, nucleus of the spinal trigeminal tract; NTS, nucleus of the tractus solitarus; PAG, periaqueductal grey; RIA, 
radioimmunological assay; RLB, radioactive ligand binding; VLM, ventral lateral medulla; XII, hypoglossal nucleus. 
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1.7 Prenatal versus Postnatal origin  
Many neurotransmitter systems and pathways are still developing or being refined in the period 
after birth. If prenatal insults were experienced, any abnormalities in the neurotransmitter 
systems might not become apparent for several months or years thereafter. An extreme example 
of this is schizophrenia, where it is hypothesised that abnormal brain development in utero, 
coinciding with a genetic predisposition for the disorder, perhaps combined with other 
environmental factors, does not result in the manifestation of schizophrenia until late teenage or 
early adolescence (reviewed in Lewis and Levitt, 2002). A similar interpretation has been 
adopted for the neurochemical changes reported in the SIDS brainstem; that is, the risk for SIDS 
is of prenatal origin and leads to the sudden death of these infants during a vulnerable postnatal 
period (Kinney et al., 1992). However, it can also be argued that SIDS is of postnatal origin 
(Guntheroth and Spiers, 2002), and this is the hypothesis explored in this project. Note that 
ultimately, a combination of the two hypotheses may be relevant, for example a vulnerability 
created pre-natally, may need to be combined with a post-natal factor before it leads to full 
expression (either Schizophrenia, or SIDS). 
 
1.7.1 Infant studies suggesting postnatal origin 
Evidence from SIDS studies contradicting the notion that SIDS victims are born with brainstem 
abnormalities are as follows: 
1- Respiratory system of SIDS infants show no functional differences when compared to 
non-SIDS infants. 
a. Ventilatory recordings in infants who subsequently died of SIDS, demonstrated   
no difference compared to age-matched controls (Waggener et al., 1990). 
b. A study of 6914 normal infants showed no difference in frequency of either short 
or long apneic pauses among controls and 16 infants who subsequently died of 
SIDS during the first month of life, but a difference was found at 2 months of age 
(Schechtman et al., 1991).  
2- The age distribution of SIDS deaths. If, as it is argued, the occurrence of SIDS is related 
to a prenatal abnormality, then the distribution of age at death for these SIDS victims 
should resemble that of any other congenital anomaly; i.e., increased during the first 
month of life and decreasing thereafter (Guntheroth and Spiers, 2002). However, this is 
not the case with a peak incidence of SIDS deaths in the second to fourth months of life.  
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3- The non-specific risk of hypoxic exposure during pregnancy.   
a. Infants born from pregnancies where maternal anaemia and foetal hypoxia were 
contributing factors had greater non-SIDS than SIDS mortality rates (Based on 
Mortality Rates in the US, 1989-1991 as summarised by Guntheroth and Spiers, 
2002).  
b. The prenatal mortality after such pregnancies was more than 4 times higher than 
the postnatal mortality rate for all causes combined (Based on Mortality Rates in 
the US, 1989-1991 as summarised by Guntheroth and Spiers, 2002). Thus, any 
hypoxic exposure occurring in the prenatal period affects all infants equally and 
in a non-specific manner rendering infants susceptible to death both pre- and 
postnatally.  
c. Nicotine receptor binding in the SIDS infant brainstem is not different to that in 
non-SIDS infants (Nachmanoff et al., 1998), suggesting that prenatal exposure to 
cigarette smoke affects all infants equally.  
d. The presence of nicotine and cotinine in SIDS infants (half life of these 
substances being 12-16 hours) (Milerad et al., 1998), provides support that 
postnatal passive smoke exposure is an independent risk factor for SIDS 
(supported further by animal studies, see section 1.8.4).  
 
In addition, evidence that SIDS is most likely of postnatal origin can be derived from many 
animal studies of relevance to SIDS, which show that postnatal exposures in these animals are 
able to induce similar changes, be it physiological or neuropathological, as observed in SIDS 
infants. Such animal studies are reviewed below.  
 
1.8 Animal studies  
Animal models of human diseases or syndromes are very important in permitting the study of 
various facets of a disease. The selection of models is a difficult one because no single animal 
species adequately models the full range of human respiratory anatomy, physiology, neurology 
and age-related changes. However, with careful selection among the many species, strains, and 
comparative ages, animals can be selected to model most, if not all, of the individual factors 
hypothesized or found to be associated with the disease or syndromes of interest (Mauderly, 
2000). For SIDS, appropriate animal models can be developed to evaluate whether 
environmental factors can cause the abnormalities identified in SIDS infants. 
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1.8.1 The piglet  
The piglet has been identified as a clinically relevant animal model for postnatal developmental 
studies of cardiovascular control mechanisms (Gootman et al., 1986). This is because it has been 
found that newborn piglets share many common features with newborn babies. These include a 
similarity in cardiovascular anatomy and physiology (reviewed in Pond and Houpt, 1978; 
Gootman et al., 1986), of the structural and functional maturation of the pulmonary vasculature 
(Haworth and Hislop, 1981; Hall and Haworth, 1986), respiratory pattern behaviour and 
sleep/wake cycles (Scott et al., 1990).  
 
Of particular interest to this thesis is the similarity in brain development, where it was shown 
that the brain growth spurt, measured by brain weight, degree of myelination, and cellularity, 
begins at about midgestation in both the human and the pig compared to at birth in the rat and 
early gestation in the monkey. The percentage of adult brain weight achieved at birth was thus 
calculated to be 27% (human), 25% (pig), 12% (rat) and 76% (monkey), indicating that at birth, 
brain development in the pig more closely resembled that of the human compared with the rat or 
monkey (Dobbing and Sands, 1979). Extrapolating their data, Dobbings and Sands, 1979, further 
suggest that piglets from birth to approximately 4 postnatal weeks are equivalent to 0– 1 year of 
human age with respect to brain development, and are therefore, an excellent model for studying 
human infant related disorders.  
 
1.8.2 Piglet models of SIDS physiology 
Piglet models that have been developed for SIDS related research have focused on the 
physiological aspects associated with SIDS. These piglet models were developed to mimic 
environments that have been identified as increasing the risk of SIDS during a postnatal period. 
It should be mentioned that many other studies concerning the effects of hypoxia, hypercapnia 
and ischaemia, in acute or chronic phases, have been conducted in the developing piglet. These 
studies give important physiological findings that may be of significance for SIDS research but 
will not be discussed here because they are not directly relevant to SIDS. To date, the piglet has 
only been used to study the sleep environment with particular focus on the sleep position and 
thermal stress. These studies will be reviewed here. 
 
In one study concerning sleep position (Campbell et al., 1997), piglets were attached to a three 
month old baby mannequin head that was placed face down in bedding surfaces by surgically 
implanting a breathing tube from the trachea of the piglet to the mannequin mouth. Piglets were 
allowed to re-breath for 1 hour and CO2 levels measured. Results showed an increase (by more 
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than 1%) in inspired CO2 levels in all 16 piglets that were studied (final CO2 levels reaching 
greater than 7%). Two out of the 16 piglets died during the experimental period. The authors 
concluded that the mechanism of death of their two piglets is rebreathing resulting from the 
prone sleeping position, a conclusion similarly reached by Kemp and Thach, (1993), who had 
used the exact model but in the rabbit. 
 
A series of studies by Galland et al., (1993, 1994 and 1996) have evaluated the relative effects of 
hyperthermia as compared to asphyxia by subjecting piglets to several experimental paradigms. 
When piglets were wrapped up and had their face exposed to different temperatures, it was found 
that facial hyperthermia could disrupt sleep patterns with characteristically more awakenings and 
less REM sleep (Galland et al., 1993). However, when piglets had their face covered with 
insulating material, it was found that the combination of hyperthermia and mild asphyxia did not 
disturb the sleep pattern (Galland et al., 1994). Yet, when piglets had their body wrapped up and 
their airways were obstructed by a fully closed nasal mask, or they experienced rebreathing of 
their own expired air from a mask attached to a closed tube, arousals from NREM were faster. 
Hyperthermia alone however, had no effect on arousal (Galland et al., 1996). After reviewing 
their findings, Galland et al., (1996) concluded that thermal stress alone is a risk factor for death 
during a sleep period in that it depresses arousal responses. 
 
In addition to the studies above by Gallands’ group, Elder et al., (1996) showed that thermal 
stress also affects normal cardiorespiratory functions. Exogenously induced hyperthermia in 
piglets resulted in an increase in the mean heart and respiratory rates, with a decrease in mean 
arterial pressure.  
 
Taken together, these physiological findings in the piglet models suggest that for at least a subset 
of SIDS infants, the mechanism of death is related to the prone sleeping position and to thermal 
stress, separately or in combination.  
 
1.8.3 Piglet models of SIDS brainstem chemical neuropathology 
The few studies to date of piglet models of SIDS which looked for comparative brainstem 
chemical neuropathologies as observed in SIDS infants, have been conducted by simply 
exposing piglets to gas mixtures of hypoxia (Yan et al., 1995; Waters et al., 1997a; Moss, 2000; 
Rodier et al., 2001) or hypercapnia (Ruggiero et al., 1999; Curran et al., 2000; Curran et al., 
2001; Messier et al., 2002), since both these conditions are considered relevant to, or 
representative of, the clinical risk factors for SIDS.  
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When piglets were exposed to acute hypoxia, it was found that met-enkephalin levels were 
increased in the NTS (Yan et al., 1995). However, after repeated (for 5 days) or isolated 
exposures to hypoxia, no changes in met-enkephalin in the NTS were observed, whereas 
substance–P levels were found to increase but only after the repeated exposure (Waters et al., 
1997a). Similarly, repeated hypoxia (for 6 days) resulted in an upregulation of the substance-P 
neurotachykinin 1 (NK-1) receptor in the NTS, DMNV, XII and NA (Rodier et al., 2001). Bax 
immunoreactivity was also reported to have increased in the XII nucleus after episodic hypoxia 
but was not associated with a change in the number of apoptotic neurons (labelled by TUNEL) 
(Moss, 2000).  
 
Artificially ventilating piglets to induce hypercapnia resulted in an increase in c-fos 
immunoreactivity in the area postrema (AP) of the medulla (Ruggiero et al., 1999). Thus, it was 
concluded that the AP participates in the chemoreceptor response to hypercapnia. Similarly, the 
rostral ventrolateral medulla (RVLM) in the piglet brainstem was also shown to contain neurons 
important for responding to systemic hypercapnia during wakefulness and NREM sleep (Curran 
et al., 2000 and 2001; Messier et al., 2002).   
 
Collectively, these studies (summarised in Table 1.4) are important in that:  
1- they show hypoxic and hypercapnic conditions in the postnatal period are able to induce 
changes in the piglet medulla similarly reported in the SIDS medulla. For example, the 
comparative finding that substance P is increased in the NTS of SIDS infants (Obonai et 
al., 1996) and after hypoxic exposure in the postnatal piglet (Waters et al., 1997a). 
2- they suggest the changes observed in the SIDS infants may have been due to hypoxic 
and/or hypercapnic conditions prior to death, and  
3- support the notion that SIDS brainstem imbalance may have been induced not only 
prenatally, but also postnatally. 
 
1.8.4 Other animal models of SIDS brainstem neurochemical pathology  
The rat and guinea pig are two other animal species used to investigate the effects of SIDS risk 
factors on brainstem neurochemical pathology. In contrast to the piglet models, studies in these 
species have largely focused on the effects of prenatal exposures, in particular the effects 
associated with maternal cigarette smoking. These studies are summarised in Table 1.4.   
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Some of these models have been successful in reproducing the same neurochemical changes as 
observed in some SIDS infants. The most significant ones, which provide comparative findings 
with those observed in the SIDS brainstem (as presented in Table 1.3 and section 1.6.4) include: 
• an increase in gliosis (identified by GFAP staining) in most nuclei of the medulla 
of the guinea pig models of low birth weight (Tolcos et al., 1997), thermal stress 
(Tolcos et al., 2000a), and maternal smoking (Tolcos et al., 2000b). 
• a decrease in tyrosine hydroxylase in the DMNV and NTS, specifically in the 
guinea pig model of maternal smoking (Tolcos et al., 2000a & b). 
• a decrease in muscarinic receptor binding in models of maternal and passive 
smoking (Slotkin et al., 1995 & 1999). 
Extrapolating from the latter two findings, it seems that the changes in TH and muscarinic 
receptors observed in SIDS infants, may actually be related to cigarette smoke exposure. This 
would require verification amongst SIDS infants (comparing those exposed to smoking with 
those that were not), and could be of potential importance in providing pathological proof of 
smoke exposure as a risk factor. 
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Table 1.4: Summary of animal models of SIDS risk factors and brainstem neurochemical 
pathologies comparative to SIDS brainstem findings. 
Model &/or SIDS risk factor 
mimicked 
Method and level of 
brainstem 
   Results References 
PIGLET    
    Postnatal hypoxia exposure RIA for ME; medulla- 
NTS only 
↑ ME in NTS Yan et al., 
1995  
    Postnatal hypoxia exposure RIA for ME & SP; 
medulla- NTS only 
↑ SP in NTS Waters et al., 
1997a 
    Postnatal hypoxia exposure RLB using [125I]SP for 
NK1 receptor; medulla 
↑ NK1 binding in NTS, XII, 
DMNV & NA. 
Rodier et al., 
2001 
    Postnatal hypoxia exposure IHC for Bax and TUNEL; 
medulla-XII  
↑ Bax in XII Moss, 2002 
    Postnatal hypercapnia IHC for c-fos; medulla –
AP only 
↑ c-fos in AP Ruggiero et 
al., 1999 
GUINEA PIG    
    Placental Insufficiency 
    [Low birth weight] 
IHC for ME, SP & GFAP 
(marker of gliosis); 
medulla 
↓ SP density in NSTT, ↑ SP counts 
in NTS, ↑ ME density in XII, ↑ 
ME counts in ventral RF, ↑ GFAP 
in DMNV, NTS and central canal.  
Tolcos et al., 
1997. 
    Postnatal hyperthermia     
    [Thermal stress] 
IHC for ME, SP, TH 
GFAP& 5-HT;medulla 
↑ GFAP in AP, ↓ ME density in 
XII & AP. 
Tolcos et al., 
2000a. 
    Prenatal Carbon Monoxide   
    (CO). [Maternal smoking] 
IHC for ME, SP, TH 
GFAP, 5-HT, ChAT & 
m2; medulla 
↓ density of TH in NTS, DMNV, 
AP & VLM; ↑ ChAT density in 
DMNV & XII. 
Tolcos et al., 
2000a & b. 
    Combined Prenatal CO &    
    Postnatal hyperthermia. [Thermal  
    stress & Maternal smoking] 
IHC for ME, SP, GFAP, 5-
HT & TH; medulla 
↑ GFAP in AP, XII, NTS, DMNV 
& ventral RF; ↑ 5-HT density in 
NTS, DMNV & XII. 
Tolcos et al., 
2000a. 
RAT    
    Postnatal hypoxia HPLC for NE; whole 
brainstem  
No changes Slotkin et al., 
1995 
    Prenatal nicotine infusion  
    [Maternal smoking] 
HPLC for NE; RBA for 5-
HT, mAch1 & mAch2 
receptors; whole brainstem 
No changes for NE, ↑ PXT 
binding, ↓ mAch2 binding 
Slotkin et al., 
1995 & 
1999; Xu et 
al., 2001 
   Combined prenatal nicotine  
   & postnatal hypoxia. 
   [Maternal smoking & hypoxia] 
HPLC for NE; whole 
brainstem  
↑ release of NE Slotkin et al., 
1995 
    Postnatal nicotine infusion  
    [Passive smoking] 
RBA for mAch1 & mAch2 
receptors; whole brainstem 
↓ mAch2 binding Slotkin et al., 
1999 
    Prenatal exposure to ETS  
    [Maternal smoking] 
RIA for PKC (α- δ) & 
NOS (e & n); medulla 
↓ PKC-χ & PKC- δ, ↓ nNOS Hasan et al., 
2001 
    Prenatal, Postnatal, separate & 
     combined exposure to ETS 
    [Maternal &/or passive smoking] 
RBA for mAch2, nicotinic 
& β-adrenergic receptors; 
whole brainstem 
No changes under any conditions 
for any of the receptors 
Slotkin et al., 
2001 
Abbreviations: ALB, autoradiography ligand binding; AP, area postrema; ChAT, choline acetyl transferase; 
DMNV, dorsal motor nucleus of the vagus; ETS, Environmental tobacco smoke; GFAP, gliofilament acid protein; 
HPLC, high performance liquid chromatography; IHC, immunohistochemistry; m2, muscarinic 2 receptor, mAch, 
muscarinic acetylcholine receptor; ME, met-enkephalin; NE, norepinephrine (noradrenaline); NK1, substance-P 
neurotachykinin 1 receptor; NOS, nitric oxide synthase; NSTT, nucleus of the spinal trigeminal tract; NTS, nucleus 
of the tractus solitarus; PKC, protein kinase C; RBA, Receptor binding assay; RIA, radioimmunological assay; RF, 
reticular formation; RLB, radioactive ligand binding; SP, substance-P; TH, tyrosine hydroxylase, VLM, ventral 
lateral medulla; XII, hypoglossal nucleus; 5-HT, serotonin receptor.  
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1.9 The Glutamatergic Neurotransmitter System 
The immature brain undergoes remarkable changes in organisation during fetal and postnatal 
development. Some of these changes include pruning of the surplus interneuronal connections 
(synapses) generated prenatally, and changes in the organisation of some neurotransmitters and 
their receptors (McDonald et al., 1990). These changes are thought to be responsible for the 
vulnerability of the brain to injury during development. One group of neurotransmitters that are 
responsible for vulnerability of the developing brain to neuronal injury are the excitatory amino 
acids (EAA), namely glutamate, aspartate and glycine (Johnston et al., 1995). Excessive 
excitation, referred to as excitotoxicity, can stimulate ionic currents through ion channels in 
synaptic membranes and result in the destruction of a neuron. This synaptic ‘overload’ is most 
likely to occur during periods of energy failure (eg hypoxia and ischaemia) when excessive 
amounts of excitatory neurotransmitters are released, but compensatory rescue mechanisms 
located in the neuronal membrane are underpowered (Choi, 1990). The glutamatergic system 
predominates in this process of excitotoxicity and so from here on, discussion will focus on the 
glutamatergic system and how it contributes to excitotoxicity.  
 
Glutamate (Glu) is the major excitatory neurotransmitter in the CNS, being utilised by as many 
as 70% of the synapses in the brain. During development Glu, by means of its receptors, plays a 
differential but important role in each of the processes of neurotransmission, neuronal 
maturation, and plasticity. It is also a potent excitotoxin when its receptor subtypes are 
overstimulated. There are at least 5 glutamate receptor subtypes, namely: 
1- NMDA: N-methyl-D-aspartate 
2- AMPA: α-amino-3-hydroxy-5-methyl-4-isoxazole-4-propionate 
3- KA: Kainate 
4- L-AP4: L-2-amino-4-phosphonobutanoic acid and 
5- trans- ACPD: 1S, 3R-trans-1-amino-cyclopentyl-1,3-dicarboxylate 
 
These can be categorised into 2 groups:  
1-  Ionotropic receptors: NMDA and non-NMDA (AMPA and KA), which contain integral 
cation-specific ion channels and 
2-  Metabotropic receptors: L-AP4 and trans-ACPD, which function by intracellular signalling 
through G proteins. 
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The distribution, electrophysiology and molecular characteristics of these receptors change 
markedly throughout brain development. It has recently been shown in the human brainstem that 
amongst the ionotropic receptors, NMDA receptor binding is increased in the infant period, 
whereas AMPA and kainate receptor binding are elevated during midgestation and decrease 
thereafter (Panigrahy et al., 2000b). The conclusion from data thus far is that in the infant brain, 
NMDA receptors dominate and are responsible for neuronal maturation and plasticity, while 
AMPA and kainate receptors are responsible for neurotransmission (Panigrahy et al., 2000b; 
Herlenius and Lagercrantz, 2001). Moreover, this predominant NMDA receptor expression in 
the infant period was observed in sites vulnerable to hypoxia, suggesting excitotoxicity mediated 
via the NMDA receptor is more likely in the infant brain compared to the adult brain. Given that 
SIDS occurs during the infant period, the NMDA receptor is an excellent candidate for study in 
the SIDS brainstem.   
 
1.9.1 The NMDA receptor  
NMDA receptors exist as heteromeric complexes containing the NR1 subunit combined with one 
or more NR2 or NR3 subunits. There are at least eight splice variants of the NR1 subunit 
(NR1A-NR1H) (Nakanishi et al., 1992), four genetically different NR2 subunits (NR2A-NR2D) 
(Monyer et al., 1992; Ishii et al., 1993) and to date, two genetically different NR3 subunits 
(NR3A, NR3B) (Nishi et al., 2001).  
 
The extent of NMDA receptor mediated processes depends on the ontogeny of the NMDA 
receptor subunits and binding sites. The NR1 subunit is an obligatory component of functional 
NMDA receptors (Petralia et al., 1994). For NMDA receptor activation, the NR1 subunit 
requires the binding of the co-agonist, glycine (Hirai et al., 1996; Wood et al., 1997), whereas 
the NR2 subunits require binding of L-glutamate (Laube et al., 1997). Pharmacologically distinct 
binding sites identified as regulating NMDA receptor activation (Fig. 1.4) include:  
1- a neurotransmitter binding site or recognition site which binds glutamate or NMDA,  
2- a co-activator site which binds glycine,  
3- a channel site that binds MK-801 in its open state,  
4- a voltage-dependent Mg2+ site,  
5- a polyamine site that binds spermine and spermidine,  
6- an ifenprodil site, and 
7- an inhibitory divalent cation site that binds Zn2+ (Monaghan et al., 1989).  
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The NMDA receptor also possesses a cation-selective ion channel that gates Na+, K+ and Ca2+ 
ions. This channel is regulated by Mg2+, which serves to block Ca2+ influx in a voltage-
dependent manner (Mayer et al., 1984). The influx of Ca2+ appears to be the initiating step for 
biochemical processes responsible for both NMDA receptor induced plasticity in the developing 
brain (Collingridge et al., 1987) and NMDA receptor mediated excitotoxicity (Ikonomidou et 
al., 1999).  
 
 
 
 
 
 
 
 
Fig. 1.4: A schematic of the NMDA receptor. 
This figure illustrates the pharmacologically distinct binding sites and cation selective ion channel of the 
NMDA receptor (refer to text, section 1.9.1) (Adapted from Mishra et al., 2001).  
 
1.9.2 Excitotoxicity 
Excitotoxicity is a pathological phenomenon induced by over stimulation of glutamate receptors. 
Excitotoxic mechanisms are initiated by an abnormal accumulation of extracellular glutamate, 
which commonly occurs during energy failure. Both astrocytes and neurons are involved in this 
process, since they are responsible for the formation, uptake and release of glutamate. Astrocytes 
take up glutamate and convert it to glutamine through the action of glutamate synthase, an 
enzyme requiring ATP. Glutamine is then released for uptake by neurons where it is reconverted 
back to glutamate via the action of glutaminase. Therefore, during energy failure (i.e. deficiency 
of ATP) the conversion of glutamate to glutamine in astrocytes is impeded resulting in increased 
intracellular glutamate. Astrocytes then act to release the glutamate by reversing the glutamate 
transporter causing increased extracellular glutamate levels. Excessive uptake of glutamate by 
neurons, via the receptors, will result in excitotoxic damage and ultimately death of these 
neurons (Lipton et al., 1994). Fig. 1.5 illustrates the mechanisms responsible for the abnormal 
accumulation of glutamate. 
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Fig. 1.5: Mechanisms responsible for abnormal accumulation of glutamate. 
1- In astrocytes, glutamate is normally taken up. However, when there is a collapse in the gradients for 
Na+ and K+ across the cell membrane, as occurs during energy failure, the transporter operates in reverse 
becoming a source of extracellular glutamate.  
2- In neurons glutamate is released from presynaptic vesicles by exocytosis to excite postsynaptic 
neurons. However, increased extracellular glutamate from other sources may enhance vesicular release.  
3- Both neurons and astrocytes contain large amounts of glutamate that would be expected to leak out of 
injured cells. (Adapted from Lipton et al., 1994) 
 
Excitotoxicity is responsible, at least in part, for the neuronal death that occurs after ischaemic 
brain injury and other certain neurodegenerative diseases (Portera-Cailliau et al., 1997). In vitro 
and in vivo studies in the CNS suggest excitotoxicity results in both apoptotic and necrotic 
neuronal death depending on the duration and intensity of the initiating insult and the age of the 
neuron. A mild excitotoxic insult leads to transient mitochondrial depolarization and reversible 
energy compromise resulting in apoptosis. Intense injury on the other hand, produces irreversible 
mitochondrial depolarization and permanent energy collapse resulting in necrosis (Portera-
Cailliau et al., 1997; Tenneti and Lipton, 2000). 
 
Studies have shown that immature neurons are more prone to apoptotic death whereas mature 
neurons tend to undergo necrosis (Yue et al., 1997; Portera-Cailliau et al., 1997). Neurons 
mature at different rates, but it is thought that many neurons during the postnatal developmental 
(infant) period are of the immature type. Thus, apoptosis is the likely form of cell death during 
development, and has been identified in SIDS infants (see section 1.6.3.4).  
 
1.10 Cell Death- Apoptosis 
The growth and maturation of neurons during early development is dependent on the presence of 
neurotransmitters and growth factors. When the interactions between neurons and their 
respective neurotransmitters and growth factors are disturbed, neurons undergo cell death.  
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Apoptosis is a form of cell death. It is the physiological process by which unwanted or useless 
cells are eliminated during development and is characterised by a number of morphological and 
biochemical features (as reviewed by Boehringer Mannheim, 1998). 
 
1.10.1 Morphological features 
• cell shrinkage and condensation- Apoptosis begins with shrinkage of the cytoplasm and 
condensation of the nucleus 
• pyknotic chromatin- chromatin becomes condensed (pyknotic) and packed into smooth 
masses applied against the nuclear membrane 
• little or no swelling of mitochondria or other organelles 
• karyohexis- break up of the nucleus into fragments, referred to as apoptotic bodies; 
considered to be the best cytological marker of apoptosis especially in isolated cells  
• fragmentation- Apoptosis ends with fragmentation of the cell into smaller bodies which are 
phagocytosed by macrophages 
 
1.10.2 Biochemical features 
• under genetic control- tightly regulated process involving activation (by chemical and 
physical agents) and enzymatic steps 
• energy (ATP) dependent- indicating that it is an active process 
• activation of the caspase cascade 
• release of various factors into the cytoplasm by the mitochondria 
• DNA fragmentation 
 
1.10.3 Apoptotic Pathway 
Many studies have reached the general conclusion that the key elements of the apoptotic 
pathway include the following:  
1-  Death receptors  
Apoptosis is induced via the stimulation of several different cell surface receptors in association 
with caspase activation. The Fas receptor ligand system is one example. Upon cross-linking by 
ligand or agonist antibody, the Fas receptor initiates a signal transduction cascade, precipitating 
caspase dependent cell death. 
2-  Membrane alterations 
In the early stages of apoptosis, changes occur at the cell surface and plasma membrane. One of 
these plasma membrane alterations is the translocation of phosphatidylserine (PS) from the inner 
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layer to the outer layer of the plasma membrane, whereby PS becomes exposed at the external 
surface of the cell. This action provides a signal that the cell is destined to die and allows 
macrophages to recognise a cell that is to be phagocytosed.  
3- Caspase cascade 
The caspases, a family of intracellular cysteine proteases (Cysteinyl- aspartate- specific 
proteinases) play a pivotal role in the initiation and execution of apoptosis induced by various 
stimuli (Stennicke and Salvesen, 1998). At least 11 different members of caspases in the 
cytoplasm of mammalian cells have been identified. Several of these are thought to mediate very 
early stages of apoptosis, one being caspase-3, also referred to as CPP32, Yama or apopain 
(Villa et al., 1997). The caspases are synthesized as pro-enzymes and their activation involves 
cleavage at aspartate residues. Once activated, they either cleave other caspases, activating the 
caspase cascade or specific proteins (proteolytic substrates). As a result, the cell is committed to 
die. Thus, as caspases are probably the most important effector molecules for triggering the 
biochemical events which lead to apoptosis, assays for determining caspase activation detect 
early apoptosis.  
4-  Mitochondrial changes 
Mitochondrial physiology is disrupted in cells undergoing either apoptosis or necrosis. However, 
during apoptosis, the mitochondrial membrane is disrupted resulting in the redistribution of 
cytochrome C to the cytosol followed by subsequent depolarisation of the inner mitochondrial 
membrane. The release of cytochrome C accelerates the process because it also leads to further 
promotion of caspase activation. 
5-  DNA fragmentation 
The final biochemical indicator of apoptosis is the fragmentation of the genomic DNA, an 
irreversible event that commits the cell to die. In many systems, this DNA fragmentation has 
been shown to result from activation of an endogenous Ca2+ and Mg2+ - dependent nuclear 
endonuclease. This enzyme selectively cleaves DNA at sites located between nucleosomal units 
generating mono and oligonucleosomal DNA fragments as well as single strand breaks (nicks). 
 
1.10.3.1 TUNEL  
The two disturbances of the DNA (i.e. fragmentation and breaks) can be detected enzymatically 
by techniques such as terminal deoxynucleotidyl transferase- mediated dUTP nick-end labelling 
(TUNEL) and in situ nick-translation (ISNT). These techniques have been used extensively to 
characterise apoptotic cells in tissue but their specificity for apoptosis compared to necrosis is 
often questioned given that necrotic cells also generate fragmented DNA strands (Negoescu et 
al., 1996). Thus, it is suggested that if one is to study for apoptotic cell death using these 
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methods, they should be combined with at least one other apoptotic assay, such as caspase 
immunoreactivity, to corroborate the nature of the cell death process as being apoptotic.  
 
1.10.3.2 Caspase-3  
Caspase activation (cleavage of the procaspase to active caspase) is a hallmark of almost all 
apoptotic systems (Stennicke and Salvesen, 1998; Gown and Willingham, 2002). Of all the 11 
known caspases, caspase-3 is a central effector caspase in many cells, especially those of the 
central nervous system, as determined by studying caspase-3 knockout mice (Kuida et al., 1996). 
Caspase- 3 is also unique in that it mediates the cleavage of itself, other downstream caspases, 
and other caspase substrates. In normal cells, caspase-3 exists as an inactive proenzyme of 
molecular weight 32 kDa (Procaspase-3) in which the potential cleavage site is intact. Once the 
apoptotic cascade is initiated, Procaspase-3 is cleaved into large and small active subunits of 
molecular weights 10-12kDa and 17-22kDa respectively. The 12 and 17kDa subunits then 
associate to form the Active caspase-3 enzyme (Fig. 1.6). The detection of this active enzyme is 
a sensitive indicator of apoptosis (Tenneti and Lipton, 2000; Gown and Willingham, 2002). 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.6 Activation of caspase-3. 
This figure is a schematic representation of the activation of caspase-3. The caspase is synthesised as an 
inactive proenzyme (Procaspase-3) and is cleaved once the apoptotic pathway is activated. The two 
subunits resulting from this cleavage (17 and 12 kDa in size) associate to form an active enzyme (Active 
caspase-3).  
 
 
1.11 Global Hypothesis of this project 
The global hypothesis of this project is that repeated hypoxic exposures induce extensive 
neuronal cell death (apoptosis) in brainstem cardiorespiratory nuclei as a consequence of 
excitotoxicity, via the NMDA receptor. Fig. 1.7 illustrates the proposed intracellular mechanism 
of this process that will be investigated in this project.       
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Fig. 1.7 A schematic representation of the proposed mechanism of neuronal death. 
nEpisodes of hypoxia result in the accumulation of extracellular glutamate.  
oExcess glutamate binds and activates the NMDA receptor on certain neurons, which causes an influx of 
positively charged ions.  
pThis results in the depolarisation of the neuron.  
qVoltage gated calcium channels are activated allowing calcium to enter the cell. However, due to the 
high extracellular glutamate levels, the NMDA receptors are being overstimulated (excitotoxicity). 
rMore calcium is allowed to enter the cytoplasm thus, increasing intracellular calcium levels.  
High intracellular calcium results in the following:  
s- release of excitatory amino acids (EAA) into the extracellular space  
t- activation of a number of enzymes (proteases) in the cytoplasm, and  
u- activation of endonucleases in the nucleus. 
vOnce the proteases are activated, they cleave one or more caspases which in turn, cleave other caspases, 
thus initiating the caspase cascade. 
wThe caspases also cleave proteolytic substrates in the nucleus whose normal function is to protect the 
cell. 
11 The final action of uandw results in the cleavage, degradation and /or fragmentation of chromosomal 
DNA, thus resulting in cell death. 
Note: the bolded parts in the scheme will be analysed in this project. 
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1.12 Project Plan  
This PhD project plans to extend the findings of apoptosis in an Australian population of SIDS 
victims and then examine for possible underlying mechanisms for the apoptosis. To identify 
these mechanisms, concurrent studies will be undertaken in piglets. Piglets exposed to repeated 
episodes of intermittent hypercapnic hypoxia (IHH) will be examined to determine whether this 
exposure induces the same abnormalities as those seen in the SIDS infants. The abnormalities 
sought will be restricted to those in the brainstem.  
 
The project has been divided into two main parts. Part I concerns the neuropathology of a piglet 
model of SIDS while Part II concerns the neuropathology of SIDS infants compared to non-
SIDS infants. Each part contains three chapters which analyse: 
1- Apoptotic changes (Chapters 4 & 8),  
2- NMDA receptor expression changes (Chapters 5 & 9), and  
3- NMDA receptor involvement in the apoptotic changes (Chapters 6 & 10).  
The final Chapter, 11, will highlight comparative findings of this project between the SIDS 
infants and the piglet model of IHH.   
 
 
 
Part I 
Piglet Dataset 
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Chapter 2 
Materials and Methods 
 
2.1 Human Infant Brain Tissue acquisition 
Archived paraffin-embedded human infant brainstem tissue was obtained from the Institute of 
Forensic Medicine, Glebe, NSW. The tissue was processed and blocked for routine post-mortem 
investigation. Fixation times, in 10% formalin, varied between 2 and 10 weeks. This study had 
approval from the University of Sydney Human Ethics Committee (Approval Number 00/07/33) 
and Central Sydney Area Health Service Ethics Committee (Approval Number X98-0199). 
 
From each case, 8 coronal sections of the brainstem were cut at 7 µm thickness and mounted on 
silanized slides (see 2.4 Silanizing slides). Sections were then dried at 37oC for 24 h and stored 
in dust free conditions at room temperature.  
 
2.2 Piglet model of IHH   
Mixed-breed miniature piglets aged 9-12 days (n = 17) were randomly assigned to either control 
or treatment groups. The treatment in this study was intermittent hypercapnic hypoxia (IHH) 
(8% O2, 7% CO2, balance N2) over 48 min, 6 min of hypercapnic-hypoxia (HH) alternating with 
6 min of air (total 24 min of HH). This treatment was delivered once per day for either two, or 
four days in the IHH exposed groups (2dIHH; n = 6, and 4dIHH; n = 5, respectively). Piglets in 
the control group (C; n = 6) breathed fresh air for 48 min in the same study environment, daily 
for 4 days.  
 
On each study day, piglets were placed, unsedated, in a vinyl hammock within a temperature-
regulated perspex box and a full face mask sealed against the snout. The respiratory circuit was 
connected to a gastight three-way tap permitting rapid switching between reservoir bags 
containing air or the required HH gas mix. The treatment pattern was designed to mimic brief 
repeated exposures to HH as might occur in clinical situations (Waters and Tinworth, 2001). 
Ethical approval was obtained from the University of Sydney Animal Ethics Committee 
(Approval Number K14/1-2000/ 3/3075).  
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2.3 Piglet Brain tissue  
2.3.1 Collection 
After piglets received their final treatment exposure, they were allowed 24 h to recover before 
euthanasia. At this stage, all piglets were aged 13-14 days. An overdose of pentobarbitone was 
administered painlessly via an arterial catheter (inserted prior to treatment exposure for another 
laboratory protocol of physiological studies). The piglets were then perfused via a thoracic 
incision and intracardiac cannula with 10% phosphate buffered formalin (Fronine). Brains were 
removed and stored in fixative (10% formalin) for 15 days. The brainstem and connecting 
cerebellum were detached from the cerebral hemisphere by a transverse cut through the superior 
border of the 3rd cranial nerve and between the superior and inferior colliculi. The 
brainstem/cerebellum was then cut transversely at 4 mm intervals using a purpose built cutting 
devise (AMTEC, Sydney, Australia) (Fig. 2.1), placed in Tissue Tek III uni-cassettes (Sakura 
Finetek, Cat.# 4120) and put back in formalin for a further 5 days. Cassettes were washed in 
70% ethanol (6-24 h) prior to tissue processing (72 h cycle) and embedding in paraffin wax (see 
2.3.2 Processing). Sagittal sections were then cut at 7 µm using a rotary microtome (Microm 
HM325, Microm Laboratories, Germany) and mounted on silanized slides (see 2.4 Silanizing 
slides). Sections were stored in dust free conditions at room temperature prior to staining. 
 
Fig. 2.1: Tissue cutting device.  
The cutting device is stainless steel and consists of: (A) metal tray, (B) lower square plate on legs with 
spacer screws (4 mm), (C) hollow set square (4mm thick) which fits into a groove of the lower plate and 
has 2 opposing ridges , (D) upper square plate with handle (same dimensions as lower plate) (E) cutting 
wire and frame.  
(A)
(E) (D)
(B)
(C)
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2.3.2 Processing 
Processing of the piglet brain tissue was performed in the Department of Pathology, University 
of Sydney, in a Tissue Tek VIP 2000 processor (Ames Division, Miles Laboratories Inc., 
Indiana) according to the following method: 
50% alcohol (4 h), 70% alcohol (4 h), 80% alcohol (4.5 h), 95% alcohol I (6 h), 95% 
alcohol II (5 h), 100% alcohol I (4 h), 100% alcohol II (4 h), xylene I (2 h), xylene II (4 
h), Wax 1 (4 h), Wax 2 (6 h), Wax 3 (6 h), Wax 4 (6 h). 
Tissue was then embedded in paraffin, and blocks stored at room temperature. 
 
2.4 Silanizing slides 
Pre-washed slides were placed in absolute alcohol for 10 min, air dried thoroughly and placed in 
2% 3-aminopropyltriethoxysilane (APTES) (Sigma, Cat.# A3648) in acetone for 2 min. Slides 
were then washed in acetone for 2 min, rinsed in tap water and left to dry overnight at 37oC. 
Once dried, slides were wrapped in foil and stored at room temperature until use.  
 
2.5 Hematoxylin and Eosin staining (H&E) 
Sections were deparaffinised in 2 changes of xylene (10 min) and dehydrated through a graded 
series of ethanols to water (2 min each in 100%, 100%, 95%, 95%, 70%, H2O). Sections were 
then stained in Harris’s Haematoxylin (3-4 min), washed in water, differentiated in acid alcohol 
to remove excess stain (several dips), washed in water briefly and placed in Scott’s blueing 
solution (30 sec). After further washing in water (2 min), slides were counterstained in 2 changes 
of eosin (30 sec each), dehydrated quickly through graded ethanols, cleared in 2 changes of 
histoclear (2 min each) and mounted in DPX (BDH laboratory supplies).  
 
2.6 Non-radioactive in situ hybridisation (non-RISH) for formalin fixed and paraffin 
embedded tissue sections 
 
2.6.1 Conditions 
RNAse contamination was avoided by using molecular biological grade reagents and by adding 
diethyl pyrocarbonate (DEPC) (Sigma, Cat.# D-5758) to all solutions. 1 ml of DEPC was added 
to 1 L of solution, left overnight and then autoclaved. RNAses were inactivated by baking all 
glassware at 180oC for 6 h. Disposable gloves were used and frequently changed during the 
entire non-RISH method.  
2.6.2 Probe related procedures 
2.6.2.1 Generation of NR1 probes 
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The localization of NMDA receptor subunit 1 (NR1) mRNA was examined using synthetic 
oligonucleotide probes (Gibco BRL) complementary to the subunit specific region between 
transmembrane region I and transmembrane region II. The probes were designed from the 
human NR1 gene (Planells-Cases et al., 1993), were 45 bases in length and had the following 
sequences:  
• NR1-antisense: 5’ CTC CTC CTC CTC GCT GTT CAC CTT GAA CCG GCC GAA 
GGG GCT GAA 3’ (complementary to sequences encoding amino acid residues 565-579 
of the mature NR1 polypeptide) and 
• NR1-sense: 5’ TTC AGC CCC TTC GGC CGG TTC AAG GTG AAC AGC GAG GAG 
GAG GAG 3’.  
These sequences were taken from Bayer et al., 1995. The probe length of 45 bases was 
chosen to optimise penetration in the formalin fixed tissue whilst still maintaining specificity. 
 
2.6.2.2 Probe labelling 
Probes were reconstituted in 1 ml DEPC treated water and labelled by 3’-tailing with 
Digoxigenin-11-dUTP (DIG-dUTP) using the DIG Oligonucleotide tailing kit from Boehringer 
Mannheim (Cat.# 1417231). One sterile microfuge tube was used for each probe. Each tube was 
placed on ice and the following reagents were added in order: 1x reaction buffer (1 M potassium 
cacodylate, 0.125 M Tris-HCL, 1.25 mg/ml bovine serum albumin, pH 6.6), 5 mM cobalt 
chloride (CoCl2) solution, 0.05 mM DIG-dUTP, 5 pmol/µl of each respective probe (NR1 sense, 
NR1 antisense, or control oligonucleotide), 0.5 mM dATP, 2.5 units/µl terminal transferase, and 
DEPC treated H2O to make up a total volume of 20 µl. Reaction was initiated by incubating each 
tube at 37oC for 20 mins, and stopped by placing the tubes on ice and adding 2 µl of an 
EDTA/glycogen mixture (0.2 M EDTA, pH 8.0 and 20 mg/ml glycogen).  
 
2.6.2.3 Purification of DIG labelled probes by ethanol precipitation  
Labelled probes were precipitated with 0.1 volume of 4 M lithium chloride (LiCl) and 3.0 
volumes of chilled ethanol. Tubes were mixed well and stored at –20oC overnight. The reaction 
tubes were then centrifuged in a microcentrifuge (13,000 g, 4oC, 15 min), the resulting 
supernatant discarded and the pellet washed with 50 µl chilled 70% ethanol. Tubes were 
centrifuged again (13,000 g, 4oC, 5 min), the resulting supernatant discarded and the pellet was 
left to dry at room temperature. Once dry, 20 µl DEPC H2O was added and the now labelled and 
precipitated probes were stored at –20oC ready for use. 
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2.6.2.4 Estimating the concentration of DIG-labelled probes 
The concentration of labelled probes was determined by serial dilution and comparison to the 
DIG-labelling oligonucleotide standards. Serial dilution was performed as depicted in Fig. 2.2 
for all probes. The concentration of the NR1 probes were determined by referring to the DIG-
labelling standard oligonucleotides as shown in Fig. 2.2. 
 
 
 
 
 
 
 
 
 
 
Fig. 2.2: Dilution scheme for estimating the concentration of DIG labelled probes. 
This scheme depicts the final volume and concentration of the DIG-labelled standard oligonucleotides, 
which was used to determine the concentration of the labelled NR1 sense and antisense probes.  
 
On a Hybond-N Nylon membrane (Amersham, Cat.# RPN.203N), 1 µl of diluted standard (L) 
from vials A-E (Fig. 2.2) were spotted in a row and then 1 µl of each diluted kit control (C), 
sense (S) and antisense (AS) probe was spotted in parallel second, third and forth rows 
respectively (Fig. 2.3). The membrane was baked at 120oC for 30 min to fix the nuclei acids to 
the membrane, washed in a 1:10 dilution of maleic acid washing buffer (10 mM maleic acid, 150 
mM NaCl; pH 7.5; 0.3% (v/v) Tween 20) for 2 min, and then incubated in blocking solution (1% 
w/v of Blocking Reagent (BR) [Roche Diagnostics, Cat.# 1096176] in maleic acid buffer) at 
room temperature for 30 min. The membrane was then incubated with a 1:5000 dilution of anti-
DIG alkaline phosphatase (AP) (Boehringer Mannheim, Cat.# 1093274) in blocking solution at 
room temperature for 30 mins,  washed in 1:10 dilution of maleic acid washing buffer twice for 
15 mins, incubated with 1:10 dilution of detection buffer (100 mM Tris, 100 mM NaCl; pH 9.5) 
for 2 min, and colour substrate solution (35 µl nitroblue tetrazolium (NBT) [Boehringer 
Mannheim, Cat.# 1383213], 45 µl 5-bromo-4-chloro-3-indolyl-phosphate (BCIP) [Boehringer 
Mannheim, Cat.# 1383221], in 10 ml detection buffer) added and left to incubate for 6 h in the 
dark for colour development. The colour reaction was stopped by washing the membrane with 
tris/EDTA (TE) buffer (1:10 dilution of 10 mM Tris, 0.1 mM EDTA; pH 8.0) for 5 min. The 
membrane was then left to dry and NR1 probe concentrations determined by comparing the spot 
intensities to the diluted standard probe row. Fig. 2.3 shows a membrane stained in this manner.  
 
Dilution
Volume of  
DNA Dilution 
buffer in tube 
Concentration 
A B C D E
2.5 pmol/µl     50 fmol/µl      10 fmol/µl      2 fmol/µl        0.4 fmol/µl       0.08 fmol/µl 
2µl 10µl 10µl 10µl 10µl 
98µl 40µl 40µl 40µl 40µl 
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Fig. 2.3: Membrane used to estimate the concentration of DIG-labelled NR1 mRNA sense and 
antisense probes. Dilutions of the kit standard oligonucleotide (L, row 1) and control (C, row 2), and the 
newly labelled NR1 mRNA antisense (AS, row 3) and sense (S, row 4) probes were spotted on, fixed to, 
and detected on a Hybond-N membrane with Anti-DIG alkaline phosphate.  
 
2.6.3 Non-RISH protocol  
2.6.3.1 In situ hybridisation  
All reactions were performed at room temperature unless noted otherwise. An optimal probe 
concentration of 50 ng/100 µl was selected for hybridisation. Sections from control and IHH 
treated piglet groups, and from non-SIDS and SIDS groups, were stained simultaneously to 
ensure uniform conditions for subsequent quantitative analyses.  
 
Sections were deparaffinised in xylene (2x 10 min), taken through a graded series of ethanols (1 
x 5 min in 100%, 95%, 75%, 50% and 30%) and washed in DEPC H2O (2 x 5 min). Sections 
were then microwaved in 10% Tris/EDTA buffer (1 mM EDTA, 1 mM sodium citrate, 2 mM 
Tris; pH 9.0) [uninterrupted cycle of 12 min for human infant tissue and 10.5 min for piglet 
tissue at full power on a rotating turntable (Samsung 850 W, Korea)] to facilitate probe and 
antibody penetration by disrupting crosslinkages formed during formalin fixation and paraffin 
embedding. Sections remained in the buffer for a further 15 min and DEPC H2O added gradually 
over 5 min to reduce the buffer to room temperature. Sections were then washed in DEPC H20 (2 
x 5 min), phosphate buffered saline (PBS) (5 min), and finally acetylated (0.25% acetic 
anhydride in 0.1 M triethanolamine/0.9% NaCl; pH 8.0) for 10 min. After washing in PBS (5 
min), a hydrophobic barrier (PAP pen, Zymed laboratories) was applied around the sections, 
rinsed in PBS (5 min) and prehybridised in 4x standard saline citrate (SSC)/50% formamide 
(Sigma, Cat.# F-9037) for 2 h at 37oC and rinsed in 2xSSC (5 min). Antisense probe (50 ng in 
100 µl of hybridisation buffer*) was then added to each section and coverslipped with Parafilm 
to prevent evaporation. Hybridisation was carried out overnight in a humid environment at 37oC. 
* hybridisation buffer = 18% formamide, 2xSSC, 1x Denhardts solution (Sigma, Cat.# D-2532), 10% dextran 
sulfate (Sigma, Cat.# D-8906), 50 mM dithiothreitol (DTT) (Sigma, Cat.# D-9779), 250 µg/ml yeast t-RNA (Roche 
Diagnostics, Cat.# 87881120), 100 µg/ml polyadenylic acid, and 500 µg/ml denatured and sheared salmon sperm 
DNA (Sigma, Cat.# D-9156) added just prior to hybridisation.  
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Negative controls to define nonspecific hybridisation included: labelled sense probe, a mixture 
of labelled antisense probe with excess (100x) unlabelled antisense probe, and no probe where 
only hybridisation mixture was added.  
 
2.6.3.2 Post hybridisation 
Post-hybridisation involved a stringent washing procedure as follows: 2xSSC until coverslips 
peeled off (15 min), 2xSSC at 37oC (twice for 15 min), 1xSSC at 37oC (15 min) and then 1xSSC, 
0.5xSSC and 0.25xSSC at room temperature (15 min each).  
 
2.6.3.3 Immunological detection 
The optimal concentration of the washing buffers differed between human and piglet tissue. The 
optimal concentrations for the human infant tissue were 10% digoxigenin buffer (DB) (100 mM 
maleic acid, 150 mM NaCl, pH 7.5) and 10% digoxigenin detection buffer (DDB) (100 mM Tris, 
100 mM NaCl, 50 mM MgCl2, pH 9.5). For piglet tissue, the optimal concentrations were 33% 
DB and 33% DDB. These concentrations were chosen because they provided the greatest signal 
to background ratio in the respective tissue types. After three washes with DB for 5 min each, 
blocking solution (10% w/v BR, 5% normal sheep serum (NSS) in DB) was added for 1 h at 
37oC.  Anti-DIG-AP antibody (1:250 dilution in DB, containing 10% BR and 1% NSS) was 
added after blocking and the sections were incubated for 2 h on a rocking platform at room 
temperature. Sections were washed twice in DB (10 min each) and then twice in DDB. The AP 
colour reaction buffer mixture was then added (35 µl NBT, 45 µl BCIP in 10 ml DDB) and 
incubated overnight (16 h) in a humidified dark box. The colour reaction was terminated by 
washing in TE buffer (5 min) and in distilled H2O (5 min), and sections were then mounted in 
aquamount solution (BDH laboratory supplies).  
 
2.7 Immunohistochemistry (IHC) 
All steps were carried out at room temperature unless otherwise noted. Sections from control and 
IHH treated piglet groups, and from non-SIDS and SIDS groups, were stained simultaneously to 
ensure uniform conditions for subsequent quantitative analyses.  
 
In all procedures, sections were first deparaffinised in xylene (2 x 10 min) and rehydrated 
through a graded series of ethanol to water (1 x 2 min 100%, 100%, 95%, 95%, 70%, H2O). 
Sections were then subjected to antigen retrieval, which involved microwaving in 10% 
Tris/EDTA buffer, uninterrupted for 12 min for human infant tissue, 11 min for piglet tissue, at 
Chapter 2: Materials and Methods            51
high power (Sharp 700W, Japan). Sections were then left to cool for 15 min, washed in distilled 
H2O (dH2O) (3 x 3 min), washed in PBS, PAP pen applied, washed again in PBS and then 
quenched for endogenous peroxidase activity by immersing in 3% H202/50% methanol in PBS 
for 30 min at room temperature. After washing in PBS (2 x 3 min) sections proceeded to 
immunostaining. 
 
2.7.1 Caspase-3 (CASP3) 
Immunostaining for caspase-3 was performed using a goat polyclonal antibody against caspase-3 
(Santa Cruz Biotechnology Inc., Cat.# sc-1226) and a goat avidin biotin complex (ABC) staining 
system (Santa Cruz, Cat.# sc-2023). This antibody recognizes both the unprocessed 32 kDa 
procaspase-3 CPP32 molecule and the cleaved/active 20 kDa subunit. For this commercial 
antibody, the company has specified that of this 19 amino acid long CASP3 antibody, 15 amino 
acids are the same for the pig caspase-3 sequence, with eight amino acids lying in a row. In total, 
there is 78% homology for this antibody to pig caspase-3.  
 
Staining was performed according to the instructions accompanying the ABC kit with the 
following modifications. Sections were incubated in 3% normal donkey serum (NDS) in PBS for 
40 min and then in CASP3 antibody (diluted 1:200 in 1.5% NDS) overnight at 4oC. Sections 
were then washed in PBS (2 x 3 min), incubated in biotinylated secondary antibody (ABC kit) 
for 40 min, washed in PBS (2 x 3 min) and incubated with the avidin-biotin enzyme reagent 
(ABC kit) for 40 min. Colour reaction was developed with diaminobenzidine (DAB, provided in 
the ABC kit) for 5-8 min. Sections were then counterstained with Harris’ Hematoxylin (30 sec) 
and mounted in DPX. Negative controls comprised sections immunostained as above but the 
primary antibody was replaced with either purified goat IgG of the same concentration as 
CASP3, or 1.5% NDS. Pig tonsil or thyroid were used as positive control tissues.  
 
2.7.2 Active caspase-3  
Immunostaining was performed using a rabbit monoclonal anti-active caspase-3 antibody (BD 
PharMingen, Cat.# 559565). This antibody recognizes only the active 17kDa subunit. Sections 
were incubated in 10% normal goat serum (NGS) in PBS for 30 min and then in the active 
caspase-3 antibody (diluted 1:500 in 1% NGS) overnight at 4oC. Sections were then washed in 
PBS (2 x 3 min), incubated in biotinylated goat anti-rabbit secondary antibody (Vector 
laboratories, Cat.# BA-1000) for 40 min, washed in PBS (2 x 3 min) and incubated with the 
avidin-biotin peroxidase reagent (Vector laboratories, Vectastain ABC kit Cat.# PK-4000) for 40 
min. Colour was developed with DAB (Dako, Cat.# K3468) for 5-8 min, counterstained with 
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Harris’ Hematoxylin (30 sec) and sections mounted in DPX. Negative controls comprised 
sections immunostained as above but the primary antibody was replaced with either purified 
rabbit IgG of the same concentration as active caspase-3, or 1% NGS. Pig tonsil or thyroid were 
used as positive control tissues.  
 
2.7.3 TUNEL 
The terminal deoxynucleotidyl transferase- mediated dUTP nick-end labelling (TUNEL) method 
was performed using a commercial kit (Intergen, ApopTag kit Cat.# S7100) following the 
manufacturers’ instructions with some modifications. Sections were incubated in equilibration 
buffer (30 sec) and then with terminal deoxynucleotidyl transferase (TdT) enzyme for 60 min at 
37oC. The reaction was stopped by placing sections in Stop/Wash solution for 10 min then 
washed in PBS (3 x 5 min). Sections were then incubated with anti-DIG-peroxidase for 30 min, 
colour developed with DAB (5-8 min), counterstained with Harris’ Hematoxylin (30 sec) and 
mounted in DPX. Negative controls were performed by omission of TdT enzyme. Pig tonsil or 
thyroid was used as the positive control tissue section. 
 
2.7.4 NR1 protein 
Immunostaining for NR1 protein was performed using a goat polyclonal antibody raised against 
a peptide mapping the carboxyl terminus of the NMDA receptor 1 of human origin (Santa Cruz, 
Cat.# sc-1467). Sections were incubated with 10% normal rabbit serum (NRS) in PBS for 30 
min and then in NR1 antibody (diluted 1:200 in 1% NRS) overnight at 4oC. Sections were then 
washed in PBS, incubated in biotinylated rabbit anti-goat IgG (Vector laboratories, Cat.# BA-
5000) diluted 1:200 in 1% NRS for 40 min, washed in PBS and incubated in avidin-biotin AP 
(Vector laboratories, Vectastain ABC kit Cat.# AK-5000) in PBS for 40 min. Sections were then 
rinsed in Tris buffered saline (TBS) pH 7.6, rinsed in 0.1 M Tris pH 9.5 and visualised by NBT 
and BCIP reaction solution containing 0.1% v/v of 1 M levamisole (Vector laboratories, 
Alkaline phosphatase substrate kit Cat.#SK5400) for 25 min. After washing in TBS and H2O, 
sections were taken through a graded series of alcohol, cleared in histoclear and mounted in 
vectamount (Vector Laboratories). Negative controls included sections where the primary NR1 
antibody was replaced with either purified goat IgG of the same concentration as NR1 or 1% 
NRS. 
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2.7.5 Double immunohistochemistry for TUNEL and NR1. 
For co-localisation studies, the TUNEL method was performed first and NR1 staining second. 
Thus, immediately after DAB colour reaction in the TUNEL protocol (section 2.7.3), sections 
were rinsed thouroughly in PBS (2 x 3min) and then proceeded with the NR1 protocol as 
described in section 2.7.4.  
 
2.8 Level of brainstem and nuclei studied 
2.8.1 Human infants 
In the human infant dataset, two levels of the brainstem were studied, the mid medulla and 
rostral pons - two levels at which tissue was available for use. Eight nuclei of the mid medulla 
and two nuclei of the rostral pons were analysed (Fig. 2.4 A & B). Nuclei at these two levels 
were selected for study on the basis of their functional relevance to cardiorespiratory, sleep and 
arousal control. To define the anatomic boundaries of the brainstem nuclei, the sections were 
stained with H&E (Fig. 2.4 D & E), and compared to the adjacent sections stained for each of the 
procedures mentioned above. The anatomical level of the mid medulla was defined with 
reference to Figure 23 from the Atlas of the Human Brainstem by Paxinos and Huang, (1995), 
and the following 8 nuclei were studied: hypoglossal (XII), dorsal motor nucleus of the vagus 
(DMNV), the principal inferior olivary nucleus (ION), arcuate nucleus (AN), the nucleus of the 
solitary tract (NTS), vestibular (Vest), cuneate (Cun) and nucleus of the spinal trigeminal tract 
(NSTT). Figure 41 from Paxinos and Huang, (1995) was used as a reference to define the 
anatomical level of the rostral pons, and the following two nuclei were studied: locus coeruleus 
(LC) and pontine nuclei.  
 
2.8.2 Piglets 
The brainstem level of the caudal medulla was studied in the piglet dataset. Eight nuclei at this 
level were quantified (Fig 2.4 C). The brain atlas for the pig (Yoshikawa, 1967), is based on the 
adult pig and consists of representative drawings rather than photomicrographs of the cytological 
structures. Therefore, Figure 17 from the Human Brainstem Atlas of Paxinos and Huang, (1995) 
was used as a reference to define the boundaries of the eight nuclei that were studied. These 
boundaries were first defined in our piglet sections by H&E staining (Fig. 2.4 F) of an adjacent 
tissue section. The following 8 nuclei were studied: XII, DMNV, lateral reticular nucleus (LRt), 
ION, NTS, gracile (Gr), Cun and NSTT.  
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Fig. 2.4 Brainstem levels and the location of the nuclei studied. 
Schematic representations (A-C) and H&E stained sections (D-F) of the mid medulla (A & D), rostral 
pons (B & E), and caudal medulla (C & F). Abbreviations in alphabetical order: AN, arcuate nucleus; 
Cun, cuneate nucleus; DMNV, dorsal motor nucleus of the vagus; Gr, gracile nucleus; ION, inferior 
olivary nucleus; LC, locus coeruleus; LRt, lateral reticular nucleus; NSTT, nucleus of the spinal trigeminal 
tract; NTS, nucleus of the tractus solitarus; Vest, vestibular nucleus; XII, hypoglossal nucleus. 
 
2.9 Quantitative non-RISH  
Slides containing tissue sections were coded so that all quantitative analyses were performed 
blinded to the study group. Quantitation of the non-RISH staining was a measure of the signal 
intensity, represented in optical density units (OD). The following method for quantification was 
modified from previous studies (Larsson et al., 1991; Guiot and Rahier, 1995). 
 
2.9.1 Image capture  
Images were viewed using a Nikon Eclipse E800 light microscope (Nikon Cooperation, Tokyo, 
Japan) and captured with a sensicam slowscan cooled colour CCD camera (PCO Computer 
Optics, Kelheim, Germany). The system was initially calibrated by a set of neutral density filters 
(Kodak-Eastman Kodak Company, Rochester NY, USA) to confirm the linearity of the cameras 
response to light. Over the range of 0-1.2 (filter OD range), there was a strong linear correlation 
between measured grey level and % transmission (Fig. 2.5). At the commencement of each 
session prior to image capturing, the camera was white balanced, and exposure time standardised 
to 0.055 ms. A combination of red, green and blue (RGB) channels were used. Frames were 
captured at 1280x1024 pixels using a x4 objective (corresponding to 2060x1649 µm). 
FD E
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Fig. 2.5: Linearity of the cameras response to light.  
This figure illustrates the correlation between the percent transmission of light and the recorded grey 
level. The relationship is approximated by a straight line (r2 = 0.9951) passing through the point of origin. 
 
2.9.2 Densitometric analysis  
Images were analysed using a Zeiss KS400 image analysis system (Carl Zeiss Vision, Munich, 
Germany). In this program, a grey level of 0 represents black (no transmission) and 255 is white 
(full transmission). The measured parameters included area, mean greyscale value and standard 
deviation of the greyscale value. Three areas were analysed from each image capture:  
1- a non tissue area which contained mounting media and coverslip but no tissue; this provided 
the measurement of the incident light, 
2- tissue containing no cells or neurons within the selected nucleus; this provided the 
measurement for background, and  
3- all the individual neurons in the selected nucleus which were stained positively. Neurons 
considered to be positively stained had a maroon/brown colour reaction which was 
distinguishable from the pink/red background tissue colour.  
 
The optical density (OD) was derived using the formula:   
optical density = log10    (incident light) 
           (transmitted light) 
 
This formula inverts the grey level scaling so that intense (dark) hybridization signal results in a 
high OD value. The background OD value was subtracted from each neuronal OD value to 
normalize data. The neuronal OD values were then averaged for each nucleus.  
 
2.10 Quantitative Immunohistochemistry  
Slides containing tissue sections were coded so that all quantitative analyses were performed 
blinded to the study group. Quantitation of the immunohistochemical staining was a measure of 
the number of positively stained neurons out of the total neuron population, represented as 
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percent positive (% positive). Results were calculated and presented as a percentage rather than 
kept as the raw counts, to rule out an inconsistency that may arise when comparing between 
cases of each dataset (human infants and piglets).  
 
2.10.1 Image capture  
Images were captured at x10 magnification using a sensicam slowscan cooled colour CCD 
camera mounted on a Nikon Eclipse E800 light microscope. Each nucleus was imaged and 
analysed in its entirety (requiring between 2-4 images depending on the size of the nucleus), 
except for the ION, which was so large that analysis was restricted to 3 representative image 
captures. 
 
2.10.2 Counting 
Using a Zeiss KS 400 image analysis system, neurons were identified and counted manually, 
with positive stained neurons being marked first, and negative stained neurons second. Neuronal 
counts were generated automatically by the computer and exported to a spreadsheet (Microsoft 
Excel 1999). Counts were summed for the 2-4 images captured per nucleus in each section and 
the number of positive neurons were expressed as a percent of the total neurons counted.  
 
2.11 Analyses 
Two adjacent tissue sections from each of the brainstem levels studied (mid-medulla and rostral 
pons for human infants and caudal medulla for piglets) were stained and analysed quantitatively 
for each individual infant or piglet. Thus, n = 2 for each infant/piglet, for each staining method. 
The two sections were stained in two different runs to verify the reproducibility of the staining 
results. This is especially important for the non-RISH method where a possible non-linear 
association between mRNA expression and OD values had to be accounted for, given that results 
are dependent on an antigen-antibody reaction. A difference between the two runs of <10% was 
set as the limit. If the difference was found to be > 10%, which was very rare, a third section was 
stained.  
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Chapter 3 
Piglet dataset characteristics 
 
3.1 Introduction 
The piglet has been identified as a clinically relevant animal model for postnatal developmental 
studies of cardiorespiratory control mechanisms. This is because newborn piglets share many 
common features with newborn human babies. These include a similarity in brain (Dobbing and 
Sands, 1979) and cardiovascular (Gootman et al., 1986) development, of the structural and 
functional maturation of the pulmonary vasculature (Haworth and Hislop 1981, Hall and 
Haworth 1986), respiratory pattern behaviour, and sleep/wake cycles (Scott et al., 1990). Thus, 
piglets from birth to about 40 days of age, thought to be equivalent to 0 – 1 year of human age 
with respect to brain development (Dobbing and Sands, 1979) are an excellent model for 
studying human infant related disorders.  
 
Piglets have been used to study the effects of hypoxia and hypercapnia alone (see Chapter 1, 
section 1.8.3). However, the effects of simultaneous hypercapnic hypoxia have not been studied. 
During infancy, clinical conditions are more often associated with repeated exposure to 
hypercapnic hypoxia rather than hypoxia alone (Kemp et al., 1993; Waters et al., 1996). 
Examples of such clinical conditions include obstructive sleep apnea (OSA) or sleeping prone 
and face down (a known risk factor for SIDS). Exposure to such asphyxial gas mixtures 
precipitates compensatory physiological and/or neurological responses.  
 
To evaluate the mechanisms and characteristics of these physiological and neurological 
responses, a novel piglet model of intermittent hypercapnic hypoxia (IHH) was developed 
(Waters and Tinworth, 2001). This model permits the study of both physiological and 
neurological changes. One physiological finding in this model to date, includes a depression of 
the ventilatory responses (Waters and Tinworth, 2001 & 2003). Other physiological parameters 
are still being investigated. This thesis focuses only on the neuropathological changes induced in 
this model, and aims to determine whether the neuropathological changes sought correlate with 
the physiological changes as observed by my co-workers (Waters and Tinworth, 2001 & 2003).  
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3.2 Materials and Methods  
3.2.1 Piglet care and handling 
The piglets from which brain tissue was collected and used in this study were from an existing 
protocol in the residing laboratory (physiology study) and as such, were cared for and handled 
on a daily basis, by Ms. Kellie Tinworth (Department of Medicine, University of Sydney).   
 
3.2.2 Piglet model of IHH 
Piglets were exposed to the IHH stimulus as described in Chapter 2 (section 2.2). A total of 17 
piglets (derived from a total of 6 litters) were studied, and were randomly assigned to either the 
control (n=6), 2dIHH (n=6) or 4dIHH (n=5) groups.  
 
3.2.3 Brainstem tissue used for staining 
Brain removal, fixation in 10% buffered formalin and, tissue processing have been described in 
Chapter 2 (section 2.3).  
 
3.2.4 Analysis 
Results are presented as mean ± SEM unless otherwise stated. Statistical analysis was 
undertaken using SPPS for Windows (V10.0.5, Chicago, USA). One-way ANOVA was used for 
comparisons amongst the three piglet groups for all characteristics with Bonferonnis’ adjustment 
for post-hoc analyses. A p-value of < 0.05 was considered statistically significant.  
 
3.3 Results 
3.3.1 Dataset characteristics 
Piglet characteristics are shown in Table 3.1. More male piglets were studied compared to 
females, but the male to female ratio was not different amongst the 3 study groups. Piglets were 
aged 9-12 days when they were first placed in the study environment. At the time of death, 
piglets were aged 13-14 days. There was no difference amongst groups for the average daily 
weight gain or the body weight at death.  
 
All brains were well perfused prior to removal (as indicated by the white grey appearance, little 
to no red coloured blood vessels, and rubbery texture), and looked normal macroscopically. 
Once removed, brains were weighed immediately and placed in 10% buffered formalin for a 
total of 21 ± 1 days. Brain weights were significantly reduced in the 2dIHH treated group when 
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compared with the control and 4dIHH groups. Brain to body weight ratios were also 
significantly less in the 2dIHH group compared to the controls and 4dIHH group (Table 3.1). 
 
3.3.2 IHH stimulus 
As determined by Waters and Tinworth, (2001), the mean arterial oxygen tension (PaO2) and 
mean arterial carbon dioxide tension (PaCO2) levels during IHH exposure were 40.9 ± 1.9 
mmHg and 61.2 ± 4.2 mmHg (SD), respectively. Thus, moderately severe, simultaneous hypoxia 
and hypercapnia were achieved. No gross morphological changes were observed in the piglets 
receiving IHH compared to controls. 
 
Table 3.1: Characteristic data for the control, 2dIHH and 4dIHH piglet groups. 
Characteristics Control (n=6) 2dIHH (n=6) 4dIHH (n=5) 
Male:female 
Pretreatment age (days)  
Age at death (days) 
Average daily weight gain (g) 
Body weight at death (kg) 
Brain weight (g) 
Brain: Body weight ratio (%) 
5:1 
9 - 10 
13 - 14 
63.3 ± 11.7 
2.44 ± 0.16 
37.0 ± 3.4 
1.5 ± 0.1 
5:1 
12 
14 
85.0 ± 6.2 
2.61 ± 0.08 
28.1 ± 2.2* 
1.1 ± 0.1** 
4:1 
9 - 10 
13 - 14 
72.0 ± 20.3 
1.95 ± 0.29 
36.2 ± 1.6# 
1.9 ± 0.4# 
Results are the average ± SEM.* p < 0.05, ** p ≤ 0.01 when compared to controls. # p < 0.05 4dIHH 
compared to 2dIHH 
 
 
3.4 Discussion 
Piglets were studied at 9-12 days of age because the brain growth spurt (Dobbing and Sands, 
1979) and cardiovascular development (Haworth and Hislop, 1981; Hall and Haworth, 1986; 
Gootman et al., 1986) at this age of the piglet are thought to be similar to that of 2-4 month old 
human infants, which is the age range of peak incidence for SIDS deaths. To control for any 
differences attributable to the stage of brain development, all piglets were aged 13-14 days at the 
time of death. 
 
Although more males were included in the study compared to females, this was consistent 
amongst the groups thus making sex a non-existent factor when comparing between the three 
study groups. However, it remains possible that responses to IHH differ between males and 
females, and this would be interesting to study in future.  
 
In this study, hypercapnic hypoxia was delivered to non-sedated and spontaneously breathing 
piglets via a nasal mask. This mode of delivery was chosen compared to other modes such as 
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airway occlusion (Guerguerian et al., 2002) or anesthetising and mechanically ventilating 
(Hoffman et al., 1994), because it more closely mimics clinical environments considered to 
increase the risk for SIDS, such as OSA (Mathur and Douglas, 1994; Tishler et al., 1996), and 
prone sleeping with the face down. It is thought that for both these clinical situations, 
experiencing the insult intermittently is more damaging than if it was experienced continuously, 
mostly because continuous exposure would allow for adaptive mechanisms and thus 
compensatory strategies (reviewed by Waters and Gozal, 2003). This has been shown 
experimentally in piglets exposed to continuous versus repetitive hypoxia where the repetitive 
exposure caused a greater depression of the responses to hypoxia when compared to the 
continuous exposure (Waters et al., 1996 and 1997b).  
 
This project focused on the effects of daily intermittent simultaneous hypercapnic hypoxia. Two 
durations of the IHH exposure were studied, 2 and 4 days. The 2 day exposure was considered to 
reflect the amount of exposure an infant would have experienced acutely (as in the case of 
infants who don’t habitually sleep prone), while that of 4 days reflects chronic exposure (as in 
the case of infants who do habitually sleep prone).  
 
The IHH stimulus of this study was delivered once per day in burst of 6 minutes duration, total 
of HH being 24 minutes. This particular protocol was chosen for neuropathological analysis 
based on physiological data from the laboratory, which has recently been published (Waters and 
Tinworth, 2003). Studying the effects of a 24 minute total HH exposure delivered in 24-,8-,4-, or 
2-minute cycles alternating with air, it was found that the animals that experienced intermediate 
(4 and 8 minute) stimulus cycles, had depression of the ventilatory responses, attenuation of the 
metabolic responses, and more severe arterial gas disturbances when compared to the other HH 
exposed groups or the control group (exposed to air only). Based on these findings, it was 
decided that an intermediate stimulus cycle time of 6 minutes, would be the most relevant for 
further studies.   
 
An unexpected observation differentiated amongst the three groups is the decrease in brain 
weight after 2 days IHH. If this was a direct effect of the IHH stimulus itself, it would be 
expected that the change would also have been maintained after 4 days of IHH. The significance 
of this difference in brain weight to the findings of this study is uncertain because the study was 
restricted to one level of the medulla in the brainstem, which is a small anatomical part of the 
total brain structure. However, possible mechanisms for such rapid weight changes include shifts 
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in water content of the brain after other compensatory mechanisms were induced by the daily 
repetition of the stimulus.  
 
The tissue fixation method of formalin fixing and paraffin embedding used for the piglet brains 
in this project was chosen to emulate the tissue fixation method used for post-mortem human 
tissue. An emulation of tissue fixation in animal models allows for the exploration and 
development of new techniques that could ultimately be extrapolated for use in the human infant 
tissue, which is limited in availability for research. Although an exact emulation of the tissue 
fixation was strived for, some differences were still present and included perfusion of the piglet 
tissue but not human tissue, 15 days of whole brain fixation for the piglet compared to 2-10 
weeks for the human infant brains, and no post-mortem delay for the piglets compared to a 5-40 
hour delay for the human tissue (these parameters concerning human tissue are discussed in 
chapter 7). 
 
3.5 Conclusion 
Piglets aged 9-12 days were used to develop a model of postnatal exposure to intermittent 
simultaneous hypercapnic hypoxia, which was aimed to mimic clinical conditions. Blood gases 
indicated that this noxious stimulus of IHH is moderately severe, but the piglets appeared normal 
after these exposures. The brain from these piglets were collected once the physiological studies 
were completed. After undergoing a  fixation process similar to that used on human post-mortem 
tissue, tissue from the brainstem at the level of the caudal medulla was evaluated in the 
neuropathological studies presented in the next three chapters (Chapters 4-6).  
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Chapter 4 
Neuronal cell death changes in a piglet model of IHH  
 
4.1 Introduction 
In animal models, stimuli involving hypoxia (Delivoria Papadopoulos and Mishra, 1998; David 
and Grongnet, 2000), ischemia (Hayashi et al., 1998; Martin et al., 1998) and hypoxic ischemia 
(Yue et al., 1997; Blomgren et al., 2001) have been shown to precipitate neuronal cell death. 
Whether this cell death is apoptotic as opposed to necrotic has been the subject of much recent 
debate (Ishimaru et al., 1999). The debate has largely arisen because apoptosis was originally 
defined by electron microscopy (Kerr et al., 1972), but recent studies have relied on 
histochemical staining.  
 
One method commonly used to identify apoptosis is the TUNEL method. TUNEL staining 
identifies DNA fragmentation, which is a feature of cells in late stages of apoptosis. However, 
the specificity of TUNEL for apoptosis is often questioned, leading to the recommendation that 
results be interpreted in conjunction with at least one other apoptotic marker (Labat-Moleur et 
al., 1998). 
 
Activation of the caspases (cysteine proteases) is an essential component of the process of 
apoptosis (Stennicke and Salvesen, 1998). In the brain, caspase-3 is especially important, where 
it plays a key role in the initiation of the apoptotic pathway (Faleiro et al., 1997) and is thought 
to be responsible for many cytological changes that characterise neuronal apoptosis (D’Mello et 
al., 2000). Caspase-3 exists as an inactive proenzyme of molecular weight 32 kDa. Noxious 
stimuli precipitate the cleavage of this proenzyme into two active subunits of molecular weights 
12 and 17kDa, which then associate to form the active caspase-3 enzyme. This active enzyme 
then cleaves a variety of enzymes and substrates including other caspases, initiating the caspase 
cascade whereafter the cell is committed to die (Lincz, 1998). Thus, caspase-3 is considered an 
early marker of the apoptotic pathway. 
 
This study utilised two biochemical markers of apoptosis; the TUNEL method, and active 
caspase-3 labelling. An antibody for Caspase-3 (CASP3) was also employed in this study and 
labels the proactive latent caspase-3 enzyme. Given recent publications criticizing the practice of 
Chapter 4: Neuronal cell death changes in a piglet model of IHH.        
    
63
defining apoptosis purely via biochemical marking without electron microscopic confirmation 
(Martin et al., 1998; Ishimaru et al., 1999; Olney et al., 2002), this study uses the general term 
“neuronal cell death” rather than “apoptosis” to define the histochemical results.  
 
Following on from the original observation that apoptotic markers were increased in the dorsal 
nuclei of the medulla of SIDS infants (Waters et al., 1999), this chapter focuses on the effects of 
IHH on markers of neuronal cell death in the piglet medulla. It was first hypothesised that a 
stimulus of IHH during early development of the piglet increases neuronal cell death, 
particularly in the dorsal nuclei of the medulla. The second hypothesis was that the amount of 
cell death is cumulative if the IHH stimulus continues over days.  
 
4.2 Materials and Methods  
4.2.1 Piglet model of IHH 
Piglets were exposed to the IHH stimulus as described in Chapter 2 (section 2.2). A total of 17 
piglets were studied and were assigned to either the control (n=6), 2dIHH (n=6) or 4dIHH (n=5) 
groups.  
 
4.2.2 Brainstem tissue used for staining 
Brain removal, fixation and tissue processing have been described in Chapter 2 (section 2.3). 
Tissue sections (7µm) at the level of the caudal medulla were used for staining. Two adjacent 
sections from each piglet were subjected to each staining method (i.e. n=2, per piglet, per stain. 
Refer to Chapter 2, section 2.11). 
 
4.2.3 IHC for CASP3, active caspase-3 and TUNEL 
The immunohistochemical methods used to identify CASP3, active caspase-3 and TUNEL have 
been described in Chapter 2 (section 2.7). 
 
4.2.4 Quantitative IHC 
Quantitation is represented as percent positive (% positive) for each marker, and was performed 
as described in Chapter 2 (section 2.10). 
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4.2.5 Analysis 
Eight nuclei of the caudal medulla were analysed, including the XII, DMNV, LRt, ION, NTS, 
Gr, Cun and NSTT (Refer to Chapter 2, section 2.8.2 and Fig. 2.4). 
 
Results are presented as mean ± SEM. Effects of IHH were evaluated amongst treatment groups 
(controls, 2dIHH and 4dIHH) for each histological method. Statistical analysis was undertaken 
using SPPS for Windows (V10.0.5, Chicago, USA). One-way ANOVA was used to compare 
amongst the three piglet groups for all staining quantification with Bonferonnis’ adjustment for 
post-hoc analyses. A 2-tailed p-value of < 0.05 was considered statistically significant.  
 
4.3 Results 
4.3.1 Dataset characteristics  
The characteristics of the piglets used for this study have been reported in Chapter 3 (section 
3.3.1) and can be found in Table 3.1. 
 
4.3.2 Distribution and pattern of staining 
Positive staining was present in neurons and other cell types, but in this study, only neuronal 
staining was considered. Neurons were distinguished from all other cell types by their larger size 
and well defined cytoplasm and nucleus. For CASP3, positive staining of neurons was mostly 
localized to the cytoplasm with occasional staining observed in the nucleus. The morphological 
appearance of CASP3 positive neurons was consistently normal (Fig. 4.1A). For active caspase-
3, positive staining in neurons was localized to the cytoplasm with occasional staining in the 
nucleus as well. Neurons positively stained for active caspase-3 were often shrunken, therefore 
demonstrating some morphological features of apoptotic cells (Fig. 4.1B). Positive staining for 
TUNEL was localized to the nucleus of neurons. Neurons were only counted as positive for 
TUNEL if they had dark nuclei staining with or without fragmentation, and either or both 
nuclear condensation and cellular shrinkage (Fig. 4.1C). Thus, neurons with lighter staining of 
the nucleus but no morphological changes were counted as negative for TUNEL, and evaluated 
as showing non-specific staining.  
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Fig. 4.1 Staining pattern of CASP3, active caspase-3 and TUNEL in the piglet medulla. 
Micrographs of the dorsal motor nucleus of the vagus (DMNV) from 3 adjacent (7µm) coronal sections at 
the level of the caudal medulla from a control piglet stained for (A) CASP3, (B) active caspase-3 and (C) 
TUNEL. Intensely labelled “positive” neurons (filled arrows) and non- labelled “negative” neurons (thick 
open arrows). Note in (B and C), the shrinkage of neurons labelled positive for active caspase-3 and 
TUNEL respectively. Scale bar = 30µm. 
 
 
4.3.3 Quantification 
Positive staining for all 3 markers was found in neurons of all 8 nuclei in control animals. 
Expression of these markers was affected by IHH for some, but not all nuclei, when compared to 
the control group (Fig. 4.2). 
 
4.3.3.1 Caspase-3 (CASP)  
In the control group, CASP3 was abundant and present in a great number of neurons per nucleus 
ranging from 67 ± 5 % in the XII to 29 ± 4 % in the Cuneate (Fig. 4.2A). After 2days of IHH 
there was a significant increase in the number of neurons positive for CASP3 in the NTS, 
Gracile and Cuneate nuclei (p<0.05 for all). The effects of 4days of IHH were a significant 
increase in the Cuneate (p<0.01) but also a significant decrease in the XII and DMNV (p<0.05) 
compared to controls.  
 
4.3.3.2 Active caspase-3 
In the control group, approximately 5% of neurons on average were positively stained for active 
caspase-3. The LRt had the greatest percentage of active caspase-3 positive neurons while the 
DMNV had the least (Fig. 4.2B). After 2 days of IHH there was a significant increase in active 
caspase-3 in the DMNV (p<0.05) and a significant decrease in the LRt (p<0.05). Exposure to 4 
days of IHH had no significant effects on the expression of active caspase-3 in any of the nuclei 
studied compared to controls. 
 
 
A B C
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4.3.3.3 TUNEL  
In the control group, approximately 5% of neurons were TUNEL positive. The NTS had the 
greatest percentage of TUNEL positive neurons while the DMNV had the least (Fig. 4.2C). The 
effect of 2days of IHH was a significant increase in TUNEL in the DMNV and in the LRt 
(p<0.05 for both). The trend towards an increase in the NTS, Gracile and Cuneate nuclei did not 
reach statistical significance. After 4days of IHH, the significant increase in TUNEL in the 
DMNV, LRt and ION (p<0.05) compared to controls, was sustained (Fig. 4.2C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.2 Quantitation of CASP3, active caspase-3 and TUNEL in the piglet caudal medulla.  
The percentage of positive neurons (% ± SEM) in eight nuclei of the piglet caudal medulla for (A) 
CASP3, (B) active caspase-3 and (C) TUNEL. Comparison amongst the 3 piglet treatments: controls, 
2dIHH and 4dIHH. * p<0.05, ** p<0.01 compared to controls. 
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4.4 Discussion 
This study examined the expression of caspase-3 (CASP3), active caspase-3 and TUNEL in 
eight nuclei of the piglet caudal medulla and assessed whether their expressions were changed 
after 2 and 4days of IHH exposure. The results show that IHH induced an increase in the 
expression of these cell death markers, but the two different durations of exposure caused 
different patterns of change. The patterns of change are interpreted to reflect different stages of 
the cell death cycle, with progression from active caspase-3 to TUNEL positivity reflecting 
progression through the cell death pathway.  
 
A neuron undergoing pathologically induced cell death is classically defined as apoptotic or 
necrotic, with each type described by distinctive morphological and biochemical characteristics. 
Defining the type of cell death using classic definitions requires morphological analysis at the 
electron microscopic level. Since electron microscopy is not feasible in formalin fixed and 
paraffin embedded tissue, this study is not able to define the type of cell death after IHH 
according to these classic definitions. As such, the term “active cell death” has been selected to 
describe the changes observed after IHH, to contrast with passive cell death. In the definition 
provided by Sloviter, (2002), active cell death defines any lethal cellular process that would 
require active intracellular processes and where death occurs over time, thus providing potential 
for therapeutic intervention. In contrast, passive cell death is instantaneous, the cell plays no role 
in its own demise, and it often occurs as a result of changed physical state, for example, rapid 
freezing, aldehyde fixation and heat denaturation. 
 
4.4.1 Neuronal cell death under normal conditions 
An antibody (designated CASP3) that detects both the unprocessed 32kDa and processed 20kDa 
subunits for caspase-3 was used in this study because an antibody for active caspase-3 for use on 
formalin fixed and paraffin embedded tissue was not initially available. The use of this antibody 
allowed determination of the proportion of neurons in the piglet medulla that synthesize caspase-
3 as the proenzyme during normal development. This study has shown, for the first time, that 
CASP3 is expressed in neurons of normal appearance in all eight nuclei studied in the piglet 
caudal medulla. On average, CASP3 was found in 45% of neurons indicating that for 
approximately half the neuronal population in the piglet medulla, proapoptotic effectors are 
present in a latent state, so new synthesis would not be required should the apoptotic pathways 
be activated in those cells (Hartmann et al., 2000). 
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A new antibody against active caspase-3 became available during the course of this study and 
was claimed to recognize the 17kDa subunit. Using this antibody, it was observed that on 
average, 5% of neurons in the control group were positive for active caspase-3, which was 
similar to the TUNEL quantification, suggesting that during normal brain development of the 
piglet, 5% of neurons are in the process of undergoing “normal” programmed cell death. This 
amount of programmed cell death under normal conditions is consistent with other reports (Yue 
et al., 1997).  
 
4.4.2 Effects of IHH 
Neuronal cell death during early development is increased after experimental manipulation 
involving changes in oxygen (and carbon dioxide) levels (Yue et al., 1997; Delivoria 
Papadopoulos and Mishra, 1998; Hayashi et al., 1998; Martin et al., 1998; David and Grongnet, 
2000; Blomgren et al., 2001). The physiological stimulus of this study was IHH, which was 
moderately severe, but would not be expected to cause gross neurological deficits or 
macroscopic neuropathology. The results of this study show that a stimulus of IHH increases 
active neuronal cell death. 
 
Although both the CASP3 and active caspase-3 antibodies detect the processed subunit, the 
staining patterns and changes after IHH were not exclusive. IHH induced CASP3 changes in 5 
nuclei including the NTS, Gracile, Cuneate, XII and DMNV, but changes for active caspase-3 
were only observed in 2 nuclei; the DMNV and LRt. This inconclusive pattern of change 
between two caspase-3 antibodies has also been reported in the rat cerebral cortex after ethanol 
treatment (Mooney et al., 2001). One feasible explanation for the non-exclusive changes is that 
the inactive and active isoforms were only studied and not the actual caspase-3 activity. Progress 
in enzyme activity may offset the changes in expression observed in this study and by others 
(Mooney et al., 2001). Another explanation may be due to the fact that CASP3 is a polyclonal 
antibody and as such, may not be as specific or sensitive compared to the monoclonal active 
caspase-3 antibody.  
 
For CASP3 expression, changes after IHH exposure differed amongst nuclei. For the NTS, 
Gracile and Cuneate nuclei, CASP3  was upregulated by exposure to 2 days of IHH whereas in 
the XII and DMNV, levels were down-regulated but only after 4 days of IHH. The implications 
of these findings are unclear and complicated by the fact that the antibody detects both the 32 
and 20 kDa subunits. Regardless, it is speculated that the up-regulation of CASP3 indicates an 
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increased vulnerability of neurons to active cell death (Krajewska et al., 1997), while down-
regulation indicates that CASP3 is present but altered so that it is no longer detectable by this 
marker, or that production has been downregulated, or there has been loss of CASP3 expressing 
neurons. In the XII and DMNV nuclei, there was no difference in the number of cells per field, 
but confirmation of neuronal loss would require stereological counting which was not part of this 
study. 
 
For active caspase-3, IHH induced an increase in the DMNV and decrease in the LRt after 2 
days of exposure. Interestingly, and in contrast, TUNEL was increased in the LRt after 2 days of 
IHH. Although the implications of these findings are uncertain, one possible explanation could 
be that the cell death pathway activated in the LRt is independent of the caspase cascade. 
Alternatively, this finding may indicate that after 2 days of IHH, neurons within the LRt are 
already in a late stage of cell death and so are detectable by the TUNEL method (a late marker of 
apoptosis) but not by staining for active caspase-3 which would already be degraded (Hartmann 
et al., 2000). This fits well with the findings in the developing mouse brain after ethanol 
treatment where the level of active caspase-3 increased to a peak at 8-12 h and then declined 
rapidly to undetectable levels by 16-24 h, the time point when ethanol induced apoptotic death 
by the DeOlmos silver stain peaked (Olney et al., 2002). Thus, in the current model of IHH, it is 
speculated that by 2 days, the peak of active caspase-3 expression may have already been 
missed. To confirm this, future studies would have to examine piglets after shorter exposures to 
IHH, for example at several time points between 12 h and 2 days. 
 
The DMNV compared to the seven other nuclei studied, exhibited changes for all 3 markers after 
IHH. Since the DMNV plays an important role in cardiorespiratory control, namely regulation of 
blood pressure and heart rate, an increase in active neuronal death after IHH may compromise 
these functions. Of interest, NMDA mediated cell death is characterised as excitotoxic (Ishimaru 
et al., 1999) raising the possibility that the increased cell death in the DMNV after IHH is via 
excitotoxic mechanisms. This possibility will be discussed further in Chapter 6.  
 
Since the cell death process is a transient phenomenon that can affect neuronal populations at 
different times and for differing durations when subjected to the same noxious stimulus, the 
effects of the duration of the IHH stimulus was studied. By using the active caspase-3 antibody, 
neurons in the early stage of the cell death pathway were detected, whereas the TUNEL stain 
(with morphological criteria) was used to detect a neuron in the late stage of its death. The 
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TUNEL data showed no significant effect of the IHH duration. The IHH stimulus given for 2 
days was sufficient to induce changes in TUNEL expression in three nuclei of the medulla and 
these same changes persisted after 4 days of IHH. For active caspase-3 however, changes 
occurred for two nuclei but only after 2 days of IHH, with none present after 4 days. These 
results suggest the cell death process was clearly underway by day 2 in certain nuclei with 
neurons at both early and late stages of the cell death cycle, whereas by day 4, only neurons at a 
late stage in the cell death pathway were present.  
 
The finding of increased TUNEL in the DMNV, LRt, and ION after IHH is clinically important, 
since it correlates well with the finding of increased TUNEL in these same nuclei in the SIDS 
infants’ medulla as observed by Waters et al., (1999). It is important however to note, that these 
infants expressed a wider distribution that extended to other nuclei as well, particularly those of 
sensory function. Nonetheless, the finding that a moderately acute stimulus of IHH is able to 
induce changes in TUNEL expression similar to that observed in SIDS infants, suggests that for 
at least a subset of SIDS infants, hypercapnic hypoxic conditions may have been experienced. 
 
4.5 Conclusion 
The important finding of this study is that a stimulus of IHH induces an increase in the number 
of neurons undergoing active cell death in the developing piglet brainstem. Although the precise 
form of cell death could not be determined, two markers for apoptosis (active caspase-3 and 
TUNEL) were affected, with different degrees depending on the duration of the stimulus. The 
results suggest that changes in active caspase-3, an early marker of the cell death pathway, may 
be occuring at less than 48 h after the initial IHH exposure. Given the functional relevance of the 
nuclei affected by IHH, in particular the DMNV, deficiencies in cardiorespiratory control may 
be present and could have important clinical implications for the mechanism of death in SIDS 
infants who slept prone.  
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Chapter 5 
NMDA receptor expression in a piglet model of IHH  
 
5.1 Introduction 
N-methyl-D-aspartate (NMDA) receptors have direct involvement in neuronal development, 
maturation and plasticity (McDonald et al., 1990, Martin et al., 1998). NMDA receptors exist as 
heteromeric complexes containing NR1 combined with one or more NR2 or NR3 subunits. The 
NR1 subunit, which is an obligatory component of functional NMDA receptors, is widely 
expressed in the central nervous system (CNS) and as such, serves as a useful marker in 
localizing NMDA receptors in brain tissue (Guthmann and Herbert, 1999).  
 
All previous reports on the cellular distribution of NR1 in the brainstem were performed in the 
cat (Ambalavanar et al., 1998), mouse (Wantanabe et al., 1994) and rat (Petralia et al., 1994; 
Kus et al., 1995;Guthmann and Herbert, 1999) using radioactive in situ hybridization (RISH) 
(Wantanabe et al., 1994; Guthmann and Herbert, 1999) and/or immunohistochemical (IHC) 
techniques (Petralia et al., 1994; Ambalavanar et al., 1998; Guthmann and Herbert, 1999). The 
cellular distribution of NR1 in the brainstem of the piglet has not yet been determined. Thus, the 
first part of this chapter reports the distribution of NR1 in the piglet brainstem at the level of the 
caudal medulla using both ISH and IHC techniques. 
 
To date, assessment of NR1 mRNA in the brainstem has only been determined by performing 
RISH. However, this does not permit accurate cellular localization of the mRNA. Furthermore, 
RISH allows only subjective and semi-quantitative comparisons of NR1 expression amongst the 
nuclei of the brainstem (Wantanabe et al., 1994). Non-radioactive in situ hybridization (non-
RISH) on the other hand, is rapidly gaining popularity because it provides more sensitive 
localization of mRNA at the cellular level. The signal intensity can also be objectively quantified 
using commercially available software (Larsson et al., 1991; Guiot and Rahier 1995). The 
second part of this chapter, reports the localisation and quantification of NR1 mRNA using non-
RISH, for eight nuclei of the caudal medulla and differentiates the findings between two 
neuronal populations, motor and sensory, since findings suggest that NR1 expression may differ 
between the two (Kus et al., 1995).   
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A body of evidence exists to support the contention that a hypoxic stimulus induces changes in 
NMDA receptor expression and function (Hoffman et al., 1994; Otoya et al., 1997; Delivoria 
Papadopoulos et al., 1998). Recent data has shown that exposing newborn piglets to hypoxia 
induces changes in NMDA receptor numbers and binding affinity in the cerebral cortex (Fritz et 
al., 2001). However, the effects of hypercapnic hypoxia have not yet been determined. The third 
part of this chapter investigates the effects of intermittent hypercapnic hypoxia (IHH) on the 
quantification of NR1 mRNA and protein expression in the same eight brainstem nuclei and tests 
the hypothesis that expression is increased after IHH exposure.  
 
5.2 Materials and Methods  
5.2.1 Piglet model of IHH 
Piglets were exposed to the IHH stimulus as described in Chapter 2 (section 2.2). A total of 17 
piglets assigned to either the control (n=6), 2dIHH (n=6) or 4dIHH (n=5) groups, were studied.  
 
5.2.2 Brainstem tissue used for staining 
Brains were removed, fixed and paraffin embedded as described in Chapter 2 (section 2.3). 
Tissue sections (7µm) at the level of the caudal medulla were used for staining. Two adjacent 
sections from each piglet were subjected to each staining method (i.e. n=2, per piglet, per stain. 
Refer to Chapter 2, section 2.11). 
 
5.2.3 Non-RISH for NR1 mRNA and quantitative analysis 
The NR1 probe sequences used and the non-RISH procedure are described in Chapter 2 (sections 
2.6.2.1 and 2.6.3, respectively). The staining intensity of NR1 mRNA was quantified using the 
procedure described in Chapter 2 (section 2.9) and was represented in optical density units (OD).  
 
5.2.4 IHC for NR1 protein and quantitative analysis 
Staining for NR1 protein was performed using a commercially available antibody for NR1 as 
described in Chapter 2 (section 2.7.4). Quantitation of NR1 protein was performed as described 
in Chapter 2 (section 2.10) and is represented as percent positive (% positive).  
 
5.2.5 Analysis 
Eight nuclei of the caudal medulla were analysed and included the XII, DMNV, LRt, ION, NTS, 
Gr, Cun and NSTT (Refer to Chapter 2, section 2.8.2 and Fig. 2.4). 
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Results are presented as mean ± SEM unless otherwise stated. Statistical analysis was 
undertaken using SPPS for Windows (V10.0.5, Chicago, USA). One-way ANOVA was used to 
compare amongst the three piglet groups for all staining quantification with Bonferonnis’ 
adjustment for post-hoc analyses. A 2-tailed p-value of < 0.05 was considered statistically 
significant.  
 
5.3 Results 
5.3.1 Dataset characteristics 
The characteristics of the piglets used for this study have been reported in Chapter 3 (section 
3.3.1) and can be found in Table 3.1. 
 
5.3.2 General distribution of NR1  
NR1 mRNA (Fig 5.1A) and protein (Fig 5.2A) were expressed in all eight nuclei of the piglet 
caudal medulla that were studied. In general, motor neurons that were large in size and 
multipolar in shape had greater NR1 mRNA and protein expression compared to sensory 
neurons, which were mostly moderate to small in size and unipolar. The average size and range 
of neuron size is shown for the eight nuclei in Table 5.1 
 
Table 5.1. Average diameter size and range of neurons in eight nuclei of the piglet caudal 
medulla.  
Nucleus Neuron size  
µm ± SEM             range (min-max)  
Motor 
     XII 
     LRt  
     ION  
     DMNV 
Sensory 
     NSTT  
     Cuneate 
     Gracile 
     NTS 
 
 35.2 ± 0.5                  (33.2 – 36.5) 
 37.7 ± 0.8                  (31.7 – 37.3) 
 26.8 ± 0.7                  (24.6 – 28.7) 
 26.4 ± 0.5                  (25.1 – 27.8) 
 
 28.2 ± 0.3                  (27.5 – 29.6) 
 28.6 ± 1.2                  (24.8 – 33.7) 
 28.1 ± 0.9                  (25.3 – 31.6) 
 20.9 ± 0.3                  (19.9 – 21.7) 
        Size was determined by image analysis software. Results are expressed as  
        average diameter size in µm ± SEM. 
 
5.3.3 NR1 staining 
mRNA expression: All neurons in the nuclei of interest stained positively for NR1 mRNA. 
Positive staining was evident by the brown/maroon colour staining. The intensity of staining 
varied. Larger motor neurons showed more intense expression of mRNA than the smaller 
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sensory neurons. The mRNA was localized in the cytoplasm and nucleolus of motor neurons 
(Fig. 5.1B) but was dispersed throughout the cellular compartments of the sensory neurons (Fig. 
5.1C) with a tendency for higher intensity in the nucleolus.  
 
protein expression: Not all neurons stained positively for NR1 protein. Neurons positively 
stained for NR1 protein were identified as having a blue stained cytoplasm as compared to 
negative neurons, which had no staining in the cytoplasm (white/pale blue in colour) and in 
which the staining intensity was equivalent to the background intensity. Staining was strictly 
localized to the cytoplasm of both motor and sensory neurons. It was difficult to distinguish 
between the staining intensity of the motor and sensory neurons and among the eight nuclei (Fig. 
5.2A). Although, the ION was always the most intensely stained, it was also associated with a 
higher level of background staining (Fig. 5.2B).  
 
5.3.4 Quantification under control conditions  
mRNA: The XII nucleus had the greatest OD (0.55 ± 0.02) whereas the NTS had the lowest (0.24 
± 0.01) (Fig. 5.3A). The nuclei difference for mRNA expression, ranked in order from highest to 
lowest OD, was XII > LRt > ION = DMNV > NSTT > Cun > Gr > NTS (Fig. 5.3A).  
 
protein: The ION had the highest proportion of positive neurons (84.8% ± 2.2) while the NTS 
had the lowest (55.5% ± 4.5) (Fig. 5.3B). The nuclei differences for NR1 protein, ranked in order 
from highest to lowest for % positive was ION > DMNV > XII > LRt > NSTT > Cun = Gr = 
NTS (Fig. 5.3B).  
 
5.3.5 Effect of IHH  
Exposure to 2 days of IHH had no significant effect on NR1 mRNA or protein expression in any 
of the nuclei studied when compared to controls. However, after 4 days of IHH, there was a 
significant increase in NR1 mRNA expression in the XII, DMNV and Gr nuclei (p<0.05 for all) 
(Fig. 5.3A), and a significant decrease in the proportion of neurons positive for NR1 protein in 
the DMNV (p<0.05) (Fig. 5.3B) when compared to controls.  
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Fig. 5.1 Staining expression for NR1 mRNA in the piglet caudal medulla.  
NR1 mRNA visualised by non-radioactive in situ hybridization in a normal control piglet. (A) Transverse 
section of the piglet caudal medulla, (B) motor neurons of the XII nucleus, and (C) sensory neurons of the 
NTS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.2 Staining expression for NR1 protein in the piglet caudal medulla. 
NR1 protein visualised by immunohistochemistry in a normal control piglet. (A) Transverse section of the 
piglet caudal medulla, and (B) neurons of the ION. NR1 positive neuron (black filled arrow) and NR1 
negative neuron (white filled arrow head). 
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Fig. 5.3 Quantitative results of NR1 mRNA and protein in the piglet caudal medulla. 
(A) Quantitation of NR1 mRNA expressed in optical density units OD ± SEM and, (B) for NR1 protein 
expressed as % positive neurons ± SEM in 8 individual nuclei of the caudal medulla. Controls (n = 6) vs 
2dIHH (n=6) and 4dIHH (n = 5). * p<0.05 between control and IHH groups.  
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5.4 Discussion 
5.4.1 NR1 distribution 
NR1 is widely distributed in the piglet medulla, which is consistent with the wide distribution 
observed in the rat (Petralia et al., 1994; Kus et al., 1995; Guthmann and Herbert, 1999), cat 
(Ambalavanar et al., 1998) and mouse (Watanabe et al., 1994). The NR1 protein distribution, 
confined to the cytoplasm of neurons, is also consistent with the above studies. This concurs 
with the hypothesis that the cytoplasmic localization of the NR1 subunit is associated with 
cytoplasmic organelles involved in protein synthesis and/or is associated with an intracellular 
NMDA receptor (Turman et al., 1999). Given that NMDA receptors are localized on the cell 
membrane (Hoffman et al., 1994), one would expect the cell membrane to also be stained for 
NR1 protein. However, such determination was beyond the scope of the methodology used in 
this study due to two main reasons. First, the strong intensity of staining in the cytoplasm of 
neurons may have obscured staining confined to the membrane. Second, the level of 
magnification used to identify staining localization did not permit separation of membrane from 
cytoplasmic staining. 
 
In contrast to RISH methods, the non-RISH method permitted cellular localization of NR1 
mRNA. It was found that like the protein, NR1 mRNA is localized to the cytoplasm but it is also 
present in the nucleolus of motor neurons. In neurons of sensory function, NR1 mRNA was 
dispersed throughout the cellular compartments with a tendency to be more intense in the 
nucleolus. This study therefore, presents for the first time, the localization and distribution of 
NR1 mRNA within brainstem neurons.  
 
Methodological note: 
The oligonucleotide probes for NR1 mRNA that were used in the non-RISH method of this 
study, were taken from Bayer et al., 1995. Bayer et al., 1995 found that compared to 
ribonucleotide NR1 cDNA probes, the NR1 mRNA oligonucleotide probes were less sensitive 
and less specific, i.e. they yielded a lower signal to background ratio and were localized in most 
cellular compartments rather than just the cytoplasm. However, the antigen retrieval method 
employed by Bayer et al., 1995 was proteinase K digestion. In this study, antigen retrieval 
involved microwaving in Tris/EDTA buffer. In our laboratory, we (Relf, Machaalani and 
Waters, 2002) compared the effects of three retrieval methods, proteinase K digestion, 
autoclaving and microwaving on the signal from the non-RISH protocol. We found that 
microwaving produced a more specific and sensitive signal compared to the other two retrieval 
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methods; i.e., a higher signal to noise ratio and specific cellular localisation was observed after 
microwaving but not the other two methods.  
 
5.4.2 NR1 quantification 
It has been suggested that the expression of mRNA in a neuron may not always coincide with 
expression of protein (Sucher et al., 1993; Petralia et al., 1994). The results of this study 
confirmed that this indeed was the case for the eight nuclei studied. All neurons demonstrated 
NR1 mRNA expression (albeit at varying levels of intensity) but not all neurons showed positive 
staining for the NR1 protein. This suggests that all neurons produce NR1 mRNA but the 
presence of the mRNA does not always equate with translation into cellular protein. For this 
reason, counting the number of positively stained neurons and expressing this value as a 
percentage of the total number of neurons was an appropriate quantitative method for NR1 
protein but not mRNA. 
 
As mentioned previously, the eight nuclei studied were selected on the basis of their functional 
relevance to cardiorespiratory control, sleep and arousal. The first objective of this study was to 
quantify the NR1 expression in these nuclei and compare them on the grounds of their primary 
function of motor or sensory, since it has been found that these two neuronal populations express 
NR1 mRNA differentially, with greater expression amongst motor neurons (Kus et al., 1995). 
This study found that all four motor nuclei had greater expressions for NR1 mRNA and protein 
compared to the four sensory nuclei. However, the precise order of ranking varied amongst the 
motor nuclei for mRNA as compared to protein. The XII had greater mRNA compared to the 
ION while the opposite was true for NR1 protein. A study of NMDA receptor binding in the 
infant human medulla (Panigrahy et al., 2000b) examined 4 of the 8 nuclei that were studied here 
and found that binding for the NMDA receptor was greatest in the ION, followed by the XII, 
DMNV and least in the NTS. This order of binding is consistent with the NR1 protein ranking 
for the 4 nuclei found in this study. Therefore, the results of this study show that there is a clear 
distinction between motor and sensory expression for NR1 in the piglet medulla and is consistent 
with the findings in the rat brainstem (Kus et al., 1995) and, to some extent the findings in the 
infant human medulla (Panigrahy et al., 2000b). However, the functional implications of these 
findings remain unclear.  
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5.4.3 Effects of IHH 
The general increase in mRNA expression may be an indication of an increased rate of gene 
transcription in response to IHH, possibly associated with inhibition of mRNA translation to 
protein. The lack of simultaneous change in the general proportion of neurons positive for NR1 
protein cannot be assumed to indicate that NR1 protein expression is unaffected by IHH. Since 
cell counts were performed only, without volumetric and/or intensity measurements, it remains 
possible that there were undetectable changes present in NR1 protein after IHH. 
 
Differential changes in mRNA levels and protein levels for NR1 have been reported in cerebellar 
granule cell cultures in response to chronic depolarization (Resink et al., 1995) and in some 
brain areas of the mouse following chronic ethanol treatment (Snell et al., 1996). Thus, 
functional interpretations of pathophysiological conditions, requires analysis of more than 
mRNA, which is not automatically reflected in the levels of protein expression. The DMNV 
showed this inverse effect of increased mRNA but decrease in protein to the greatest extent with 
some evidence also in the NTS after IHH exposure.  
 
In the postnatal piglet, stimulation of ventilation during hypoxia by the carotid body is mediated 
by the release of glutamate and its interactions with NMDA receptors in the NTS (McCormick et 
al., 1998). The NTS is the main sensory nucleus in the medulla and receives input necessary for 
cardiovascular and respiratory control (Dampney, 1994). Functional studies have shown that 
afferents from the NTS activate NMDA receptors in the DMNV (Willis et al., 1996). Thus, 
under IHH, it seems likely that NTS neurons are excited causing glutamate to be released which 
then act on the NMDA receptors of the DMNV. This finding of changed NMDA expression in 
the DMNV after IHH is noteworthy, especially since the DMNV was also found to have changes 
in cell death markers as observed in Chapter 4, suggesting that NMDA mediated excitotoxicity 
may be the mechanism of cell death after IHH.  This will be examined further in Chapter 6. 
 
5.5 Conclusion 
NR1 is widely distributed in the piglet caudal medulla and is consistent with the distribution 
observed in other species. This study reports, for the first time, the cellular distribution of NR1 
mRNA in neurons of the brainstem of piglets and shows that it is localized to the cytoplasm and 
nucleolus of motor neurons but dispersed throughout the cellular compartments of sensory 
neurons. All neurons were found to express NR1 mRNA but not protein, so two different 
methods for quantification had to be used. Both methods showed a clear distinction in the level 
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of NR1 expression between motor and sensory nuclei with expression in the motor nuclei being 
greater. Exposure to IHH caused changes in both mRNA and protein levels but only after 4 days 
of IHH, with more changes observed for mRNA than protein. NR1 mRNA levels increased in 
three nuclei while protein levels decreased in one of these three nuclei. These results support the 
involvement of the NMDA receptor in responses to IHH, and suggest that the effects are induced 
after chronic exposure (4 days).   
 
 
 
 
Chapter 6: Correlation between the NMDA receptor and neuronal death in a piglet model of IHH.  
          
81
Chapter 6 
Correlation between the NMDA receptor and 
neuronal death in a piglet model of IHH  
 
6.1 Introduction 
NMDA mediated excitotoxic cell death appears to be the main form of neuronal injury after 
hypoxia and hypoxic ischemia, particularly since both types of exposures induce changes in 
NMDA receptor expression and/or function ( Chapter 5; Hoffman et al., 1994; Kim et al., 1998; 
Fritz et al., 2001; Guerguerian et al., 2002; Zanelli et al., 2002). NMDA receptors dominate in 
the immature brain as compared to the adult brain (Panigrahy et al., 2000b), making the 
immature brain more vulnerable to excitotoxic damage (McDonald et al., 1990).  
 
As documented in Chapter 5, NR1 mRNA and protein are widely distributed in the piglet 
medulla and exposure to IHH induced changes in the expression of both, but only in selected 
nuclei. Similarly, in Chapter 6, IHH was shown to induce an increase in TUNEL, but also only 
in selected nuclei. 
 
Because NMDA expressing neurons are vulnerable to excitotoxicity after noxious stimulation, 
the hypothesis for this chapter is that active neuronal cell death would be more prevalent in 
NMDA expressing neurons after IHH compared to non-NMDA expressing neurons. Double 
immunohistochemistry, performed to co-localise NR1 protein and TUNEL, evaluated:  
1- cell death expression amongst NMDA and non-NMDA neuronal populations in the 
caudal medulla under normal conditions, and  
2- whether a correlation exists between the presence of the NMDA receptor and increased 
active cell death after IHH.  
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6.2 Materials and Methods  
6.2.1 Piglet model of IHH 
Piglets were exposed to the IHH stimulus as described in Chapter 2 (section 2.2). A total of 17 
piglets, assigned to either the control (n=6), 2dIHH (n=6) or 4dIHH (n=5) groups were studied.  
 
6.2.2 Brainstem tissue used for staining 
Brain removal, fixation and tissue processing have been described in Chapter 2 (section 2.3). 
Tissue sections (7µm) at the level of the caudal medulla were used for staining. Two adjacent 
sections from each piglet were subjected to each staining method (i.e. n=2, per piglet, per stain. 
Refer to Chapter 2, section 2.11). 
 
6.2.3 Double IHC for TUNEL and NR1 protein 
The co-localisation of TUNEL and NR1 protein was performed as described in Chapter 2 
(section 2.7.5).  
 
6.2.4 Quantitative IHC 
Images were captured as described in Chapter 2 (section 2.10.1) and four counts were made for 
each image as follows: 1- NR1 positive, 2- NR1 negative, 3- NR1 and TUNEL co-localised and 
4- TUNEL in NR1 negative. Counts for each animal were summed for the captured images from 
within each nucleus and results calculated to give the percent of neurons positive for: 
1- NR1 (%NR1),  
2- TUNEL (%TUNEL),  
3- TUNEL amongst the NR1 population of neurons (% TUN in NR1) and  
4- TUNEL amongst the remainder (non-NR1) population of neurons (% TUN in non-NR1).  
 
6.2.5 Analysis 
Eight nuclei of the caudal medulla were analysed and included the XII, DMNV, LRt, ION, NTS, 
Gr, Cun and NSTT (Refer to Chapter 2, section 2.8.2 and Fig. 2.4). 
 
Results are presented as mean ± SEM. Statistical analysis was undertaken using SPSS for 
Windows (V10.0.5, Chicago, USA). One-way ANOVA was used to compare amongst the control, 
2dIHH and 4dIHH piglet groups for all staining quantification (% positive for counts 1,2,3 or 4) 
with Bonferonnis’ adjustment for post-hoc analyses. A 2-sided p-value of < 0.05 was considered 
statistically significant.  
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6.3 Results 
6.3.1 Dataset characteristics 
The characteristics of the piglets used for this study have been reported in Chapter 3 (section 
3.3.1) and can be found in Table 3.1. 
 
6.3.2 Staining  
A neuron that was positive for NR1 had a blue stained cytoplasm. Neurons were only counted as 
TUNEL positive if they had a dark brown/black nucleus and appeared shrunken with clumping 
of nuclear material, both of which are characteristic of a neuron undergoing cell death (Fig. 6.1). 
Light brown nuclear staining was not counted as TUNEL positive since morphologically, these 
neurons did not show characteristics of a dying neuron.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6.1 Double immunostaining for NR1 protein and TUNEL  
Staining in the dorsal motor nucleus of the vagus (DMNV) of a control piglet (A) compared to a piglet 
exposed to 2 days of IHH (B), and in the inferior olivary nucleus (ION) of a control piglet (C) compared 
to a piglet exposed to 2 days of IHH (D). NR1 positive only neuron (black filled arrow), TUNEL positive 
only neuron (black filled arrow head), TUNEL positive in an NR1 positive neuron with shrunken 
appearance (white filled arrow). Note the large NR1 positive neurons that seem to be TUNEL positive 
(small white filled arrow heads) but were not counted as such because they were not morphologically 
consistent as dying neurons (refer to text). Calibration bar = 30 µm for all panels. 
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6.3.3 Quantification 
6.3.3.1. NR1 alone 
Quantification of NR1 has been presented in Chapter 5 (sections 5.3.4 and 5.3.5) and in Fig. 
5.3B. These results are re-presented in Table 6.1 to allow for easier comparison with the 
following results.  
 
6.3.3.2 TUNEL alone 
Quantification of TUNEL has been presented in Chapter 4 (section 4.3.3.3) and in Fig. 4.2C. 
These results are re-presented in Table 6.2 to allow for easier comparison.  
 
6.3.3.3 TUNEL amongst the NR1 vs non-NR1 population 
In controls, of the eight nuclei studied, the NTS had a significantly greater amount of TUNEL 
positive neurons amongst the NR1 population than amongst the non-NR1 population (ratio of 
TUNEL in NR1 to non-NR1 = 1:0.5, p=0.03). There was no significant difference in ratio for 
any of the nuclei in the 2dIHH group, whereas for the 4dIHH group, the %TUN in the non-NR1 
population was greater than in the NR1 population in the LRt (ratio 1:1.5, p=0.02) (Table 6.3). 
 
6.3.3.4 TUNEL amongst the NR1 population 
In controls, the % TUN in NR1 varied from 1% (DMNV) to 5% (LRt, Gr, Cun, NSTT) (Table 
6.4). After 2 days of IHH, % TUN in NR1 was significantly increased in the DMNV (p=0.007) 
and ION (p=0.05). After 4 days of IHH, the increase remained significant in the ION (p=0.05) 
and was now significant in the NSTT (p=0.03) but no longer in the DMNV (Table 6.4). 
 
6.3.3.5 TUNEL amongst the non-NR1 population 
In controls, the % TUN in non-NR1 varied from 2% (NTS) to 6% (NSTT), (Table 6.5). After 2 
days of IHH, there was a significant increase in the % TUN in non-NR1 in the LRt (p=0.05), 
NTS (p=0.004) and gracile (p=0.05). After 4 days of IHH, the increase persisted in the LRt (p= 
0.006) and the NTS (p=0.05) (Table 6.5).  
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Table 6.1: Comparison between the 3 piglet 
groups for percent NR1 positive in eight 
nuclei of the caudal medulla. 
Nuclei Control 2dIHH 4dIHH 
ION 
DMNV  
XII 
LRt 
NSTT 
Gracile 
Cuneate   
 NTS 
84.8 ± 2.2 
74.7 ± 5.2 
72.1 ± 2.4 
71.4 ± 4.1 
65.8 ± 3.0 
56.0 ± 3.8 
55.5 ± 4.2 
55.8 ± 4.5 
85.8 ± 1.3 
73.3 ± 3.3 
74.4 ± 3.2 
72.4 ± 3.7 
69.0 ± 1.4 
60.0 ± 2.0 
58.3 ± 3.5 
56.1 ± 2.5 
79.8 ± 3.9 
55.8 ± 4.7*, # 
69.4 ± 2.4 
75.3 ± 4.0 
66.9 ± 5.2 
61.5 ± 4.3 
50.8 ± 8.8 
41.8 ± 3.2# 
Results are presented as % ± SEM in order from 
highest to lowest %NR1 according to the control 
group. * p < 0.05 when compared to controls, # p < 
0.05 4dIHH compared to 2dIHH.  
 
 
Table 6.2: Comparison between the 3 piglet 
groups for percent TUNEL positive in eight 
nuclei of the caudal medulla.  
Nuclei Control 2dIHH 4dIHH 
ION  
DMNV  
XII 
LRt 
NSTT 
Gracile 
Cuneate 
NTS 
5.2 ± 2.2 
3.1 ± 1.0 
3.8 ± 1.0 
5.1 ± 0.8 
5.8 ± 1.4 
5.3 ± 1.0 
5.6 ± 1.1 
7.3 ± 2.1 
6.5 ± 2.5 
7.6 ± 1.0* 
4.7 ± 0.8 
8.1 ± 1.0* 
7.9 ± 1.1 
12.0 ± 2.4 
9.9 ± 1.7 
13.4 ± 2.3 
10.3 ± 3.8* 
7.1 ± 0.7* 
4.6 ± 1.4 
7.6 ± 0.8* 
6.6 ± 1.1 
8.5 ± 1.8 
7.2 ± 1.0 
11.9 ± 2.1 
Results are presented as % ± SEM. * p < 0.05 when 
compared to controls. Note the non-significant 
increasing trends in the gracile, cuneate and NTS in 
the 2dIHH group.
Table 6.3: Ratio of percent TUNEL in NR1 to percent TUNEL in non-NR1 in eight nuclei of the 
caudal medulla for each individual piglet group. 
Nuclei Control p-value 2dIHH p-value 4dIHH p-value 
ION 
DMNV  
XII 
LRt 
NSTT 
Gracile 
Cuneate 
NTS 
1:2.2 
1:0.7 
1:2.1 
1:0.8 
1:1.3 
1:0.7 
1:0.9 
1:0.5 
0.08 
0.38 
0.69 
0.64 
0.33 
0.08 
0.73 
0.03 
1:0.6 
1:1.4 
1:1.0 
1:1.4 
1:1.1 
1:1.5 
1:1.4 
1:1.1 
0.23 
0.50 
0.28 
0.43 
0.79 
0.88 
0.69 
0.78 
1:1.1 
1:1.0 
1:0.6 
1:1.5 
1:1.1 
1:1.1 
1:1.3 
1:1.2 
0.91 
0.42 
0.15 
0.02 
0.57 
0.47 
0.39 
0.67 
 P value compares the %TUN in NR1 to %TUN in non-NR1 for each piglet group. 
 
Table 6.4: Comparison between the 3 piglet 
groups for percent TUNEL positive amongst 
the NR1 population in eight nuclei of the 
caudal medulla.  
Nuclei Control 2dIHH 4dIHH 
ION 
DMNV  
XII 
LRt 
NSTT 
Gracile 
Cuneate 
NTS 
2.9 ± 1.3 
1.3 ± 1.3 
2.7 ± 2.3 
4.6 ± 1.7 
4.5 ± 1.2 
5.0 ± 0.3 
5.2 ± 1.0 
4.3 ± 0.5 
7.7 ± 3.5* 
5.5 ± 0.9** 
5.5 ± 1.6 
8.2 ± 1.3 
7.9 ± 0.8 
8.2 ± 1.5 
6.3 ± 1.2 
7.4 ± 1.5 
6.1 ± 1.9* 
4.5 ± 1.1 
5.1 ± 2.0 
7.4 ± 1.5 
6.7 ± 0.9* 
5.3 ± 1.8 
7.1 ± 1.4 
7.4 ± 1.8 
Results are presented as % TUN in NR1 ± SEM. 
**p<0.01, * p<0.05 when compared to controls 
Table 6.5: Comparison between the 3 piglet 
groups for percent TUNEL positive amongst 
the non-NR1 population in eight nuclei of 
the caudal medulla.  
Nuclei Control 2dIHH 4dIHH 
ION 
DMNV  
XII 
LRt 
NSTT 
Gracile 
Cuneate 
NTS 
5.3 ± 1.1 
3.1 ± 2.1 
4.0 ± 2.1 
3.6 ± 2.0 
5.7 ± 1.1 
3.5 ± 0.9 
4.5 ± 1.9 
2.3 ± 0.8 
5.0 ± 1.2 
6.9 ± 1.5 
2.4 ± 1.5 
10.2 ± 1.4* 
8.4 ± 1.2 
8.6 ± 1.5* 
7.1 ± 1.3     
6.9 ± 1.2** 
6.2 ± 1.5 
6.0 ± 1.9 
2.6 ± 1.9 
10.9 ± 1.8**
7.7 ± 1.5 
7.3 ± 1.8 
8.8 ± 1.6 
8.6 ± 1.5* 
Results are presented as % TUN in non-NR1 ± SEM. 
**p<0.01, * p<0.05 when compared to controls 
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6.4 Discussion 
The aim of this chapter was to determine the relationship between cell death, labelled by 
TUNEL, and NR1 protein expression in nuclei of the piglet medulla after IHH. The results 
provide insight into the characteristics of the neurons vulnerable to cell death. Double 
immunohistochemistry was used to indicate the receptor phenotype of the neurons undergoing 
cell death at the light microscopic level. This method involved co-localising NR1 protein and 
TUNEL and aimed to identify whether NMDA expressing neurons are susceptible to cell death 
after IHH.  
 
Under control conditions, neuronal death was equivalent amongst both NMDA and non-NMDA 
neurons in all nuclei studied except for the NTS where there was a high correlation between 
NMDA expression and neuronal death. After IHH, NMDA expressing neurons (NR1 positive) 
showed vulnerability to death in nuclei with high baseline NMDA expression (>75% positive for 
NR1). In contrast, for brainstem nuclei with relatively low baseline NMDA expression (<60% 
positive for NR1), death after IHH predominantly tended to affect non-NMDA expressing 
neurons. The chronicity of the IHH stimulus had no significant effect on the results of this study, 
with most of the changes that were evident after 2 days of IHH persisting after 4 days of IHH. 
 
A variety of mechanisms can cause DNA fragmentation. But after hypoxic insults (for example, 
hypoxia alone, hypoxic ischemia, or hypercapnic hypoxia), it is postulated that excitotoxicity, by 
way of the NMDA receptor, is responsible. This is supported by the wide distribution of the 
NMDA receptor in the piglet brain (Chapter 5; Guerguerian et al., 2002), the known changes in 
expression and function under each condition ( Chapter 5; Hoffman et al., 1994; Kim et al., 
1998; Fritz et al., 2001; Guerguerian et al., 2002; Zanelli et al., 2002) and the involvement of the 
NMDA receptor in cell death when pathologically overstimulated, a process known as 
excitotoxicity (Choi, 1990).  
 
Nuclei with high NMDA receptor content (>75% of cells NR1 positive) appear to have been 
more vulnerable to IHH induced cell death as compared to NMDA expressing neurons in nuclei 
of a low NMDA receptor content (<60% of cells NR1 positive). Although an increase in cell 
death after IHH occurred in both NR1 and non-NR1 neurons, the affected phenotype was 
consistent within each nucleus. In the control group, and therefore during normal development of 
the piglet, the proportion of neurons undergoing cell death is not different between the NR1 and 
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non-NR1 neurons, except for the NTS where more NR1 neurons were TUNEL positive. 
However, after IHH, NR1 neurons in the DMNV, ION and NSTT showed a significant increase 
in TUNEL positivity, whilst in the NTS, Gracile and LRt, the increase in TUNEL positivity was 
in non-NR1 neurons. This specificity for phenotype within particular nuclei followed the same 
pattern as the basal NR1 content of the nucleus. Nuclei with a greater NR1 content, such as the 
ION and DMNV, were more likely to have NR1 neurons undergo cell death compared to nuclei 
such as the NTS and Gracile, where the non-NR1 neurons were predominantly affected. These 
findings support the hypothesis that NMDA expressing neurons in brain regions with a higher 
NMDA receptor content are more vulnerable to hypoxic insults compared to NMDA expressing 
neurons in regions with a lesser NMDA content (Panigrahy et al., 2000b).  In nuclei with 
intermediate NMDA expression (60 to 70% NR1 neurons, i.e. LRt and NSTT), TUNEL 
positivity showed no bias towards NMDA or non-NMDA neurons. 
 
Although the basal NMDA content may be the major determinant of nuclei vulnerability to IHH, 
the difference in functional activity of these nuclei in regulating cardiovascular, respiratory, 
sleep and arousal functions may participate in the vulnerability, and this would be of clinical 
importance. 
 
It has been suggested that the ION is especially vulnerable to hypoxia induced excitotoxicity in 
early life (Kinney et al., 2002), namely because of the high concentration of glutamate receptors 
in this nucleus (Panigrahy et al., 2000b). In the control piglets of this study, the ION had the 
greatest proportion of NR1 neurons compared to the other seven nuclei studied. Despite this 
finding, the proportion of NR1 neurons that were TUNEL positive was less than that of non-NR1 
neurons with a ratio of 1:2.2, suggesting that for every one NMDA bearing neuron that is dead in 
the ION under control conditions, two non-NMDA bearing neurons are also dead. However, 
after IHH, TUNEL increased within the NR1 population of neurons, suggesting that NMDA 
bearing neurons of the ION are more vulnerable to the IHH stimulus compared to non-NMDA 
expressing neurons. The functional role of the ION is to co-ordinate ventilatory skeletal muscles 
and airway patency via its precerebellar connections (Panigrahy et al., 2000a). Thus, IHH 
induced neuropathological changes in the ION would theoretically affect ventilatory muscle co-
ordination and airway patency.   
 
In the DMNV, after 2 days of IHH, there was a significant increase in TUNEL that was specific 
to the NR1 neurons. After 4 days of IHH, these levels were still increased but the total 
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percentage of NR1 neurons present in the nucleus had decreased. Given that increased cell death 
ultimately equates to cell loss, the decrease in NR1 protein after 4 days may represent a loss in 
NMDA expressing neurons. Any functional outcome resulting from the changes observed in the 
DMNV have yet to be determined, but cardiorespiratory activities, particularly regulating blood 
pressure and heart rate, would be of interest. 
 
In the NTS, most cell death after IHH occured in neurons that did not express NR1. When 
studying for TUNEL alone, there was a non-significant trend to increased TUNEL, but when 
seperated by phenotype, the increase in TUNEL was only significant amongst the non-NR1 
neurons. Thus, it seems that in the NTS, non-NMDA neurons are more correlated with active 
cell death after IHH. The NTS is involved in cardiovascular and respiratory control, being the 
principal site of termination of primary afferent fibres arising from cardiovascular receptors and 
other visceral and somatic receptors (Dampney, 1994). Electrophysiological and 
pharmacological studies of the NTS mediated aortic baroreceptor and chemoreceptor reflexes 
found that the aortic baroreceptor reflex was completely abolished by blocking the non-NMDA 
type receptors whilst blocking the NMDA receptors had no effect (Andresen et al., 1990; 
Gordon et al., 1991; Kubo et al., 1990). The chemoreceptor reflex on the other hand, was 
abolished by simultaneously blocking both NMDA and non-NMDA type receptors (Vardhan et 
al., 1993). Given that the NTS mediated chemoreceptor reflex is subject to respiratory 
modulation (Daly et al., 1986), it seems resonable to conclude that IHH induced depression of 
subsequent respiratory responses to CO2 and enhancement of respiratory responses to hypoxia 
observed in a group of these piglets (Waters and Tinworth, 2001), may be the functional 
correlate of the induced of neuronal death after IHH as it pertains to the NTS. Further studies 
will be required to determine whether baroreceptor reflexes have also been affected. 
 
6.5 Conclusion 
This study examined neuronal cell death expression in NMDA as compared to non-NMDA 
expressing neurons, within eight nuclei of the piglet caudal medulla and determined whether 
IHH induced active cell death correlated with a particular neuronal phenotype. The results 
showed that in piglets exposed to IHH, active cell death labelled by TUNEL increased and 
correlated with NMDA expressing neurons in the DMNV, ION and NSTT. TUNEL positivity 
was also increased in non-NMDA expressing neurons in the LRt, NTS and Gracile. The affected 
neuronal phenotype (NMDA or non-NMDA) was consistent within the nucleus being studied 
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after 2 and 4 days of IHH. NMDA-expressing neurons were more likely to undergo active cell 
death if they were present in nuclei with greater baseline NMDA expression. These same nuclei 
tend to be involved in control of airway patency, heart rate and blood pressure control. This 
study therefore identifies, for the first time, nuclei in the developing brainstem that are 
vulnerable to a moderate IHH stimulus and in which the NMDA receptor appears to be involved 
in the vulnerability to, and/or modulation of cell death.  
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Chapter 7 
Infant dataset characteristics 
7.1 Introduction 
Sudden Infant Death Syndrome (SIDS) is a major cause of postneonatal mortality (i.e. deaths 
between 28 days and one year of age) in developed countries. The diagnosis of SIDS is one of 
exclusion and current criteria depend on epidemiological and autopsy data. Here in NSW, 
Australia, every infant who dies in their first year of life becomes a case where the Coroner must 
determine the cause of death. As such, for each infant, a death scene investigation is performed, 
clinical data collected and, an autopsy is conducted.  
 
There are currently no autopsy findings widely accepted as being specific to, or a characteristic 
finding of, SIDS. However, the presence of petechiae in the thoracic cavity and pulmonary 
congestion and/or oedema are often reported (Valdes-Dapena, 1992; Haas et al., 1993; Becroft et 
al., 1998; Krous et al., 2001).  
 
Other features have been identified and still remain characteristic of SIDS deaths. These include 
an incidence peak between 2 and 4 months of age, death during a sleep period with more reports 
in the winter months (Dwyer et al., 1995), and being found in the prone sleeping position with or 
without the face down into the sleeping surface or head covering. 
 
Other characteristics said to enhance the risk of SIDS include gender (male predominance)  
(Mitchell and Stewart, 1997; Adams et al., 1998; AIHW, 2001), prematurity (< 37 weeks 
gestation) (Kulkarni et al., 1978; Hoppenbrouwers et al., 1993; Malloy et al., 1995), low birth 
weight (< 2.5 kg) (Yount et al.,1979; Black et al., 1986; Pollack and Frohna, 2001), younger 
maternal age (16-29 years of age) (Wierenga et al., 1990; Leach et al., 1999; Arnestad et al., 
2001), and cigarette smoke exposure (Anderson and Cook, 1997; Henderson-Smart et al., 1998).  
 
This chapter will characterise a dataset of infant deaths that was available for study, and then 
compare it with other published datasets. Analyses are also provided for a subgroup of this 
dataset for whom neuropathological studies were carried out and for which the results are 
presented in Chapters 8-10. The subgroup was studied neuropathologically before ethical 
constraints; i.e. changes in the Human Tissue Act in NSW, Australia were implemented.  
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7.2 Materials and Methods  
7.2.1 Data collection 
Death scene reports, clinical data sheets and autopsy records were accessed at the Institute of 
Forensic Medicine in Glebe, NSW, for all cases from 1997 to February 2000. All cases were 
number coded and identifying information (name and address), removed prior to analysis.  
 
A standard questionnaire [Appendix 2] was developed and used to collect information relevant 
in SIDS research. The information collected fall under 5 general categories as summarized in 
Table 7.1. Additional information relating to tissue handling was also obtained because of the 
potential for these factors to impact histopathological outcomes. 
 
Table 7.1: General category and specific information of data collected for all infant cases under 
the age of 1 year. (Refer to Appendix 2 for the actual questionnaire form). 
General Category Specific information collected 
Identification Subject number, diagnosis, age, gender, date and time of death 
Perinatal history Date of birth, gestational age, birth weight 
Autopsy findings Date and time of autopsy, weight, length, head circumference, brain 
weight, neurological findings including gliosis, pulmonary oedema/ 
aspiration/ congestion, petechiae (thymic/pulmonary/epicardial/thoracic)  
Past history Immunisation, presence of recent upper respiratory tract infection (URTI), 
duration of URTI, malformations/other diagnosis 
Family history History of SIDS, other history, maternal age  
Risk factors Sleep related: bedshare, sleep position last placed and found, head/face 
position, time last seen alive, time found.  
Exposure to cigarette smoke or drugs.  
Month and season of death. 
 
7.2.2 Data analysis 
Data was collated and where appropriate, was exported to SPSS for Windows (V11.5, Chicago, 
USA) for statistical analysis. Clinical and autopsy characteristics were compared between groups 
(SIDS and non-SIDS) using Student’s t-test, and all results are presented as mean ± SD unless 
otherwise stated. Information concerning past history, family history and risk factor parameters, 
were calculated as a percentage of the total number of cases and compared between the two 
groups. Where data was not available for the entire group, the total number included in the 
calculation is presented in parentheses along with the analyses. A p-value of < 0.05 was 
considered statistically significant. 
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7.3 Results 
7.3.1 Composition of the entire infant dataset  
A total of 139 cases were analysed. Full data for all individual cases is included in Appendices 3 
and 4. Of 139 cases, 62 were diagnosed as SIDS, 13 as consistent with SIDS and 2 as probable 
SIDS. Although “consistent with SIDS” and “probable SIDS” are not definite diagnoses, these 
cases have been included as part of the SIDS group (see 7.4 Discussion). 51 cases were 
diagnosed with a specific cause for death and this group has been designated “non-SIDS”. The 
remaining 11 cases were diagnosed as undetermined or unascertained and were excluded from 
subsequent analyses. The remainder of this chapter only presents data for these 2 groups; SIDS 
(n=77) and non-SIDS (n=51).  
 
7.3.2 Characteristics of SIDS vs non-SIDS  
7.3.2.1 Perinatal and autopsy findings 
Autopsy data are summarised in Table 7.2. Between the two groups, significant differences were 
only present for gestational age of the infant (p=0.01) and maternal age (p=0.04), both of which 
were higher for the SIDS infants. Other characteristics, including gender, age at death, birth 
weight, body weight, brain weight, body length at death and head circumference at death, were 
not different between the groups.  
 
The age distribution of cases was also similar between the two groups, with 77% of SIDS cases 
in the age range of 1-4 months compared to 63% of non-SIDS cases (Fig. 7.1).  
 
The autopsy findings of pulmonary oedema/ aspiration/ congestion, or petechiae (thymic/ 
pulmonary/ epicardial/ thoracic), were present in both groups. Petechiae were reported in a 
significantly greater number of SIDS cases (82%) than non-SIDS cases (24%) (p<0.001). 
Pulmonary changes were not different between groups and were present in 58% of SIDS cases 
and 43% of non-SIDS (p= 0.11).  
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Table 7.2: Characteristics of non-SIDS vs SIDS. 
Characteristics Non-SIDS (n=51) SIDS (n=77) p-value 
Number of Males:female (%) 33:18 (65:35) 46:31 (60:40) - 
Gestational age (weeks) 36.2 ± 5.0 38.5 ± 2.7 0.01 
Age at death (months) 4.2 ± 2.3 3.7 ± 2.2 0.26 
Birth weight (kg) 2.67 ± 1.07 2.90 ± 0.70 0.23 
Body weight (kg) 6.10 ± 2.20 5.83 ± 1.61 0.43 
Brain weight (kg) 0.70 ± 0.20 0.69 ± 0.19 0.79 
Body Length at death (cm) 60.4 ± 7.80 59.9 ± 5.7 0.64 
Head circumference at death (cm) 40.6 ± 4.3 40.0 ± 3.3 0.44 
Maternal age (years) 24.3 ± 6.1 28.0 ± 7.6 0.04 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.1 Distribution of cases by age at death.  
This figure illustrates the percent of non-SIDS and SIDS cases by age in months. Note that 77% 
of the SIDS and 63% of non-SIDS are 1-4 months of age. 
 
 
7.3.2.2 Past history and risk factors 
In the clinical history, there was no significant difference between the two groups for 
immunisation (non-SIDS = 81% vs SIDS = 72%, p= 0.57) or recent URTI (non-SIDS = 47% vs 
SIDS = 48%, p= 1.0).  
 
There were no significant differences between the two groups for the risk factors associated with 
sleep environment or sleep position, cigarette smoke or other drug exposures (Table 7.3).  
 
Comparing the two groups for month and season of death, SIDS cases were greatest during the 
autumn month of April (17%), when there co-incidentally was the least number of non-SIDS 
cases (2%). The opposite pattern was observed in the winter month of August (SIDS= 4% vs 
non-SIDS= 18%) (Fig. 7.2). A greater percentage of SIDS compared to non-SIDS cases were 
reported in Autumn whilst the opposite was true for Spring (Fig. 7.3). 
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Table 7.3: Non-SIDS vs SIDS for risk factor parameters. 
Risk factor Non-SIDS (n=51) SIDS (n=77) P-value
Bed-share (% yes) 45% 45% 1.0 
Usual sleep position (% prone) 13% 12% 1.0 
Sleep position found (% prone) 35% 51% 0.31 
Exposure to cigarette smoke (% yes) 77% 82% 0.77 
Exposure to drugs (% yes) 19% 8% 0.16 
 
 
 
Fig. 7.2 Percent of non-SIDS and SIDS cases per month. 
Distribution pattern of non-SIDS (n=51) and SIDS (n=77) cases by month.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.3 Percent of non-SIDS and SIDS cases per season. 
Distribution pattern of non-SIDS (n=51) and SIDS (n=77) cases by season.  
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7.3.3 Characteristics of SIDS infants   
The ratio of males to females amongst the SIDS group was 1.5:1.0. The majority of the SIDS 
cases (77%) fell within the age of 1-4 months (Fig 7.1).  
 
For sleep position, 12% of the SIDS group usually slept prone with 51% found prone at death 
(an increase of 4 times). A positive history of cigarette smoke exposure was present for 82% of 
SIDS cases (Table 7.3)  
 
When analysed by season, there was no seasonal distribution for SIDS cases although 65% died 
in the colder seasons (autumn and winter combined) and 35% in the hotter seasons (summer and 
spring combined) (p= 0.17) (Fig. 7.3).  
 
 
For gestational age, 80% of the SIDS cases were born at term (i.e. 37-42 weeks of gestation) 
(Fig. 7.4). For birth weight, 3% of SIDS infants were <1.5 kg (very low), 26% were 1.5-2.5 kg 
(low) with the remaining 71% within the normal range of 2.5-4.0 kg (Fig 7.5). Maternal age of 
SIDS infants ranged from 16-49 years with 71% of mothers aged 16-30 years (Fig. 7.6). 
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Fig. 7.4 Distribution of SIDS cases by 
gestational age. This figure illustrates the 
percent of SIDS cases by gestation age in 
weeks. Note that 80% of SIDS cases were of 
normal term (i.e. born at 37-42 weeks of 
gestation). 
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Fig. 7.5 Distribution of SIDS cases by 
birth weight. This figure illustrates the 
percent of SIDS cases by birth weight in 
kilograms (kg). Note that 71% of SIDS cases 
were of normal birth weight (i.e. >2.5 kg). 
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Fig 7.6 Distribution of maternal age for SIDS cases. 
This figure illustrates the distribution of the maternal age of SIDS infants.  
 
7.3.4 Characteristics of the subgroup used in the neuropathological studies of Chapters 8-10. 
7.3.4.1 Perinatal, autopsy and risk factor parameters 
The subgroup used for neuropathological staining in Chapters 8-10 comprised 25 cases (10 non-
SIDS and 15 SIDS). The subgroup was selected through external factors that nullified the prior 
Ethics approval (changes to the tissue act). These infants of this subgroup studied 
neuropathologically are identified in Appendix 3 as case numbers 5, 6, 8, 9, 10, 11, 19, 27, 39, 
51 [non-SIDS] and 55, 57, 61, 62, 65, 79, 80, 86, 96, 98, 99, 101, 115, 123, 127 [SIDS]. Causes 
of death in the non-SIDS group are given in Table 7.4. All of these non-SIDS cases died 
suddenly and none were ventilated prior to death. Thus, at the time of death, these infants are 
thought to have experienced mild or acute hypoxia at most. There was no significant difference 
between groups for gender, gestational age, age at death, birth weight, body weight, body length 
at death, or head circumference at death (Table 7.5). There was a non-significant trend towards 
higher brain weight in the non-SIDS group (p=0.07).  
 
Information regarding sleep position was only available for 5 of the 10 non-SIDS cases, but was 
available for all SIDS cases, for whom standardised questionnaire data had been collected. Of 
the 15 SIDS cases, 4 were usually put to bed in the prone position (27%) whereas at the time of 
death, 6 were found in the prone position (40%).  
 
7.3.4.2 Parameters relevant to histological analyses 
Post-mortem interval (non-SIDS: 17.4 ± 10.4h vs SIDS: 19.5 ± 15.2h) and fixation time (non-
SIDS: 6.7 ± 1.5 vs SIDS: 7.6 ± 3.0 weeks) were not different. All 25 cases in this dataset were 
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studied at the mid medulla level. However, only 15 cases had tissue available for additional 
studies at the level of the pons; 8 SIDS and 7 non-SIDS. As a result, quantitative analyses 
concerning sleep position, were only conducted for data at the mid medulla level.   
 
Table 7.4: Causes of death in the non-SIDS group used for neuropathology staining. 
Diagnosis                                             N 
brompheniramine toxicity 
bronchopneumonia                               
gastroenteritis 
intraabdominal teratoma 
septicemia 
Waterhouse-Friedrichson Syndrome 
TOTAL 
1 
5 
1 
1 
1 
1 
10 
 
 
Table 7.5: Characteristics of the dataset used for neuropathology staining in Chapters 8-10. 
Characteristics Non-SIDS (n=10) SIDS (n=15) p-value 
Male:female 7:3 8:7 - 
Gestational age (weeks) 38.3 ± 2.63 37.6 ± 3.41 0.41 
Age at death (months) 3.23 ± 1.22 2.83 ± 1.01 0.66 
Birth weight (kg) 3.29 ± 0.99 2.71 ± 0.60 0.20 
Body weight (kg) 5.42 ± 1.34 5.03 ± 1.44 0.50 
Brain weight (kg) 0.68 ± 0.11 0.59 ± 0.11 0.07 
Body Length at death (cm) 58.2 ± 4.42 57.43 ± 5.61 0.73 
Head circumference at death (cm) 39.9 ± 2.71 38.4 ± 1.94 0.14 
 
7.4 Discussion 
7.4.1 Entire infant dataset 
Diagnosing SIDS is difficult, especially since it “remains a diagnosis by exclusion, distinguished 
from other infant deaths only by subjective and permissive variables that can be interpreted 
according to the whims of the diagnosing pathologist” (Beckwith, 2003). Between the period of 
January 1997 to February 2000, of all the cases under the age of 1 year presented to the Institute 
of Forensic Medicine in Glebe, this study shows that 55% were diagnosed as SIDS; when 
diagnoses of  “probable SIDS” or “consistent with SIDS” were included. Cases diagnosed as 
“undetermined” or “unascertained” were not included in this study although for most of these 
cases, their autopsy and past history findings appear to have been consistent with the definition 
of SIDS. It is possible that during this period, the actual number of SIDS deaths was under-
reported due to pathologists’ methods of diagnosis or hesitance in applying the term “SIDS”. 
This pattern has been observed globally and is of recent concern (Beckwith, 2003). Nevertheless, 
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the percentage of SIDS diagnoses in this infant population reflects the fact that SIDS is still one 
of the major causes of death amongst infants under the age of one year in a developed country.  
It has been widely thought that SIDS infants are characterised by factors such as prematurity, 
low birth weight, younger maternal age, cigarette smoke exposure and prone sleeping. However, 
the significance of these factors are often questioned because the majority of SIDS infants seem 
to lack them or to be indistinguishable from non-SIDS infants of the same age (Haas et al., 
1993). Moreover, these factors are often intertwined making it difficult to pinpoint which factor 
is more important. The following discussion focuses on how factors characteristic to this dataset 
compare with other published datasets. 
 
Gender: SIDS continues to be gender biased towards males, with no explanation to date. The 
SIDS group of this dataset show a greater male predominance with 1.5 times more male than 
female SIDS cases. This ratio reflects the recent trend observed across Australia where it was 
reported that over the past decade, the male death rate for SIDS was on average 1.4 times higher 
than female death rates (AIHW, 2001). Similar rates have been reported in New-Zealand (1.42 
times more males)(Mitchell and Stewart, 1997) and in California, USA (1.60 times more males) 
(Adams et al., 1998).  
 
Age at death: The age distribution of SIDS is 0-12 months with a characteristic peak incidence 
between 2-4 months (Adams et al., 1998; AIHW, 2001). In this dataset, 77% SIDS cases were 
aged 1-4 months. It has been suggested that SIDS deaths predominate in the first 6 months of life 
because during this time myelination and maturation of the central and autonomic nervous 
system is rapid and accompanies dramatic changes in the neurologic control of breathing, cardiac 
function and sleep/wake cycles (Adams et al., 1998). 
 
Gestational age and birth weight:  It has been shown that the earlier the gestational age of the 
infant and the lower the birth weight, the greater the risk for SIDS (Young et al.,1979; Black et 
al., 1986; Malloy et al.,1995). However, most SIDS cases still occur amongst infants of normal 
birth weight (Black et al., 1986; Pollack and Frohna, 2001). This was true in the current dataset, 
where amongst SIDS infants, only 7% were in the extreme range of prematurity (i.e. gestational 
age ≤33 weeks and birth weight <2.0kg). 
 
Brain weight: The question of whether brain weight is greater in SIDS victims has been 
controversial with evidence both for and against this. In this dataset, the brain weight amongst 
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SIDS infants did not differ to that amongst non-SIDS infants, a finding in line with that of Falck 
and Rajs, (1995) and Sparks et al., (1996). 
 
Maternal age:  The SIDS rate amongst younger mothers has been demonstrated to be greater 
than in older mothers (Wierenga et al., 1990; Leach et al., 1999; Arnestad et al., 2001). In this 
dataset, the average maternal age was significantly greater for the SIDS group when compared to 
the non-SIDS group, which is in contrast to other reports (Haas et al., 1993). However, when 
examining maternal age amongst the SIDS infants, the great majority (71%) were in the 16-30 
year age range. Some possible explanations as to why younger mothers are more likely to have 
an infant die from SIDS compared to other mothers include: poor prenatal care (Hoffman and 
Hillman, 1992), the infant being a first child (Wierenga et al., 1990), the high prevalence of 
smoking amongst this age group (Leach et al., 1999; Arnestad et al., 2001), and/or the mother 
being less likely to place their infants in the supine position (Willenger et al., 1994). 
 
Sleep position: The introduction of campaigns to promote the supine sleep position has been 
associated with a decrease in the number of infants reported as being placed prone for sleep in 
Australia (Henderson Smart et al., 1998). The infants of this dataset reflect this trend with only 
15% of infants reported as “usually placed prone when put to bed”. Despite the low incidence of 
prone sleeping amongst the SIDS population of this dataset, at the time of death, the number of 
SIDS infants found in the prone position was increased by a factor of four. For most of these 
cases, this was also reported to be the first time that they were known to have taken this position 
suggesting that a proportion of these infants were unable to overcome some stress associated 
with this sleep position, for example head covering and suffocation (Cote et al., 2000).  
 
Exposure to cigarette smoke and/or illicit drugs: Evidence of prior cigarette smoke exposure 
being a risk for SIDS is fast accumulating (Refer to section 1.4.1.2.1). Despite campaigns 
promoting a “smoke free environment” for babies (Henderson Smart et al., 1998), data shows 
that the presence of smoking continues to be a problem for infants, and particularly those who 
latter succumb to SIDS. Although the number of SIDS infants with prior exposure to cigarette 
smoke did not differ to that of non-SIDS infants in this dataset, the incidence of smoking for 
both groups was still high (greater than 80%). 
 
Despite data showing an association between illicit drug use and increased incidence of SIDS 
(Kandal et al., 1993; Fares et al., 1997), it has been suggested that this association is weak 
compared with smoking when considering other confounding risk factors, since most drug users 
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also smoke cigarettes (Slotkin, 1998). Within this dataset, drug exposure was more prevalent in 
the non-SIDS group compared to the SIDS group, suggesting that drug exposure may not be a 
significant contributing factor to the aetiology of SIDS, or that the questionnaire data may not 
reveal this, or that the dataset is too small for this relatively minor risk factor to be evident. 
 
Season of death and upper respiratory tract infection (URTI):  An association between the 
winter season and SIDS has been reported in several datasets (Beal and Porter, 1991; Dwyer et 
al., 1995; Douglas et al., 1996), with the incidence being increased during winter. In line with 
those studies, this dataset had a significantly greater percentage of SIDS cases in autumn and 
winter combined. The winter peak of SIDS deaths has been interpreted to suggest an interaction 
with a seasonal factor, perhaps thermal environment or infection (Dwyer et al., 1995). The 
finding of this dataset that the incidence of an URTI prior to death was not different between the 
SIDS and non-SIDS groups supports the conclusion reached by others that an infectious 
aetiology is not likely (Byard et al., 1992, Smith et al., 1992). 
 
Immunisation:  Despite public claims of an association between immunisation and SIDS, no 
studies have been able to confirm this. On the contrary, large epidemiological studies have 
shown that immunisation has a protective effect (Walker et al., 1987; Mortimer, 1987). The 
finding of the current dataset of an equal number of SIDS and non-SIDS cases immunized (45% 
for both) is in agreement with these previous findings. 
 
Intrathoracic Petechiae:  Intrathoracic petechiae, specifically, petechial haemorrhages of the 
thymus, visceral pleura and epicardium are reported in 80-90% of cases, yet, “they are neither 
diagnostic nor obligatory findings of SIDS and are found in a variety of natural and unnatural 
deaths in infants” (Byard and Krous, 2003). In this dataset, a significantly greater number of 
SIDS cases (82%) had some form of petechiae compared to non-SIDS infants (24%) which is 
similar to findings in other datasets (Becroft et al., 1998; Krous et al., 2001). Petechial 
haemorrhages are assumed to result from upper airway obstruction or terminal gasping 
(agonally), but the precise aetiology remains unconfirmed.   
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7.4.2 Subgroup dataset 
Parameters that may potentially interfere with the staining data of the forthcoming chapters 
(Chapters 8-10), such as post-mortem interval and fixation time, were well matched between the 
two study groups (SIDS and non-SIDS) and therefore, not used as additional covariates during 
analyses. However, disadvantages are still evident and include: 
 
1- A small and biased control “non-SIDS” group. As with all SIDS pathology research, it is 
very hard to obtain good control groups where hypoxia prior to death is minimal to none. 
This was certainly true for this study in which the non-SIDS group included five control 
cases with a post-mortem diagnosis of bronchopneumonia and may have experienced 
hypoxia prior to death. However, all five died suddenly and unexpectedly so, it has been 
assumed that no chronic or repeated hypoxia occurred.  
2- The limited age range. The ages of the cases of this subgroup ranged from 1-5 months, 
which although covers the peak age range of SIDS, does not reflect the whole age 
spectrum. 
3- The small number of cases, which meant that correlations with risk factors was limited. 
Nonetheless, preliminary analysis for sleep position amongst the SIDS infants was 
included.  
 
Despite these limitations, this subgroup allows for preliminary observations that could be 
significant and opens the pathway for future studies within larger datasets, although would be 
contigent upon ethics approval, funding, and tissue availablity.  
Chapter 8: Neuronal cell death in the SIDS infant brainstem.        
    
102
Chapter 8 
Neuronal cell death in the SIDS infant brainstem.  
 
8.1 Introduction 
Hypoxic insults are potent triggers of cell death, which during development, is most often in the 
form of apoptosis as compared to necrosis (Portera-Cailliau, 1997). Given the contention that 
SIDS is associated with hypoxia, and that hypoxia induces cell death, it seems highly likely that 
SIDS infants have an increased expression of cell death.    
 
To date, four studies have looked for changes in neuronal cell death markers in the brainstem of 
SIDS infants (Sparks et al., 1996; Oehmichen et al., 1998; Waters et al., 1999, Sawaguchi et al., 
2002). Using Alz-50 as a marker of cell degeneration, Sparks et al., (1996) found an increase in 
Alz-50 immunoreactive neurons in regions of the dorsal medulla (mid medulla level) in SIDS 
infants when compared to the non-SIDS controls. They proposed that this increase in Alz-50 
reflected an increase in apoptotic neurodegeneration occurring in SIDS. These findings were later 
confirmed independently by Oehmichen et al. (1998), who also found increased Alz-50 in the 
medulla of a different SIDS dataset.  
 
Using TUNEL as a specific marker for apoptosis, Waters et al., (1999) were the first to report that 
apoptosis was increased in SIDS infants compared to non-SIDS cases. Of the 29 SIDS cases, 96% 
showed an increase in TUNEL positive neurons. The distribution of this increase was mostly in 
dorsal sensory nuclei of the medulla (NSTT and vestibular nuclei) at both the caudal and rostral 
levels. Due to this particular distribution, the authors interpreted the data as providing a possible 
link between apoptosis and the prone sleeping position as a risk factor for SIDS.  
 
A recent quantitative analysis of TUNEL staining in glial cells of the periaqueductal gray matter 
at the midbrain level (Sawaguchi et al., 2002), showed that SIDS infants had a greater number of 
TUNEL positive glial cells compared to controls, that was also associated with a high frequency 
of obstructive apneas during life. This group concluded that the two abnormalities indicated 
deficiency in the autonomic and arousal pathways. 
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This chapter hypothesizes that neuronal cell death is increased in the dorsal nuclei of the medulla 
of SIDS infants, consistent with the findings of Waters et al., (1999). To test this hypothesis, 
immunohistochemistry for active caspase-3 and the TUNEL method were employed and eight 
nuclei at the level of the mid medulla and two nuclei at the level of the rostral pons were studied.  
 
8.2 Materials and Methods  
8.2.1 Tissue collection and processing 
Brainstem tissue was available for study from a total of 25 infants who died at less than 1 year of 
age. Brain removal, fixation and tissue processing have been described in Chapter 2 (section 2.3).  
 
8.2.2 Immunohistochemistry for active caspase-3 and TUNEL 
The immunohistochemical methods used to identify active caspase-3 and TUNEL have been 
described in Chapter 2 (section 2.7). 
 
8.2.3 Quantitative immunohistochemistry 
Quantitation for each marker was performed as described in Chapter 2 (section 2.10) and is 
represented as percent positive (% positive).  
 
8.2.4 Analysis 
Two adjacent sections for each case at each brainstem level were subjected to each staining 
method (i.e. n=2, per case, per stain. Refer to Chapter 2, section 2.11). Eight nuclei of the mid 
medulla (XII, DMNV, ION, AN, NTS, Vest, Cun and NSTT) and two nuclei of the rostral pons 
(LC and pontine) were analysed (Refer to Chapter 2, section 2.8.1 and Fig. 2.4). Tissue sections 
from SIDS and control cases were closely matched at each of these two levels, respectively. 
 
For each staining method, values were averaged for 2 sections per infant and then the average was 
calculated for all infants per group and presented as age-adjusted mean ± SEM. Statistical 
analyses were undertaken using SPPS for Windows (V11.5, Chicago, USA). Analysis of 
covariance (ANCOVA) was used to evaluate differences in quantification by diagnosis (SIDS vs 
non-SIDS), adjusted for age and gender. When there was a significant difference in quantification 
by case diagnosis across groups with ANCOVA, the Bonferroni procedure was employed to 
evaluate pairwise comparison of the means. Subgroup analyses compared quantification by sleep 
position (amongst SIDS only). A 2-sided p-value of <0.05 was considered statistically significant. 
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8.3 Results 
8.3.1 Dataset characteristics  
The characteristics of the infant cases used in this study have been described in Chapter 7, 
sections 7.3.4 and 7.3.5. Briefly, a total of 25 cases were studied at the mid medulla level (10 non-
SIDS vs 15 SIDS) while 15 of these cases had further studies at the rostral pons level (7 non-SIDS 
vs 8 SIDS). Further, subgroup analysis for ‘sleep position the infant usually slept in’ was 
performed for the SIDS group, and only at the mid medulla level (4 usually prone vs 11 usually 
non-prone). 
 
8.3.2 Distribution and pattern of staining 
Positive staining was present in neurons and other cell types, but in this study we only considered 
neuronal staining. For active caspase-3, positive staining in neurons was localized to the 
cytoplasm with occasional staining in the nucleus as well. Neurons positively stained for active 
caspase-3 were often shrunken, therefore demonstrating some morphological features of apoptotic 
cells (Fig. 8.1A-C). Positive staining for TUNEL was localized to the nucleus of neurons. Neurons 
were only considered positive if they had dark nuclei staining with or without fragmentation, and 
either or both nuclear condensation and cellular shrinkage (Fig. 8.1D-F). Thus, neurons with 
lighter staining of the nucleus but no morphological changes were counted as negative for 
TUNEL, since they were taken to show non-specific staining.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8.1 Staining pattern of active caspase-3 and TUNEL in the infant medulla. 
Micrographs of the DMNV, ION and Cuneate nucleus at the level of the mid medulla from a SIDS infant 
stained for (A-C) active caspase-3 and (D-F) TUNEL. Intensely labelled “positive” neurons (black arrows) 
and non- labelled “negative” neurons (white filled arrows). Note the shrinkage of neurons labelled positive 
for active caspase-3 and TUNEL respectively. Scale bar = 50µm for all panels. 
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8.3.3 Quantification 
8.3.3.1 Active caspase-3 
mid medulla: Active caspase-3 positive neurons were observed in most nuclei of each case of this 
dataset. In the non-SIDS group, an overall average of 12% of neurons were positively stained for 
active caspase-3. The XII had the greatest percentage of active caspase-3 positive neurons while 
the NTS had the least (Table 8.1). There was no significant difference for any of the eight nuclei 
when comparing the SIDS to the non-SIDS group, although a trend to decrease was observed in 
the ION and DMNV of the SIDS group (Table 8.1).  
 
Amongst the SIDS cases, % active caspase-3 was not statistically different between the two sleep 
positions, usually prone (n=4) vs usually non-prone (n=11), in any of the 8 nuclei (Table 8.2).  
 
rostral pons: In the non-SIDS group, the LC had a greater percentage of active caspase-3 neurons 
compared to the pontine nuclei. Comparing non-SIDS (n=7) to SIDS (n=8), there was no 
statistical difference in % active caspase-3 in either the LC or pontine nuclei (Table 8.1). 
 
8.3.3.2 TUNEL  
mid medulla: TUNEL positive neurons were not always observed in all nuclei of each case and, 
varied amongst the cases, with some exhibiting no positive neurons at all. In the non-SIDS group, 
approximately 2% of neurons were TUNEL positive. The Cun had the greatest % TUNEL positive 
neurons while the AN had the least (Table 8.3). There was no significant difference for any of the 
eight nuclei when comparing the SIDS to the non-SIDS group, although a trend to increase was 
observed in the AN and DMNV (Table 8.3). 
 
Amongst the SIDS cases, % TUNEL was not statistically different between the two sleep 
positions, usually prone vs usually non-prone, in any of the 8 nuclei, although a trend to increase 
was observed in the ION and NTS (Table 8.2)  
 
rostral Pons: In the non-SIDS group, the pontine nucleus had a greater percentage of TUNEL 
positive neurons compared to the LC. Comparing non-SIDS to SIDS, there was no statistical 
difference in % TUNEL in either the LC or pontine nuclei (Table 8.3). 
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Table 8.1: Comparison between non-SIDS and SIDS for active caspase-3 in the mid medulla and 
rostral pons.  
Nuclei Non-SIDS SIDS p-value 
Mid medulla 
   XII  
   ION  
   AN 
   Cuneate 
   Vestibular  
   DMNV  
   NSTT 
   NTS 
Rostral pons 
   LC 
   pontine 
 
24.7 ± 5.8 
11.1 ± 3.9 
11.2 ± 3.3 
17.7 ± 4.4 
10.2 ± 1.6 
11.5 ± 2.9 
4.7 ± 0.8 
3.9 ± 0.8 
 
6.7 ± 0.8 
1.8 ± 0.3 
 
25.0 ± 5.4 
4.9 ± 1.2 
9.4 ± 2.2 
14.0 ± 2.8 
8.7 ± 1.7 
7.1 ± 0.9 
3.7 ± 0.5 
3.3 ± 0.8 
 
8.9 ± 1.9 
1.4 ± 0.2 
 
0.97 
0.09 
0.65 
0.46 
0.56 
0.11 
0.32 
0.61 
 
0.37 
0.32 
Results are expressed as the age-adjusted mean % active caspase-3 ± SEM. 
 
Table 8.2: Comparison between the non-prone and prone usual sleep positions for active caspase-
3 and TUNEL in the mid medulla of SIDS infants. 
 Active caspase-3  TUNEL  
Nuclei Non-prone prone p-value Non-prone prone p-value
   XII  
   ION  
   AN 
   Cuneate 
   Vestibular  
   DMNV  
   NSTT 
   NTS 
22.7 ± 6.6 
4.9 ± 1.4 
9.3 ± 2.8  
12.8 ± 3.4 
 9.3 ± 1.8  
7.2 ± 1.1 
3.7 ± 0.6 
3.7 ± 1.0 
31.4 ± 11.1 
4.9 ± 2.4 
9.8 ± 4.9 
17.3 ± 3.1 
7.3 ± 3.1 
6.8 ± 1.9 
3.7 ± 0.9 
2.0 ± 1.6 
0.5 
1.0 
0.9 
0.5 
0.6 
0.9 
1.0 
0.4 
1.9 ± 0.4 
1.0 ± 0.8 
1.8 ± 0.4 
3.6 ± 1.5 
2.8 ± 0.4 
2.2 ± 0.6 
2.5 ± 0.6 
2.6 ± 1.0 
2.4 ± 0.8 
3.3 ± 1.3 
1.4 ± 0.9 
7.4 ± 2.6 
1.4 ± 0.7 
3.2 ± 1.0 
1.0 ± 1.1 
5.5 ± 1.8 
0.6 
0.2 
0.7 
0.3 
0.1 
0.4 
0.3 
0.2 
Results are expressed as the age-adjusted mean % ± SEM. 
 
Table 8.3: Comparison between non-SIDS and SIDS for TUNEL in the mid medulla and rostral 
pons.   
Nuclei Non-SIDS SIDS p-value 
Mid medulla 
   XII  
   ION  
   AN 
   Cuneate 
   Vestibular  
   DMNV  
   NSTT 
   NTS 
Rostral pons 
   LC 
   pontine 
 
1.6 ± 0.5 
1.7 ± 0.7 
1.0 ± 0.4 
3.2 ± 1.4 
2.8 ± 0.7 
1.6 ± 0.6 
2.6 ± 0.6 
2.7 ± 1.0 
 
6.7± 0.8 
1.8 ± 0.3 
 
2.1 ± 0.4 
1.6 ± 0.6 
1.8 ± 0.3 
4.6 ± 1.1 
2.5 ± 0.6 
2.5 ± 0.5 
2.2 ± 0.5 
3.4 ± 0.8 
 
1.2 ± 0.4 
2.8 ± 2.3 
 
0.46 
0.98 
0.10 
0.43 
0.70 
0.21 
0.60 
0.60 
 
0.76 
0.67 
Results are expressed as the age-adjusted mean % TUNEL ± SEM. 
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8.4 Discussion 
This study examined the expression of active caspase-3 and TUNEL in eight nuclei of the infant 
mid medulla, and assessed whether the expressions were different between the non-SIDS and 
SIDS groups, with the specific hypothesis being that the expressions would be increased in the 
dorsal nuclei of the medulla in SIDS infants. The results of this study showed no statistical 
difference for either marker, in any of the nuclei studied, when comparing the SIDS to the non-
SIDS group, although some trends were observed. Preliminary subgroup analysis by ‘sleep 
position the infant usually slept in’ showed that the prone versus non-prone (supine and side) 
position had no effect on either marker amongst the SIDS group. Taken together, the results of 
this study suggest that in this dataset, neuronal cell death is not exacerbated in the SIDS 
brainstem.  
 
Apoptosis is a specific form of cell death that requires initiation of a genetically programmed 
enzyme sequence within the cell. It is a normal physiological process by which unwanted or 
useless cells are eliminated during development. Apoptosis was originally defined 
morphologically by electron microscopic analysis and involves shrinking of the cytoplasm, 
clumping of nuclear material, nuclear fragmentation and formation of membrane-bound bodies 
(Kerr et al., 1972). However, the use of formalin fixed and paraffin embedded tissue does not 
allow for electron microscopic analysis, so only biochemical identification of apoptosis is 
possible.  
 
This study utilised two biochemical markers, the TUNEL method and active caspase-3 labelling. 
TUNEL staining identifies DNA fragmentation, a feature of a cell in the late stages of apoptosis, 
while the active caspase-3 antibody labels the cleaved form of caspase-3 thus marking a cell in the 
early stage of the apoptotic pathway. Given recent publications (Ishimaru et al., 1999, Martin et 
al., 1998, Olney et al., 2002) criticizing the practice of defining apoptosis purely via biochemical 
marking without electron microscopic confirmation, the general term “neuronal cell death” rather 
than “apoptosis” is used to define the histochemical results.  
 
Methodological note: 
Post-mortem delay (PMD) is a parameter with the potential to effect the expression of apoptotic 
markers, the relationship thought to be a linear increase (i.e, with increasing PMD, the expression 
of apoptotic markers increases). Although a linear increase was observed in a study of the number 
of DNA breaks present in the human brain using the alkaline elution method (Mullaart et al., 
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1990), it was not observed when applying the in-situ end labelling technique (termed ISEL but 
equivalent to the TUNEL method) (Lucassen et al., 1995). The latter study showed that PMDs of 
as little as 3.5 hours and as great as 44.5 hours had no effect on ISEL expression in the human 
brain. The authors thus concluded that for ISEL on human brain tissue, PMDs up to 44.5 hours are 
apparently of no major concern (Lucassen et al., 1995). A similar conclusion can be made for this 
study. In this study, the PMD of the infant tissue ranged from 5-40 hours. The relationship 
between PMD and TUNEL, and active caspase-3, was a straight horizontal line [R2 = 0.04 
(TUNEL), 0.008 (active caspase-3)].  Thus, PMD was not a contributing factor in this study 
either.  
 
8.4.1 TUNEL and active capase-3 expression in the infant brainstem 
TUNEL expression in the infant medulla has been studied previously (Waters et al., 1999) using 
the same labelling kit as used in this study. However, the method employed in this study differs to 
that by Waters et al., (1999) in that microwaving was used as the antigen retrieval method rather 
than proteinase K digestion. Although this may have accounted for any disimilarities in the 
staining pattern observed between this and the previous study, initial studies setting up this 
protocol suggest otherwise. When microwaved sections were compared to sections treated with 
proteinase K, no major differences in the staining pattern were observed. Yet, microwaving was 
chosen as the optimal antigen retrival method because it allowed for shorter treatment time and 
thus, was less time consuming, it preserved the tissue and was cheaper. Using proteinase K 
digestion however, would have required adjustments of time, temperature and concentration. 
 
The study by Waters et al., (1999), focused on two medullary levels, the obex (closed) medulla 
and the rostral (open) medulla. In their non-SIDS population, at the level of the obex, TUNEL was 
identified in only two nuclei, the Gracile and Cuneate dorsal sensory nuclei, while at the level of 
the open medulla, TUNEL positive neurons were found in all nuclei, except for the DMNV, with 
greatest expression amongst the dorsal sensory nuclei. This study in contrast, focused on the mid 
medulla level due to availability of tissue, and found that in most of the non-SIDS cases, TUNEL 
positive neurons were present in all nuclei studied, and that greatest expression was also amongst 
the dorsal sensory nuclei. Thus, it seems that although TUNEL positive neurons are not present in 
all nuclei at each medullary level, it is consistent amongst the dorsal sensory nuclei compared to 
all other functional nuclei.  
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The findings by Sparks and Hunsaker, (2002) using Alz-50 as a marker, are consistent with the 
TUNEL findings in that Alz-50 was also found to be predominant in the dorsal sensory nuclei of 
the medulla. However, the pattern of Alz-50 expression along the axis of the medulla followed a 
bell shaped curve whereby, there was an increase in expression from caudal to mid medulla and 
then subsequent decrease from mid to rostral medulla (Sparks and Hunsaker, 2002). The reason 
for this varing pattern along the axis is unclear but may be important functionally.  
 
This study is the first to have looked at active caspase-3 expression in the infant brainstem. Within 
this study dataset, the active caspase-3 expression compared to TUNEL expression, was greater in 
all the nuclei studied except for the pontine nuclei of the rostral pons. Overall, there were 
approximately 10 times more active caspase-3 neurons than TUNEL neurons. Given that active 
caspase-3 expression is indicative of a neuron in the early stages of apoptosis, the greater 
expression of active caspase-3 compared to TUNEL suggests that at the time of death, apoptosis 
may just have been initiated. In the developing mouse brain after ethanol treatment, it was found 
that the level of active caspase-3 increased to a peak at 8-12h and then declined rapidly to 
undetectable levels by 16-24h, the time point when ethanol induced apoptotic death by the 
DeOlmos silver stain peaked (Olney et al., 2002). If these findings are representative of the 
apoptotic pathway time frame involving caspase-3, then the high levels of active caspase-3 
observed in the non-SIDS group of this study would suggest that cell death was initiated 
approximately 8h prior to death, and had not yet progressed to the final stages where TUNEL 
expression would be at its greatest.  
 
There was no distinctive pattern of active caspase-3 expression amongst the nuclei of the mid 
medulla as observed for TUNEL expression. That is, active caspase-3 was not predominant 
amongst the dorsal sensory nuclei but rather, was wide spread with greatest expression in the XII 
nucleus. Why one nucleus would have more expression compared to another is not certain but 
may be due to the prior insult causing death, the death process itself, and/or the function of the 
nucleus affected.   
 
8.4.2 non-SIDS vs SIDS 
No statistically significant differences were observed when comparing the non-SIDS to SIDS 
groups for either TUNEL or active caspase-3 expression amongst any of the nuclei studied. This 
was in contrast to the hypothesis that expression of both would be increased in the SIDS group, 
specifically in the dorsal nuclei of the medulla. If anything, the trend for active caspase-3, 
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particularly in the ION and DMNV, was towards a decrease whereas for TUNEL, the trend was 
towards an increase, particularly in the AN and DMNV.  
 
It is not clear why the TUNEL results of this study did not confirm the findings of Waters et al., 
(1999). Some possible explanations include the difference in the level of the medulla studied, the 
size of the dataset (Waters et al., studied 29 SIDS vs 9 non-SIDS, compared to 15 SIDS vs 10 
non-SIDS in this study) and the limited age-range of the infants in this study (all were 1-4 months 
compared to 1-12 months in the study by Waters et al., 1999).  
 
The difference in the level of the medulla studied may be important because of regional variation. 
When Sparks and Hunsaker, (2002) compared their SIDS infants to the non-SIDS infants for Alz-
50 expression at eight different levels of the medulla, they found that Alz-50 was significantly 
increased in the SIDS infants at six of these levels, which extended from the open medulla to just 
below the mid medulla level. For the two levels closest to the obex, no difference was observed. 
However, they further noticed that although Alz-50 was increased in the SIDS infants at the mid-
medulla level, the difference was at its smallest compared to the difference between the two 
groups at the other levels.  
The findings of a predominant increase in TUNEL amongst the dorsal nuclei of the medulla in 
SIDS infants observed by Waters et al., (1999) was interpreted to suggest a potential link with the 
prone sleeping position, since the dorsal nuclei are involved in controlling the orientation of the 
head and proprioceptive sensations from skin, muscles and joints of the face and mouth.  
 
However, in that study, they were not able to perform subgroup analyses for the sleep position 
because that information was not available. In this study, a subgroup analysis by ‘sleep position 
the infant usually slept in’ was performed amongst the SIDS infants to determine whether the 
SIDS infants who usually slept prone had an increase in TUNEL expression compared to those 
who usually slept non-prone. No such significant difference was found between the two sleep 
positions, suggesting that the sleep position is not a contributing factor. However, a trend to 
increase was observed in the ION and NTS for the prone position. These findings are based on a 
small number of cases and should be taken as preliminary. Nevertheless, the trends observed 
highlight the importance of studying for this factor in larger datasets.   
 
8.5 Conclusion 
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Two markers for neuronal cell death, TUNEL and active caspase-3, were studied at the mid 
medulla and rostral pons levels of the brainstem of non-SIDS and SIDS infants, and the 
expression for each was compared between the two groups. No statistically significant differences 
were observed for either TUNEL or active caspase-3 expression amongst any of the nuclei studied 
when comparing the groups, although some trends were evident. This study has a number of 
weaknesses, including small numbers, limited age-range of the infants, and only one level of the 
medulla and pons were analysed. Despite these weaknesses, the findings of this study highlight 
the importance and urgency of undertaking further analysis for this neuropathology in larger 
datasets and at multiple brainstem levels to definitively conclude the specificity of neuronal cell 
death as a marker for, or explanation of, the mechanisms of SIDS.  
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Chapter 9 
NR1 expression changes in the SIDS infant brainstem.  
 
9.1 Introduction 
One underlying cause of SIDS is postulated to be a developmental disorder of brainstem 
cardiorespiratory responses, particularly to hypoxic and hypercapnic challenges (Kinney et al., 
1995). A number of studies have sought to define neuroreceptor abnormalities that could be 
responsible for this cardiorespiratory control defect. To date, these studies focused on the 
muscarinic (Kinney et al., 1995; Mallard et al., 1999), nicotinic (Nachmanoff et al., 1998), 
opioid (Kinney et al., 1998), adrenergic (Mansouri et al., 2001), serotonergic (Panigrahy et al., 
2000a) and kainate (Panigrahy et al., 1997) receptors.  
 
A previous finding of neuronal apoptosis in SIDS infants (Waters et al., 1999), led to this studies 
interest in the NMDA glutamatergic receptor. The NMDA receptor, amongst other functions, is 
involved in cardiorespiratory control and in cell death by excitotoxic mechanisms. Changes in 
NMDA receptor expression and neuronal vulnerability to excitotoxic damage during early 
development (Portera-Cailliau et al., 1997), would be consistent with NMDA receptor 
involvement in an age specific phenomenon such as SIDS.   
 
The NMDA receptor belongs to the glutamatergic neurotransmitter system, which also includes 
the α-amino-3-hydroxy-5-methyl-4-isoxazole-4-propionate (AMPA) and kainate receptors. 
NMDA receptor binding is increased in the human brainstem between midgestation and early 
infancy whereas AMPA and kainate receptor binding are elevated during midgestation and 
decrease thereafter (Panigrahy et al., 2000b). It has been suggested that in the immature brain, 
NMDA receptors dominate and are responsible for neuronal maturation and plasticity while 
AMPA and kainate receptors are responsible for neurotransmission (Panigrahy et al., 2000b; 
Herlenius and Lagercrantz, 2001).  
 
NMDA receptors exist as heteromeric complexes containing NR1 combined with one or more 
NR2 or NR3 subunits. The NR1 subunit is an obligatory component of functional NMDA 
receptors and serves as a useful marker for localizing NMDA receptors in brain tissue 
(Guthmann and Herbert, 1999). The NR1 subunit has been shown to be widely distributed in the 
brainstem of the piglet (Chapter 5), cat (Ambalavanar et al., 1998), rat (Petralia et al., 1994; 
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Guthmann and Herbert, 1999) and mouse (Watanabe et al., 1994). Its wide distribution in the 
brainstem, a site containing nuclei generally responsible for controlling cardiac activity, 
respiration, sleep and arousal suggests that NMDA receptors are important in mediating these 
functions. Animal physiological studies support this contention (Feldman et al., 1992; 
Dutschmann et al., 1998). The distribution of NR1 in the brainstem of the human infant has not 
been previously determined. The first part of this study therefore reports the distribution of NR1 
mRNA and protein in the human infant mid medulla and rostral pons using non-radioactive in 
situ hybridisation and immunohistochemistry, respectively.  
 
NMDA receptors share a close association with hypoxia including their role in the hypoxic 
ventilatory response (Hoop et al., 1999; Ohtake et al., 2000) and changes in their expression and 
function after hypoxic stimulation (Hoffman et al., 1994; Otoya et al., 1997; Delivoria 
Papadopoulos and Mishra, 1998). Moreover, changes in NMDA receptor activity, either too 
much or too little, can precipitate cell death. Excessive and abnormal activation of glutamate 
receptors that leads to cell death is called excitotoxicity (Choi, 1990). During infancy, hypoxic 
conditions increase neuronal vulnerability to NMDA mediated excitotoxicity and the neurons in 
turn, become vulnerable to apoptosis (Portera-Cailliau et al., 1997). Apoptosis, as identified by 
DNA fragmentation, was found to be increased in hypoxia sensitive regions of the hippocampus 
and in the dorsal sensory nuclei of the brainstem of SIDS infants. The conclusion of that study 
was that hypoxic exposure preceded the death of these infants by at least a few hours (Waters et 
al., 1999). This conclusion is further supported by the finding that Vascular Endothelial Growth 
Factor (VEGF), a marker for hypoxia, was significantly increased in the cerebral spinal fluid of a 
subset of SIDS infants (Jones et al., 2003). 
  
Given the associations between both NMDA receptors and SIDS with hypoxia, this study 
hypothesised that NMDA receptor dysfunction is increased in SIDS infants. The second part of 
this study therefore compares the distribution and expression of NR1 mRNA and protein in SIDS 
with non-SIDS infants.  
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9.2 Materials and Methods  
9.2.1 Tissue collection and processing 
Brainstem tissue was available for study from a total of 25 infants who had died at less than one 
year of age. Brain removal, fixation, tissue processing, and collection have been described in 
Chapter 2 (section 2.3). 
 
 9.2.2 Non-RISH for NR1 mRNA 
The NR1 probe sequences used in the non-RISH procedure are described in Chapter 2 (section 
2.6.2.1). The non-RISH protocol has been described in Chapter 2 (section 2.6.3). 
 
9.2.3 Quantitative non-RISH  
The staining intensity of NR1 mRNA was quantified using the procedure described in Chapter 2 
(section 2.9) and was represented in optical density units (OD).  
 
9.2.4 Immunohistochemistry for NR1 protein 
The immunohistochemical method used to identify NR1 protein has been described in Chapter 2 
(section 2.7.4). 
 
9.2.5 Quantitative immunohistochemistry 
Quantitation was performed as described in Chapter 2 (section 2.10) and is represented as 
percent positive of neurons (% positive).  
 
9.2.6 Analysis 
Two adjacent sections for each case at each brainstem level were subjected to each staining 
method (i.e. n=2, per case, per stain. Refer to Chapter 2, section 2.11). Eight nuclei of the mid 
medulla (XII, DMNV, ION, AN, NTS, Vest, Cun and NSTT) and two nuclei of the rostral pons 
(LC and pontine) were analysed (Refer to Chapter 2, section 2.8.1 and Fig 2.4). Tissue sections 
from SIDS and control cases were closely matched at each of these two levels, respectively. 
 
Statistical analyses were undertaken using SPPS for Windows (V11.5, Chicago, USA). Analysis 
of covariance (ANCOVA) was used to evaluate differences in NR1 mRNA and protein 
quantification by diagnosis (SIDS vs non-SIDS), adjusted for age and gender. When there was a 
significant difference in quantification by diagnosis across groups with ANCOVA, the 
Bonferroni procedure was employed to evaluate pairwise comparison of the means. Subgroup 
analyses compared NR1 mRNA and protein levels by sleep position (amongst SIDS only). 
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Staining results are presented as age-adjusted mean ± SEM. A 2-sided p-value of <0.05 was 
considered statistically significant. 
 
9.3 Results 
9.3.1 Dataset characteristics  
The characteristics of the infant cases used in this study have been described in Chapter 7, 
sections 7.3.4 and 7.3.5. Briefly, a total of 25 cases were studied at the mid-medulla level (10 
non-SIDS vs 15 SIDS) while 15 of these cases had further studies at the rostral pons level (7 
non-SIDS vs 8 SIDS). Further, subgroup analysis for ‘sleep position the infant usually slept in’ 
was performed for the SIDS group, and only at the mid medulla level (4 usually prone vs 11 
usually non-prone).  
 
9.3.2 NR1 mRNA staining 
Overall, NR1 mRNA was found to be widely distributed in the infant brainstem at the two levels 
studied, with a similar pattern of distribution amongst the non-SIDS and SIDS groups. Positive 
staining of neurons for NR1 mRNA was identified by a maroon/brown colour reaction in the 
cytoplasm, and occasionally the nucleus. The general staining pattern and cellular distribution of 
NR1 mRNA in a non-SIDS infant is presented in the mid medulla (Figs. 9.1 A,B,C) and rostral 
pons (Figs. 9.1 D,E,F). Staining for NR1 mRNA was present in all neurons from all of the nuclei 
selected for this study but varied in intensity. Regardless of diagnosis, NR1 mRNA expression 
was greatest in the XII nucleus, and lowest in the NTS at the level of the mid medulla (Fig. 
9.3A) with no difference between the LC and pontine nuclei at the level of the rostral pons 
(Table 9.1).  
 
9.3.3 NR1 protein staining 
NR1 protein showed a similar pattern of distribution amongst the non-SIDS and the SIDS 
groups. Positive staining of neurons for NR1 protein was identified by a blue colour reaction in 
the cytoplasm. The general staining pattern and cellular distribution of NR1 protein in a non-
SIDS infant is presented in the mid medulla (Figs. 9.2 A,B,C). Although NR1 protein was 
present in all nuclei studied, the number of neurons positive for NR1 protein varied amongst the 
nuclei. Thus, regardless of diagnosis, the number of NR1 protein positive neurons was greatest 
in the XII and lowest in the NTS at the level of the mid medulla (Fig. 9.3B) with a greater 
expression in the LC than pontine nucleus at the level of the rostral pons (Table 9.1).  
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Fig. 9.1: Non-RISH staining for NR1 mRNA in the infant brainstem. 
Photomicrographs illustrating NR1 mRNA staining by non-radioactive in-situ hybridisation in the 
brainstem of one non-SIDS infant at the level of (A) mid medulla with enlargement of (B) XII and (C) 
NTS; (D) rostral pons with enlargement of (E) LC and (F) pontine nucleus. Calibration bar: A,D = 
0.11cm; B,C = 125µm; E,F = 100µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 9.2: Immunohistochemical staining for NR1 protein in the infant medulla. 
Photomicrographs illustrating NR1 protein staining by immunohistochemistry in the brainstem of one 
non-SIDS infant at the level of (A) mid medulla with enlargement of (B) DMNV and (C) ION. 
Calibration bar: A = 0.11cm; B,C = 80µm. 
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Fig. 9.3: Quantitation of NR1 mRNA and protein in the infant medulla. 
(A) Quantitative measurement of NR1 mRNA (optical density (OD) units) age adjusted mean OD ± SEM 
and, (B) for NR1 protein (% positive) age adjusted mean % ± SEM in 8 individual nuclei of the mid 
medulla arranged from highest to lowest according to the non-SIDS group (open bars). Comparison 
between non-SIDS (n=10) and SIDS (filled bars, n=15). * p<0.05. 
 
 
 
Table 9.1: Comparison between non-SIDS (n=7) and SIDS (n=8) for NR1 mRNA and protein in 
two nuclei of the rostral pons.  
              NR1 mRNA             NR1 protein 
Nucleus non-SIDS SIDS p value non-SIDS SIDS p value 
LC 0.17 ± 0.02 0.22 ± 0.02 0.23 79.7 ± 2.2 80.7 ± 3.3 0.71 
pontine 0.19 ± 0.02 0.22 ± 0.02 0.36 64.3 ± 4.2 73.4 ± 4.0 0.35 
The values are expressed as age-adjusted mean OD ± SEM for NR1 mRNA and age-adjusted mean % positive ± 
SEM for NR1 protein. 
 *
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9.3.4 NR1 mRNA quantitation 
mid medulla: For 6 of the 8 nuclei examined, there was a significant increase in NR1 mRNA. 
OD values were significantly higher in the SIDS group (n=15) when compared to the non-SIDS 
group (n=10) for the XII, ION, DMNV, Cun, Vest and NSTT (Fig. 9.3A).  
 
Amongst the SIDS cases, NR1 mRNA OD was not statistically different between the two sleep 
positions that the infant usually slept in, prone (n=4) vs non-prone (n=11), in any of the 8 nuclei 
(Table 9.2). Thus, sleep position had no effect on NR1 mRNA amongst the SIDS infants. 
 
rostral pons: There was no statistical difference in NR1 mRNA OD in either the LC or pontine 
nuclei when comparing non-SIDS (n=7) to SIDS (n=8) (Table 9.1). 
 
9.3.5 NR1 protein quantitation 
mid medulla: Age was a covariate for the DMNV (p=0.01) and for the AN (p=0.02) when 
analysing % positive NR1 protein. Amongst the 8 nuclei examined, there was a significant 
increase in NR1 protein in the DMNV (after adjusting for age, p=0.04) and significant decrease 
in the NSTT in the SIDS group (p=0.03) when compared to the non-SIDS group (Fig. 9.3B).  
 
Amongst the SIDS cases, examining by sleep position, NR1 protein was significantly decreased 
in the Vestibular nucleus of infants who usually slept prone (p=0.02) compared to those who 
usually slept non-prone. A trend to decreases was also observed in the XII and AN (Table 9.2). 
 
rostral pons: There was no statistical difference for NR1 protein in either the LC or pontine 
nuclei when comparing non-SIDS to SIDS (Table 9.1).  
 
Table 9.2: Comparison between the non-prone and prone usual sleep positions for NR1 mRNA 
and protein in the mid medulla of SIDS infants. 
 NR1 mRNA  NR1 protein  
Nuclei Non-prone prone p-value Non-prone prone p-value
   XII  
   ION  
   AN 
   Cuneate 
   Vestibular  
   DMNV  
   NSTT 
   NTS 
0.45 ± 0.03 
0.32 ± 0.02 
0.32 ± 0.02 
0.32 ± 0.02 
0.27 ± 0.02 
0.25 ± 0.02 
0.18 ± 0.01 
0.16 ± 0.01 
0.44 ± 0.05 
0.35 ± 0.04 
0.29 ± 0.04 
0.30 ± 0.03 
0.24 ± 0.03 
0.23 ± 0.03 
0.18 ± 0.01 
0.15 ± 0.02 
0.8 
0.5 
0.5 
0.6 
0.4 
0.7 
0.9 
0.7 
83.2 ± 3.6 
77.4 ± 2.1 
78.7 ± 2.7 
72.9 ± 3.3 
63.2 ± 3.2 
75.0 ± 2.1 
36.1 ± 3.9 
35.9 ± 3.4 
73.9 ± 6.1 
76.1 ± 3.6 
70.6 ± 5.3 
66.0 ± 5.6 
46.8 ± 5.2 
73.2 ± 3.6 
34.4 ± 6.6 
35.1 ± 5.8 
0.2 
0.8 
0.2 
0.3 
0.02 
0.7 
0.8 
0.9 
The values are expressed as age-adjusted mean OD ± SEM for NR1 mRNA and age-adjusted mean % positive ± 
SEM for NR1 protein.  
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9.4 DISCUSSION 
This study examined the expression of NR1 mRNA and protein in the brainstem of human 
infants, and then assessed whether expression was increased in SIDS infants when compared to 
non-SIDS infants. The two major findings of this study are that compared to non-SIDS infants, 
NR1 mRNA was increased in 6 medullary nuclei and NR1 protein was changed in only 2 of the 
same 6 medullary nuclei of SIDS infants. Preliminary subgroup analysis by sleep position 
showed that the prone position amongst SIDS infants was not related to the changes in NR1 
mRNA but was associated with a decrease in NR1 protein in the Vestibular of the SIDS infants 
who usually slept prone. Taken together, these findings support the hypothesis that abnormalities 
of the NMDA receptor are present in certain nuclei of the brainstem of SIDS infants.  
 
9.4.1 NR1 mRNA and protein expression in the infant brainstem 
This study reports for the first time, the distribution and quantification of NR1 mRNA and NR1 
protein expressions in 8 nuclei of the mid medulla and two nuclei of the rostral pons in human 
infants. The localization of NMDA receptors in the human infant brainstem has been studied by 
autoradiography (Panigrahy et al., 2000b). However, such ligand-binding studies are limited in 
that they do not discriminate between the different subtypes of receptors nor do they give 
detailed information regarding the cellular distribution of the receptor. Methods such as in situ 
hybridization and immunohistochemistry allow for specific cellular localisation of receptors and 
their subtypes. 
 
The results of this study show that NR1 mRNA and protein are widely distributed in the mid 
medulla and rostral pons in the human infant, which is consistent with the distribution of NR1 
mRNA and protein reported in the piglet (Chapter 5), cat (Ambalavanar et al., 1998), rat 
(Petralia et al., 1994; Guthmann and Herbert, 1999) and mouse (Watanabe et al., 1994). 
Considering the wide distribution of NR1 in the infant brainstem, it is suggested that the NMDA 
receptor has functional significance in all nuclei controlling cardiorespiratory, sleep and/or 
arousal mechanisms, with the extent of this control dependent on the quantity of NMDA receptor 
expression.  
 
The quantitative pattern of NR1 mRNA and protein expression amongst the nuclei were similar, 
with both NR1 mRNA and protein expressions greater in the XII nucleus and least in the NTS, a 
pattern similarly observed for NMDA receptor binding by autoradiography in the infant medulla 
(Panigrahy et al., 2000b). Interestingly, AMPA and kainate binding in the infant medulla were 
opposite, with higher AMPA and kainate binding in the NTS compared to the XII nucleus 
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(Panigrahy et al., 1997; Panigrahy et al., 2000b). Taken together, these findings suggest that 
neurons of the XII may be functionally more dependent on the NMDA glutamatergic receptor 
compared to neurons of the NTS, which may have a tendency to be functionally dependent on 
the AMPA and kainate glutamatergic receptors.  
 
Although NR1 mRNA was found in all neurons of all the nuclei studied, this does not imply all 
mRNA is translated into protein or functional NMDA receptors. It has been shown that the NR1 
subunit, which was abundantly expressed intracellularly, is only transported to the plasma 
membrane when it is co-assembled with an NR2 subunit (McIlhinney et al., 1996). Thus, it 
remains possible that the expression and distribution of receptor subunits is different to that of 
functional receptors. This may explain some of the difference in the detection levels and 
expression pattern of NMDA in the human infant brainstem when comparing the in situ 
hybridisation and immunohistochemical results of this study to the autoradiographic results of 
Panigrahy et al. (2000b).  
 
9.4.2 non-SIDS vs SIDS  
As hypothesized, NMDA receptor expression was different in SIDS infants compared to non-
SIDS infants. However, all such changes were restricted to nuclei within the mid-medulla. The 
changes were more evident for NR1 mRNA than for NR1 protein where mRNA was increased in 
6 nuclei. The pattern of changes in NR1 expression support the hypothesis that NMDA 
excitotoxic mechanisms may contribute to neuronal cell death in SIDS infants. However, given 
that protein expression was also measured, three patterns of change were observed:  
1- NR1 mRNA and protein were both increased in the DMNV,  
2- mRNA was increased but protein decreased in the NSTT, and  
3- mRNA was increased but protein unchanged in the XII, ION, Vestibular and Cuneate. 
Any change in protein without mRNA also being affected was not observed.  
 
At the molecular level, the normal process is for NR1 mRNA to be translated to protein, which 
forms functional NMDA receptors by co-assembling with other NMDA subunits (NR2A-D 
and/or NR3A,B). In this study, altered mRNA expression was translated to altered protein 
expression in the DMNV of SIDS infants. Although our study did not extend to the functional 
receptor level, abnormal heart rate and blood pressure responses have been reported in some 
SIDS cases (Schechtman et al., 1992; Meny et al., 1994; Schechtman et al., 1996), and both of 
these physiological parameters are controlled by the DMNV, suggesting a possible functional 
correlation.  
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The differential change between NR1 mRNA and protein observed in the NSTT of the SIDS 
group, i.e. increased mRNA and decreased protein, has been reported in cerebellar granule cell 
cultures in response to chronic depolarisation (Resink et al., 1995), in some brain areas of the 
mouse following chronic ethanol treatment (Snell et al., 1996), and in the DMNV of the piglet 
model after IHH (Chapter 5). Possible explanations for this differential change include receptor 
downregulation and/or neuronal loss. Stereological counting would be required to confirm loss 
of neurons and was not part of this study. Although no other study to date has investigated for 
cell loss in the NSTT in SIDS infants, cell loss has been studied in the XII and DMNV of the 
SIDS brainstem, although results are conflicting (O'Kusky and Norman, 1992; Lamont et al., 
1995; Pamphlett and Treloar, 1996). In the ION, a marginal decrease in neuronal numbers has 
been reported (Kinney et al., 2002). The issue of cell loss as a specific neuropathological finding 
in SIDS infants appears to remain open. The association between increased apoptosis and cell 
loss is relevant to this discussion. The finding of increased apoptosis in the NSTT of the SIDS 
medulla (Waters et al., 1999), may support the contention of cell loss being the reason for the 
decrease in NR1 protein observed in the current study. Given that increased NMDA receptor 
expression suggests an increased vulnerability to excitotoxic neuronal damage and cell death, the 
finding of increased NR1 mRNA may underlie increased neuronal apoptosis in SIDS infants. 
This will be further investigated in Chapter 10.  
 
The dissociation between mRNA and protein expression in the XII, ION, Vestibular and Cuneate 
nuclei of SIDS infants may reveal a problem of mRNA turnover, with over-abundance of mRNA 
that is not expressed at the protein level. This suggests a defect in translation of mRNA to 
protein in some nuclei of the SIDS medulla. Alternatively, the changes in mRNA may have 
commenced without time for translation to protein prior to death. This would also suggest that 
the pathological process resulting in increased NR1 expression is occurring at a faster rate in the 
DMNV compared to the other nuclei.  
 
It is uncertain what functional changes would result from the dissociation between mRNA and 
protein particularly since the protein expression is “normal”. If the proper level of NR1 protein is 
present but mRNA not, is physiology compromised? It remains possible that although mRNA 
was affected in the XII, ION, Vestibular and Cuneate nuclei, this would not have translated to 
physiological compromise. 
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The lack of significance in changes in NR1 mRNA and/or protein levels amongst other nuclei in 
SIDS infants does not preclude the involvement of NMDA receptors within those nuclei. Only 
the NR1 subunit was studied, which although is obligatory for functional NMDA receptors, it 
does not determine the electrophysiological properties of the receptor, which are regulated by the 
NR2 (A-D) subunits (Guthmann et al., 1999). Future studies of other NMDA receptor 
components, for example NR2 subunit expression (via in situ hybridization and 
immunohistochemistry) and pharmacological studies for NMDA receptor site binding would 
clarify these issues when comparing SIDS infants to non-SIDS infants. Such studies will provide 
a better understanding of the role of NMDA receptors in mediating responses under the 
pathological conditions hypothesised in SIDS infants such as hypoxia, hypercapnia and 
ischemia, alone or in combination. 
 
9.4.3 Possible mechanism(s) involved in NMDA receptor expression changes 
The precise mechanism involved in the changes of NR1 mRNA and protein expression is not 
known. So, it is not clear whether the changes in NMDA expression could actually cause death, 
or instead, be the result of some event (eg. prolonged or repeated apnoea) preceding and 
underlying death from SIDS. If the changes in NR1 caused death in SIDS, this would imply that 
SIDS infants have a pre-existing defect in the NMDA receptor expression and thus, a 
predisposing vulnerability to an exogenous stressor. If this vulnerability overlaps with a critical 
developmental period, and the presence of an exogenous stressor, the infant will die of SIDS as 
proposed by the triple-risk model (Filiano and Kinney, 1994). If the NMDA receptor changes 
occur as a result of the mechanism of death in SIDS, this would imply that the changes in the 
NMDA receptor expression are secondary to other factors and most likely induced by the 
exogenous stressor. An hypoxic stimulus is a strong candidate as the common, exogenous 
stressor in the above scenarios, since the NMDA receptor is highly vulnerable to hypoxic 
exposures. Studies of non-SIDS infants who died with known prior exposure to moderate or 
severe hypoxia would help to clarify these issues.  
 
The NMDA receptor is responsible for neuronal maturation and plasticity (Bear et al., 1987; 
Komuro and Rakic, 1998), and changes in its expression may be associated with synaptic 
plasticity after injury (Grossman et al., 2000). It has been suggested that NR1 mRNA up-
regulation may facilitate reactive synaptogenesis; a reorganization of neurons to alter their 
connections or form new ones in response to lesions (Shapiro, 1997). Thus, up-regulation of NR1 
mRNA in the SIDS medulla may be associated with transient, albeit unsuccessful, attempts at 
regeneration of neurons after hypoxic injury.  
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There is strong evidence that changes in the NMDA system are inducible during early 
development. Chapter 5 showed that a stimulus of IHH, increased NR1 mRNA levels in the XII, 
DMNV and gracile nuclei of the piglet caudal medulla, and simultaneously decreased NR1 
protein in the DMNV. This finding is significant for two reasons. First, it shows that the NMDA 
receptor is sensitive to the common clinical stimulus of hypercapnic hypoxia. Second, it supports 
the notion that the changes in NR1 mRNA and protein expressions may be induced by postnatal 
environmental insults with no pre-existing defect. The changes observed in the piglets were not 
as dramatic nor were they present in as many nuclei as seen in the SIDS infants. It therefore 
remains possible that SIDS infants have a specific and innate abnormality in NMDA receptors.  
 
In regards to the sleep position, NR1 mRNA levels were not different between SIDS infants who 
usually slept prone and those who did not. In contrast, NR1 protein was decrease in the 
vestibular nucleus of the prone sleepers, suggesting a deficit in the NMDA neurotransmitter 
system. This finding that the vestibular nucleus alone was affected by the prone sleep position is 
very important, especially when considering that the vestibular participates in making necessary 
adjustments in blood pressure during movement and changes in posture in the awake (Yates et 
al., 2000) and sleep states (Harper et al., 2000). Thus, a deficit in the NMDA system in the 
vestibular may prevent the protective role of the vestibular in blood pressure control during sleep 
in the prone position, with potentially life-threatening consequences.  
 
9.5 Conclusion 
This study contributes to the increasing evidence that neurotransmitter abnormalities exist in 
SIDS infants. It was demonstrated that NR1 mRNA and protein are widely expressed in nuclei of 
homeostatic function in the human infant mid medulla and rostral pons and that the overall 
pattern of expression amongst nuclei did not differ between SIDS and non-SIDS infants. 
Nonetheless, expression of NR1 mRNA was greater in SIDS than non-SIDS infants in 6 of 8 
nuclei associated with cardiorespiratory control or facial sensation, while NR1 protein was 
altered in 2 of these 6 nuclei. Preliminary findings show an association between changes in NR1 
protein and the prone sleep position for the vestibular nucleus in SIDS infants. Taken together, 
these results suggest that NMDA receptor expression is altered in brainstem medullary nuclei 
that regulate cardiorespiratory functions in some SIDS infants, rendering these nuclei vulnerable 
to excitotoxic degeneration. However, a deficit in the NMDA system seems to be present in the 
vestibular nucleus of SIDS infants who usually sleep prone, suggesting that an association 
Chapter 9: NR1 expression changes in the SIDS infant brainstem.        
    
124
between prone sleeping and deficient NMDA receptors exists. This is the first ‘preliminary 
pathological proof’ of such an association.  
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Chapter 10 
Correlation between the NMDA receptor and 
neuronal death in the SIDS brainstem.  
 
10.1 Introduction 
In humans, the brain growth spurt period starts in the sixth month of pregnancy and extends to 
the third year after birth (Dobbing and Sands, 1979). During this period, NMDA receptors are 
hypersensitive, making neurons bearing the NMDA receptor exceedingly sensitive to excitotoxic 
degeneration when subjected to a noxious stimulus (McDonald et al., 1988).  
 
As documented in Chapter 9, NR1 mRNA and protein were widely distributed in the infant 
brainstem. Changes in the expression of both were observed in certain nuclei of the mid medulla 
of SIDS infants, with the general change being an increase in expression. This finding was taken 
to suggest an increased vulnerability of these nuclei to NMDA mediated excitotoxic damage. To 
test this hypothesis, this chapter employed double IHC to co-localise NR1 protein and TUNEL 
with the aim of determining whether a correlation exists between NMDA receptor expression 
and neuronal death. The specific hypothesis tested is that neuronal death is more prevalent in 
NMDA expressing neurons compared to non-NMDA expressing neurons in SIDS infants.  
 
10.2 Materials and Methods  
10.2.1 Tissue collection and processing 
Brainstem tissue was available for study from a total of 25 infants who had died at less than one 
year of age. Brain removal, fixation and tissue processing have been described in Chapter 2 
(section 2.3). 
 
10.2.2 Double Immunohistochemistry for TUNEL and NR1 protein 
The co-localisation of TUNEL and NR1 protein was performed as described in Chapter 2 
(section 2.7.5).  
 
10.2.3 Quantitative immunohistochemistry 
Images were captured as described in Chapter 2 (section 2.10.1) and four counts were made for 
each image as follows: 1- NR1 positive, 2- NR1 negative, 3- NR1 and TUNEL co-localised and 
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4- TUNEL in non-NR1 neurons. Counts for each case were summed for the captured images 
from within each nucleus and results calculated to give the percent of neurons positive for: 
1- NR1 (%NR1),  
2- TUNEL (%TUNEL),  
3- TUNEL amongst the NR1 population of neurons (% TUN in NR1) and  
4- TUNEL amongst the remainder (non-NR1) population of neurons (% TUN in non-NR1).  
 
10.2.4 Analysis 
Two adjacent sections for each case at each brainstem level were subjected to each staining 
method (i.e. n=2, per case, per stain. Refer to Chapter 2, section 2.11). Eight nuclei of the mid 
medulla (XII, DMNV, ION, AN, NTS, Vest, Cun and NSTT) and two nuclei of the rostral pons 
(LC and pontine) were analysed (Refer to Chapter 2, section 2.8.2 and Fig. 2.4). Tissue sections 
from all of the SIDS and control cases were closely matched at each of these two levels, 
respectively. 
 
Statistical analyses were undertaken using SPPS for Windows (V11.5, Chicago, USA). Analysis 
of covariance (ANCOVA) was used to evaluate differences in quantification by diagnosis (SIDS 
vs non-SIDS), adjusted for age and gender. When there was a significant difference in 
quantification by diagnosis across groups with ANCOVA, the Bonferroni procedure was 
employed to evaluate pairwise comparison of the means. Subgroup analyses compared 
quantification by sleep position amongst SIDS cases only. Staining results are presented as age-
adjusted mean ± SEM. A 2-sided p-value of <0.05 was considered statistically significant. 
 
10.3 Results 
10.3.1 Dataset characteristics  
The characteristics of the infant cases used in this study have been described in Chapter 7, 
sections 7.3.4 and 7.3.5. Briefly, a total of 25 cases were studied at the mid-medulla level (10 
non-SIDS vs 15 SIDS) while 15 of these cases had further studies at the rostral pons level (7 
non-SIDS vs 8 SIDS). Further, subgroup analysis for ‘sleep position the infant usually slept in’ 
was performed for the SIDS group, and only at the mid medulla level (4 usually prone vs 11 
usually non-prone).  
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10.3.2 Staining 
A neuron that was positive for NR1 had a blue stained cytoplasm. Neurons were only counted as 
TUNEL positive if they had a dark brown/black nucleus and appeared shrunken with clumping 
of nuclear material, both of which are characteristic of a neuron undergoing cell death (Fig. 
10.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10.1 Double immunostaining for NR1 protein and TUNEL  
Micrographs of the (A) inferior olivary nucleus (ION), and (B) cuneate nucleus from a coronal 
section at the level of the mid medulla from a non-SIDS infant. NR1 positive only neuron (black 
filled arrow), TUNEL positive only neuron (yellow filled arrow), TUNEL positive in an NR1 
positive neuron (white filled arrow). Calibration bar = 50 µm for both panels. 
 
10.3.3 Quantification 
10.3.3.1 TUNEL amongst the NR1 vs the non-NR1 population for each individual group 
non-SIDS: Of the eight nuclei in the mid-medulla, the number of TUNEL positive neurons 
amongst the non-NR1 population was significantly greater than that amongst the NR1 population 
in the DMNV (ratio %TUN in NR1 to %TUN in non-NR1 = 1:4.7, p=0.03. Note, that the ratios 
were calculated from non-adjusted mean values). For the LC and pontine nuclei of the rostral 
pons, there was a greater % TUNEL in non-NR1 compared to NR1 that did not reach statistical 
significance (Table 10.1). 
 
SIDS: In the mid-medulla, the number of TUNEL positive neurons amongst the non-NR1 
population was greater than that amongst the NR1 population in the XII and AN (p=0.05 for 
both), and statistically greater in the DMNV (ratio %TUN in NR1 to %TUN in non-NR1 = 1:2.3, 
p=0.01. Ratios calculated from non-adjusted mean values). A similar pattern was observed for 
the LC and pontine nuclei of the rostral medulla, but was not significant (Table 10.1). 
A B
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Table 10.1: Ratio of % TUN in NR1 to % TUN in non-NR1 for each infant group (non-SIDS 
and SIDS) in the mid medulla and rostral pons.  
Nuclei Non-SIDS p-value SIDS p-value 
Mid medulla 
   XII  
   ION  
   AN 
   Cuneate 
   Vestibular  
   DMNV  
   NSTT 
   NTS 
Rostral pons 
   LC 
   pontine 
 
1:1.2 
1:3.2 
1:1.5 
1:1.5 
1:1.2 
1:4.7 
1:0.7 
1:1.1 
 
1:2.2 
1:1.5 
 
0.53 
0.22 
0.30 
0.16 
0.77 
0.03 
0.92 
0.82 
 
0.22 
0.29 
 
1:1.5 
1:1.4 
1:2.9 
1:1.3 
1:1.4 
1:2.3 
1:0.6 
1:0.9 
 
1:1.4 
1:1.6 
 
0.05 
0.47 
0.05 
0.50 
0.27 
0.01 
0.58 
0.24 
 
0.39 
0.56 
P value compares the %TUN in NR1 to %TUN in non-NR1 for each infant group. 
 Ratios were calculated from non-adjusted mean values. 
 
 
10.3.3.2.  TUNEL amongst the NR1 population: SIDS vs non-SIDS 
mid medulla: In the non-SIDS group, the % TUN in NR1 varied from 3.2 ± 0.8 % (Vest) to 1.2 ± 
0.4 % (AN). There was no significant difference for any of the eight nuclei when comparing the 
SIDS to the non-SIDS group (Table 10.2).  
 
Amongst the SIDS cases examining by sleep position, % TUN in NR1 was significantly 
increased in the AN of SIDS infants who usually slept prone (p=0.05) compared to those who 
usually slept non-prone. A trend to increase was further observed in the ION and vestibular 
(Table 10.3).  
 
rostral pons: In the non-SIDS group the pontine nucleus had a greater % TUN in NR1 compared 
to the LC. Comparing non-SIDS to SIDS, there was no statistical difference in either the LC or 
pontine nuclei (Table 10.2). 
 
10.3.3.3 TUNEL amongst the non-NR1 population: SIDS vs non-SIDS 
mid medulla: In the non-SIDS group, the % TUN in non-NR1 varied from 4.7 ± 1.2 % (Cun) to 
1.7 ± 1.0 % (AN). There was no statistically significant difference for any of the eight nuclei 
when comparing the SIDS to the non-SIDS group. In the AN, there was a trend towards an 
increase (p=0.05) (Table 10.4).  
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Amongst the SIDS cases examining by sleep position, % TUN in non-NR1 was significantly 
increased in the Cun of SIDS infants who usually slept prone (p=0.04) compared to those who 
usually slept non-prone (Table 10.3).  
 
rostral Pons: In the non-SIDS group the pontine nucleus had a greater % TUN in non-NR1 
compared to the LC. Comparing non-SIDS to SIDS, there was no statistical difference in either 
the LC or pontine nuclei (Table 10.4). 
 
Table 10.2: Comparison between non-SIDS and SIDS for % TUN in NR1 in the mid medulla 
and rostral pons.  
Nuclei Non-SIDS SIDS p-value 
Mid medulla 
   XII  
   ION  
   AN 
   Cuneate 
   Vestibular  
   DMNV  
   NSTT 
   NTS 
Rostral pons 
   LC 
   pontine 
 
2.4 ± 0.5 
1.7 ± 0.6 
1.2 ± 0.4 
2.6 ± 0.9 
3.2 ± 0.8 
1.5 ± 0.5 
2.9 ± 0.6 
2.9 ± 0.9 
 
0.7 ± 0.5 
1.3 ± 0.8 
 
1.5 ± 0.4 
1.4 ± 0.5 
1.8 ± 0.3 
3.6 ± 0.7 
2.6 ± 0.6 
2.0 ± 0.4 
2.2 ± 0.5 
3.6 ± 0.7 
 
1.2 ± 0.5 
2.1 ± 0.7 
 
0.15 
0.66 
0.29 
0.38 
0.53 
0.43 
0.42 
0.53 
 
0.55 
0.43 
        Results are expressed as the age adjusted mean % ± SEM. 
 
Table 10.3: Comparison between the non-prone and prone usual sleep positions for % TUN in 
NR1 and % TUN in non-NR1 in the mid medulla of SIDS infants. 
 % TUN in NR1  % TUN in non-NR1   
Nuclei Non-prone prone p-value Non-prone prone p-value
   XII  
   ION  
   AN 
   Cuneate 
   Vestibular  
   DMNV  
   NSTT 
   NTS 
1.7 ± 0.3 
1.0 ± 0.6 
1.4 ± 0.4 
3.2 ± 1.0 
2.5 ± 0.5 
1.7 ± 0.4 
2.1 ± 0.5 
3.2 ± 1.0 
0.8 ± 0.5 
2.6 ± 1.0 
3.3 ± 0.7 
4.7 ± 1.7 
3.5 ± 0.8 
2.5 ± 0.7 
2.5 ± 0.9 
4.7 ± 1.7 
0.2 
0.2 
0.05 
0.5 
0.2 
0.4 
0.7 
0.5 
2.4 ± 1.0 
2.7 ± 1.0 
3.9 ± 1.2 
3.3 ± 0.8 
4.0 ± 0.6 
5.3 ± 0.9 
2.9 ± 0.8 
2.8 ± 0.4 
3.8 ± 1.6 
1.8 ± 1.6 
6.0 ± 2.3 
7.2 ± 1.4 
2.5 ± 1.0 
4.2 ± 1.6 
2.2 ± 1.4 
2.1 ± 0.6 
0.5 
0.6 
0.4 
0.04 
0.3 
0.6 
0.7 
0.3 
 Results are expressed as the age-adjusted mean % ± SEM. 
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Table 10.4: Comparison between non-SIDS and SIDS for % TUN in non-NR1 in the mid 
medulla and rostral pons.  
Nuclei Non-SIDS SIDS p-value 
Mid medulla 
   XII  
   ION  
   AN 
   Cuneate 
   Vestibular  
   DMNV  
   NSTT 
   NTS 
Rostral pons 
   LC 
   pontine 
 
3.3 ± 1.2 
2.7 ± 0.6 
1.7 ± 1.0 
4.7 ± 1.2 
3.7 ± 0.9 
4.0 ± 1.0 
2.8 ± 0.8 
3.2 ± 0.6 
 
1.8 ± 0.8 
3.9 ± 2.0 
 
3.5 ± 1.0 
1.9 ± 0.5 
4.4 ± 0.8 
4.4 ± 0.9 
3.4 ± 0.8 
4.5 ± 0.8 
2.6 ± 0.7 
2.6 ± 0.5 
 
2.1 ± 0.7 
2.9 ± 1.8 
 
0.90 
0.26 
0.05 
0.85 
0.82 
0.71 
0.85 
0.43 
 
0.81 
0.72 
        Results are expressed as the age-adjusted mean % ± SEM. 
 
10.4 Discussion 
This study examined the amount of neuronal cell death (TUNEL positivity) in NR1 as compared 
to non-NR1 expressing neurons within eight nuclei of the infant mid medulla and two nuclei of 
the rostral pons to determine which neuronal population within each nucleus is more prone to 
death. The study then examined for these expressions in SIDS infants to see whether they were 
changed when compared to the non-SIDS infants, and to determine whether the usual sleep 
position had an effect.  
 
10.4.1 TUNEL in NR1 and non-NR1 neurons of the infant brainstem 
Chapter 8 reported the “normal” (as determined by the non-SIDS group) TUNEL expression in 
all neurons of the nuclei examined. This chapter however, went one step further and delineated 
the TUNEL expression amongst two neuronal phenotypes, NMDA versus non-NMDA. The 
results show that neuronal cell death occurred equally in both phenotypes for all nuclei examined 
except for the DMNV, where death was four times more prominent amongst the non-NMDA 
population. This was an unexpected observation since the DMNV is a nucleus with high NMDA 
receptor content (75%, see Chapter 9), and thus, one would expect the reverse, i.e., greater cell 
death.   
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10.4.2 non-SIDS vs SIDS 
Comparing the non-SIDS and SIDS infants, the hypothesis tested was that TUNEL positivity is 
increased in the NMDA population of neurons, and would reflect excitotoxic mechanisms. 
Similar to the non-SIDS group, there were more cell deaths amongst the non-NMDA neurons of 
the DMNV but now, the ratio was less, with twice as many non-NMDA neurons dying compared 
to the 4 times observed for the non-SIDS infants. This suggests either two things: 1- that death 
amongst the NMDA neurons of the DMNV is increased in SIDS, or 2- death amongst the non-
NMDA neurons is decreased in SIDS. When examining for these two parameters separately, 
neither held true statistically, but the results lean more towards the first suggestion, as evident by 
the trend to increased TUNEL amongst the NMDA neurons. In Chapter 9, it was observed that 
NR1 protein was only increased in the DMNV and no other nuclei, and hypothesised that this 
increased expression suggests an increased vulnerability of these NMDA neurons to excitotoxic 
cell death. Given the trend observed in this chapter, it is possible that this hypothesis may hold 
true and that excitotoxic mechanisms are present in the DMNV of SIDS infants.   
 
The only other observation that differentiated the two study groups was that the ratio for TUNEL 
positivity in NR1 to non-NR1 in the XII and AN was now significant in the SIDS group. When 
examined to see which neuronal phenotype was affected, it was found that for the AN, the non-
NMDA neurons were affected and had an increase in death whereas for the XII, the change was 
likely due to the observation that death amongst the NMDA neurons was slightly decreased. The 
finding in the AN could be interpreted to indicate that NMDA mediated excitotoxicity is not the 
predominant mechanism for cell death in the AN of SIDS infants and that other mechanisms may 
be involved, most likely a mechanism that involves the serotonergic system given recent findings 
of changes in this receptor in the SIDS infant AN (Panigrahy et al., 2000a). However, the results 
of this study with regards to the sleep position provide a basis where such an interpretation is 
misleading. For the SIDS infants who usually slept prone, NMDA neurons of the AN had an 
increase in TUNEL suggesting that the prone sleep position may have a causal link with the 
mechanism of death for these infants and that excitotoxicity in the AN may have been a 
contributing factor.  
 
The prone sleep position in SIDS infants was also associated with an increase in cell death 
amongst the non-NMDA neurons of the cuneate nucleus. In Chapter 8, it was observed that there 
was an increased trend in TUNEL expression in the cuneate of the prone sleepers. This chapter 
shows that this increased trend was significant amongst the non-NMDA population, a finding 
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that does not support the hypothesis tested. Instead, it suggests that non-excitotoxic mechanisms 
may predominate in the cuneate nucleus during prone sleeping. Regardless, considering that the 
cuneate nucleus is an important brainstem processing center of cutaneous information (mediates 
sensory and tactile inputs) (Xu and Wall, 1996), a deficit in the neuronal population in the 
cuneate may interfer with the relay of the sensory and tactile information, and could be 
potentially life-threatening.  
 
10.5 Conclusion 
This chapter has demonstrated that in non-SIDS infant brainstems, neuronal cell death labelled 
by TUNEL, affected NMDA and non-NMDA neurons equally, except for the DMNV where 
non-NMDA neurons were more prone to death. In SIDS infants, the DMNV, XII and AN 
showed a different pattern of expression of cell death between the phenotypes. Only the change 
in the DMNV is somewhat in agreement with the hypothesis that NMDA expressing neurons are 
more vulnerable to cell death. This was also true for the AN of SIDS infants who usually slept 
prone. Despite these findings, it is not possible to definitively conclude that nuclei with 
increased NMDA receptor expression have an increase in neuronal cell death in SIDS infants. 
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Chapter 11 
Concluding Remarks.  
 
11.1 Comparison between the datasets, and significance of findings 
This thesis presented data from two separate datasets; a piglet dataset comparing piglets exposed 
to IHH with ‘control’ piglets that underwent the same protocol without the noxious insult, and an 
infant dataset comparing SIDS with non-SIDS infants. These two datasets were studied with the 
aim of: 
1- verifying a previously documented brainstem pathology in the SIDS infant of increased 
neuronal cell death. 
2- studying for other abnormalities in the SIDS infant brainstem, specifically, in NMDA 
receptor expression. 
3- verifying that exposure to IHH could be an underlying mechanism for the abnormalities 
found in the SIDS brainstem. 
4- verifying that the piglet model of IHH is appropriate for studies of SIDS neuropathology. 
 
Staining methods for markers of cell death and for the NMDA receptor were employed on 
formalin fixed and paraffin embedded brainstem tissue. Results from these studies are 
summarised in Table 11.1, where a comparison between findings in the two datasets is made. 
 
Table 11.1: Summary of data and comparison between the infant and piglet datasets for each 
marker analysed.  
Marker analysed Piglets 
(IHH vs controls) 
Infants 
(SIDS vs non-SIDS) 
SIDS 
(prone vs non-
prone) 
TUNEL 
 
Active caspase-3 
 
 
NR1 mRNA 
 
 
 
NR1 protein 
 
 
Co-localisation 
 (NR1 & TUNEL) 
Increased in DMNV, LRT, 
ION 
Increased in DMNV, 
decreased in LRT  
 
Increased in 3 nuclei (XII, 
DMNV, Grac) 
 
 
Decreased in DMNV 
 
 
NMDA neurons of DMNV 
and ION vulnerable to 
death  
No changes 
 
No changes 
 
 
Increased in 6 nuclei  
 (XII, ION, DMNV, 
  Vest, Cun, NSTT) 
 
Increased in DMNV, 
decreased in NSTT 
 
NMDA neurons of 
DMNV vulnerable to 
cell death 
Increased trend in 
most nuclei 
No changes 
 
 
No changes 
 
 
 
Decreased in Vest 
 
 
NMDA of AN 
vulnerable to cell 
death. 
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These findings are significant in that they show for the first time that:   
• IHH induced an increase in neuronal cell death and changes in NMDA receptor 
expression in selected nuclei of the medulla from piglets with no prior abnormality, or 
other noxious exposure. 
• The correlation between IHH induced increases in neuronal cell death and abnormalities 
in the NMDA receptor system in selected nuclei supports the hypothesis that 
excitotoxicity may be involved in the mechanism for cell death in these nuclei.  
• Nuclei affected by IHH are functionally relevant to the hypothesis that cardiovascular 
control abnormalities can be induced by IHH; the DMNV was consistently affected in 
piglets exposed to IHH and in SIDS infants. 
• Abnormalities in NMDA receptor expression are present in selected nuclei of the medulla 
of SIDS infants. 
• NMDA neurons of the DMNV appear to have increased vulnerability to cell death in 
SIDS infants. 
• SIDS infants who usually slept prone have decreased NR1 protein in the Vest nucleus, 
and increased cell death amongst NR1 neurons of the AN compared to those who usually 
slept non-prone.  
 
In reference to the four aims mentioned at the beginning,  
1- The findings of this thesis were not able to verify that increased neuronal cell death in the 
brainstem is a specific neuropathology to the diagnosis of SIDS. However, the infant 
dataset was small. The results pertain to only one level of the medulla, and this did not 
match the original study that reported this finding, so further studies will be required to 
verify this issue. 
2- Abnormalities of the NMDA receptor are present in the brainstem of SIDS infants but 
further verification of this finding should be made.  
3- The studies in this thesis suggest that exposure to IHH, such as may occur in SIDS risk 
factors, may underlie the abnormalities present in the brainstem of SIDS infants. This 
conclusion is based on similarities of findings between the two datasets (NMDA changes 
induced by IHH are similar to those observed in SIDS infants, and the DMNV is 
consistently affected), in conjunction with the finding that neuronal cell death changes in 
piglets after IHH are similar to the changes observed in a Canadian population of SIDS 
infants (Waters et al., 1999).  
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4- The piglet model of IHH seems to be appropriate for studies of SIDS neuropathology, 
and for a subset of SIDS infants. The neuropathological changes observed in piglets 
provide a potential explanation for those observed in SIDS infants, and aligns with 
known risk factors. Further verification of the effects of IHH in a bigger piglet dataset 
with better male to female ratios (in this thesis it was 5 male to 1 female) should be 
made.  
 
These findings lend support to the argument that SIDS is of postnatal rather than prenatal origin. 
The IHH exposure was presented to the piglets postnatally and was able to induce similar 
changes as observed in the SIDS infants, although they were more severe in the brainstem of 
SIDS infants. The fact that the piglets had no pre-existing vulnerability makes it plausible that 
the finding of increased neuronal cell death and changes in NMDA receptor expression in the 
brainstem of SIDS infants were induced in the postnatal period, and that death resulted because 
this postnatal insult overlapped with a critical developmental period of the infant (as proposed by 
the Triple Risk Model, Fig. 1.1, Filliano and Kinney, 1994).  
 
The global hypothesis of this thesis (Chapter 1, section 1.11) was that IHH induces neuronal cell 
death and that this process involves the NMDA receptor. The studies presented herein suggest 
that this is likely to be true amongst some brainstem nuclei, most notable being the DMNV. The 
affected nuclei also have relevant functional significance. The results also raise the possibility 
that neurons and/or other cell types in other brain regions could be similarly affected.  
 
The findings of this thesis that the risk factor of prone sleeping amongst SIDS infants is 
associated with specific changes in NR1 protein in the Vest and AN is very important. To date, 
no neuropathological study has been able to provide evidence of the much accepted and proven 
epidemiological finding that the prone sleep position is a risk factor for SIDS. Although the 
findings of this thesis are derived from a small number of cases per sleep position (4 prone vs 11 
non-prone), and must therefore be considered preliminary, the fact that the difference was 
demonstrable implies that the sleep position has a significant impact. Further analysis will be 
required amongst larger SIDS datasets to verify whether this ‘preliminary pathological proof’ of 
an association between prone sleeping and deficient NMDA receptors exists.  
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11.2 Future directions of research 
• Now that the Tissue Act has been amended and permits renewal of Ethical approval for 
studies in the full infant dataset (characterised in Chapter 7), further studies can be 
undertaken on larger numbers of infants regarding neuronal cell death and NMDA 
receptor changes. The studies would permit correlations to be made with clinical risk 
factors including sleep position, age, gender, and cigarette-smoke exposure. 
• The effects of concurrent nicotine exposure can be studied in the piglet model that was 
used in this thesis with neuropathological studies to determine whether nicotine exposure 
induces or compounds the changes observed.  
• Neuropathological staining can be extended to include studies of other cell death 
markers, NMDA receptor subunits, and other receptor systems. Other receptor systems of 
interest include the serotonergic system and growth factors (for example the 
neurotrophins). The serotonergic system is of interest because changes in this receptor 
have been reported in SIDS and also because it too plays a role in the mechanism of 
apoptosis. Of the growth factors, brain derived neurotrophic factor (BDNF), is of 
particular interest because it too has a role in apoptosis, it has been implicated as 
affecting NMDA receptor function, and it has been shown to be integral to the normal 
development of respiratory control.  
• A more comprehensive study of neurotransmitter/receptor systems could be undertaken 
using new techniques, such as microarray analyses of protein and/or mRNA levels after 
IHH exposures. Such analyses would complement the histological studies of this thesis. 
If histological methods are used to determine the timing of changes in the processes 
being studied, microarrays could be undertaken on blood or fresh tissue samples at that 
time to determine the markers relevant to the process. At the time of writing, it is not 
clear how the method of microarray analysis could be applied to post-mortem SIDS 
material. However, the demonstration that other experimental methods, for example in 
situ hybridisation, were established in fresh material but subsequently adapted for use on 
post mortem fixed material, suggests that it will also be feasible to adapt the microarray 
systems to use on post-mortem material. 
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Appendix 1- 
International incidence of SIDS and introduction of reducing the risk campaigns 
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Appendix 2- 
Standard questionnaire used to collect information relevant in SIDS research 
Subject number   
Diagnosis   
Date of birth   
Date of death   
Age   
Gender   
Gestational age   
Birth weight   
Immunisation  
(days since) 
  
Family history (SIDS)   
Family history (other)   
Parental smoking    
Maternal age   
Paternal age   
Usual sleep position   
Sleep position found   
Head pos. found   
Face pos. found   
Time last seen alive   
Time found   
Time of Autopsy   
Weight   
Length   
Head circumference   
Brain weight   
Neurological findings   
Gliosis (location)   
Hepatic extrapoises   
Pulmonary -oedema,    
aspiration, congestion 
  
Petechiae- thymic, 
thoracic, pulmonary, 
epicardial 
  
URTI (upper respiratory 
tract infection) 
  
URTI duration   
Malformations   
Diagnosis final   
Other information   
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Appendix 3 
 Infant clinical and autopsy data 
 
 
Case # Diagnosis Gender Age 
Gestational 
age, birth 
method 
Birth 
weight 
(g) 
Body 
weight 
(g) 
Brain 
weight 
(g) 
Length 
(cm) 
Head 
circumference 
(cm) 
Neurological 
findings 
Pulmonary- 
o,a,c 
Petechiae 
(t,p,e,th)
Fixation 
time (w)
Post 
Mortem 
Interval (h) 
1 
aspiration of gastric 
contents M 3m 
premature, 
caesarean 2918 6500 760 59.0 42.0 none a none no data 33.62 
2 
aspiration of gastric 
contents M 5m 40w, normal 3560 9385 1060 70.5 47.5 none a p,t,e 8.70 17.00 
3 
aspiration of gastric 
contents M 7m 40w, normal 2900 7580 840 69.0 43.0 hemosiderin c,o none 4.00 31.00 
4 
bronchopulmonary 
dysplasia & co-
sleeping accident M 2m 2w 30w, normal 1360 2234 450 46.5 34.0 none none p,e 9.00 9.25 
5 
brompheniramine 
toxicity & RTI M 3m 37w, induced 3146 4730 704 55.0 39.0 none c,o t 6.60 9.25 
6 bronchopneumonia F 2m 
33w, normal, 
one of twins 2030 3278 444 51.5 33.5 none o none 8.35 6.80 
7 bronchopneumonia F 5m 28w 970 3610 528 52.0 37.5 none none none 6.70 8.00 
8 bronchopneumonia F 5m no data no data 6390 738 63.0 40.5 none c,o none 5.60 19.8 
9 bronchopneumonia M 1m 1w 40w, caesarean 4610 4474 542 53.0 38.0 none none none 7.00 7.60 
10 bronchopneumonia M 2m 3w no data no data 5110 652 58.0 40.5 none none p,t,e 6.60 6.80 
11 bronchopneumonia M 4m 40w, normal 3530 5144 736 61.0 42.5 
white matter 
congestion none none 9.70 4.50 
12 bronchopneumonia M 6m no data no data 9200 900 70.0 43.5 none c,o none no data 15.25 
13 
cardiac arrythmia/ 
hypoxic insults F 4m 40w, normal 2050 5040 670 54.0 39.5 none none none 9.00 18.30 
14 cardiomyopathy M 10m 
preterm, 
caesarean 2777 7800 1036 72.0 45.3 none none none 9.35 38.00 
15 
congenital heart 
disease F 2m no data no data 3824 432 49.5 35.5 none none none 11.00 52.00 
16 
diaphragmatic 
hernia M 1m 
37w, caesarean 
(severe 
preeclampsia) 2828 2510 378 54.0 35.0 none none none 5.35 9.00 
 
17 drowning F 2m no data no data 5020 610 68.0 37.0 
subdural 
haemorrhage c none 10.00 21.88 
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Table: Infant clinical and autopsy data 
Abbreviations: Petechia- t, thymic; p, pulmonary; e, epicardial; th, thoracic; Pulmonary- o, oedema; a,, aspiration, c, congestion; RTI, respiratory tract infection. 
 
 
 
Case # Diagnosis Gender Age 
Gestational 
age, birth 
method 
Birth 
weight 
(g) 
Body 
weight 
(g) 
Brain 
weight 
(g) 
Length 
(cm) 
Head 
circumference 
(cm) 
Neurological 
findings 
Pulmonary- 
o,a,c 
Petechiae 
(t,p,e,th)
Fixation 
time (w)
Post 
Mortem 
Interval (h) 
18 drowning M 10m no data no data 8710 982 68.0 46.0 none none none 1.00 21.16 
19 gastroenteritis M 2m 1w 38w, normal 2065 4328 695 55.0 39.5 none none none 7.50 7.25 
20 
genetic 
chromosomal F 2m 
36w, normal, 
labour 
induced 3630 3950 470 53.5 36.5 none none p,e 5.60 6.80 
21 head injury F 3m no data no data 6020 660 65.0 41.0 none none none no data 36.25 
22 head injury F 4m 37w 3070 5920 730 65.0 no data none none none 10.00 21.16 
23 head injury M 1m 2w no data no data 6035 870 60.0 42.8 
some brain 
petechia none none 13.00 61.50 
24 head injury M 4m no data no data 8115 815 69.0 47.0 none haemorrhages none no data 16.90 
25 head injury M 6m no data no data 8700 894 66.0 45.0 none none none 12.00 33.80 
26 head injury M 9m no data no data 10260 936 73.0 no data 
some 
haemorrhage none none 12.00 39.03 
27 
intraabdominal 
teratoma M 4m 2w no data no data 7560 653 60.0 42.0 
encephalopathy 
gliosis none none 6.70 19.56 
28 leukaemia M 2m no data no data 5000 540 56.0 39.0 leukaemia c,o e 8.35 17.40 
29 lower RTI M 4m no data no data 7200 718 59.0 41.5 none  c,o p,t,e 13.00 8.50 
30 multiple injuries M 7m no data no data 9700 942 75.2 45.5 congestion none none 5.35 10.08 
31 myocarditis M 3m 38w, induced no data 6975 824 61.0 40.0 
intravascular 
neurophils none none 10.00 9.16 
32 
necrotising 
enterocolitis F 2m 3w 23w no data
1198 
(small) 196 38.5 26.0 none none none 3.00 8.64 
33 
pneumococcal 
meningitis M 6m no data no data 9630 no data 69.0 46.0 pneumococci none none 8.00 99.50 
34 pneumonia F 5m 28w 740 6300 550 55.0 39.5 none none none 12.00 35.70 
35 pneumonia F 6m no data no data 5230 734 62.0 41.5 none c e 8.00 24.00 
36 positional asphyxia M 4m 
40w, 
caesarean 3322 5310 626 63.0 40.0 none none none 5.00 49.50 
37 positional asphyxia M 7m 40w, normal 3687 9940 1008 69.5 45.0 none c,o p,t,e 7.00 14.70 
38 positional asphyxia M 8m 39w, normal 2947 8315 912 70.5 45.0 congestion none none 10.00 47.00 
39 septicaemia M 2m 40w, normal 3350 6050 753 60.0 42.0 some gliosis c none 5.70 23.50 
 
40 
shaking impact 
syndrome M 6m no data no data 9000 940 68.0 47.0 
some 
haemorrhage none none 28.00 19.70 
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Table: Infant clinical and autopsy data continued… 
 
 
 
Case # Diagnosis Gender Age 
Gestational 
age, birth 
method 
Birth 
weight 
(g) 
Body 
weight 
(g) 
Brain 
weight 
(g) 
Length 
(cm) 
Head 
circumference 
(cm) 
Neurological 
findings 
Pulmonary- 
o,a,c 
Petechiae 
(t,p,e,th)
Fixation 
time (w)
 
Post 
Mortem 
Interval (h) 
41 sleeping accident F 2m 2w 
premature, 
normal no data 4620 534 57.0 38.0 
mononuclears 
in 
leptomeningy a e 10.00 11.50 
42 sleeping accident F 5m 28w, normal 600 3780 524 52.0 37.0 none c,o p 9.00 27.50 
43 sleeping accident F 7m 40w, normal no data 8440 928 67.0 46.0 none c,o none 9.35 30.00 
44 sleeping accident M 1m 
40w, head up 
forceps birth 2890 3186 350 54.0 37.5 
neuronal 
malorientation c none 9.70 11.00 
45 sleeping accident M 1m 
37w, 
caesarean no data 2850 460 50.0 34.0 none none none 10.00 28.00 
46 sleeping accident M 2m 2w 
36w, 
caesarean 2000 3308 520 51.0 37.0 
white matter 
gliosis none none 10.00 10.08 
47 sleeping accident M 3m 40w, normal no data 4456 775 59.5 42.0 none none none 8.70 29.40 
48 
tracheobronchitis & 
pneumonia F 4m 28w, normal 1400 4150 520 56.0 37.0 none a,c,o p,t 11.00 31.93 
49 
valvular heart 
disease M 5m no data no data 8035 710 64.0 44.5 
hypoxic 
encephalopathy 
& neuronal 
necrosis c,o none 12.00 14.08 
50 
ventricular septal 
defect F 3m no data no data 5206 674 58.0 40.5 none a,c,o none 11.00 11.67 
51 
waterhouse 
friderichsen 
syndrome F 4m 3w 40w, normal 4307 7095 850 65.0 42.0 
reactive 
astrocytosis c,o none 4.00 9.00 
52 SIDS F 1m premature 2777 4023 460 55.0 35.0 none c,o p,e 2.70 21.88 
53 SIDS F 1m 
36w, normal 
but prior 
haemorrhage 2170 4252 450 56.0 34.0 hemosiderin a,c,o p,t,e 9.00 26.50 
54 SIDS F 1m 37w, normal 2170 3024 510 52.0 35.5 none c,o none 11.70 26.00 
55 SIDS F 1m 2w 30w, normal 1750 2360 322 45.0 34.5 none c none 8.70 16.00 
56 SIDS F 1m 3w term, normal 2298 2728 516 55.2 36.0 none none p 11.35 8.00 
57 SIDS F 2m 37w, normal 2050 4200 500 52.0 37.0 none none p 12.00 21.64 
58 SIDS F 2m no data 2610 4600 576 53.0 38.0 none none p,t,e no data 8.25 
59 SIDS F 2m 40w, normal 2820 4518 532 56.0 36.5 none c,o none 8.00 27.70 
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Table: Infant clinical and autopsy data continued… 
Abbreviations: Petechia-t, thymic; p, pulmonary; e, epicardial; th, thoracic; Pulmonary- o, oedema; a,, aspiration, c, congestion; SIDS, sudden infant death syndrome. 
 
 
 
Case # Diagnosis Gender 
 
 
Age 
Gestational 
age, birth 
method 
Birth 
weight 
(g) 
Body 
weight 
(g) 
Brain 
weight 
(g) 
Length 
(cm) 
Head 
circumference 
(cm) 
Neurological 
findings 
Pulmonary- 
o,a,c 
Petechiae 
(t,p,e,th)
Fixation 
time (w)
Post 
Mortem 
Interval (h) 
60 SIDS F 2m 40w, normal 2290 4800 626 55.0 38.0 none a p,t,e no data 6.70 
61 SIDS F 2m 1w 40w, normal 2890 4320 632 57.0 39.0 none c,o p 2.50 24.50 
62 SIDS F 2m 2w 40w, normal 3460 6085 638 58.0 38.0 none a,c t,p,e 8.00 21.50 
63 SIDS F 2m 3d 40w, normal 3645 5628 572 58.0 36.5 none c,o none 8.00 12.25 
64 SIDS F 3m no data no data 4700 576 58.0 no data 
microglial 
nodules in pons none none 6.00 25.00 
65 SIDS F 3m 40w, normal no data 5300 578 59.0 38.5 none c,o p 8.60 10.50 
66 SIDS F 3m 2w 36w, normal 2975 6680 664 60.0 39.0 none a t,e no data 19.25 
67 SIDS F 3m 2w no data no data 4800 666 59.0 40.0 none none t,e no data 24.70 
68 SIDS F 4m 
term, but 
forceps, gas 
& epidural 3635 6770 656 64.0 40.0 none none none 9.70 10.25 
69 SIDS F 4m 
term, 
caesarean no data 6800 722 61.5 41.0 none none p,t,e no data 8.00 
70 SIDS F 4m 40w, normal 3780 6720 820 61.0 41.0 
cerebellar 
neuronal 
heterotopia none t,e 6.70 24.08 
71 SIDS F 4m 3w 40w, normal 3480 6800 730 66.5 40.5 none a,c,o p,t,e no data 20.00 
72 SIDS F 6m 
35w, 
caesarean 2120 6930 740 66.0 41.0 none a t,p 8.50 18.50 
73 SIDS F 6m 38w, normal 2720 6450 890 73.0 40.0 hemosiderin none e 2.00 21.00 
74 SIDS F 7m 40w, normal 3550 8340 836 67.0 42.5 none none p,t 5.00 28.25 
75 SIDS F 
8m 
(size=3m)
28w, normal, 
one of twins 760 5100 678 58.2 41.0 none none p,t,e no data 19.32 
76 SIDS F 9m 40w, normal 2700 8450 880 66.5 42.5 none c p,t,e no data 10.00 
77 SIDS M 1m 35w, normal 2010 2296 394 48.0 31.0 none c,o t 2.20 13.00 
78 SIDS M 1m 40w, normal 3300 4788 656 56.0 39.0 none none p,t 9.70 5.70 
79 SIDS M 1m 1w 33w, normal no data 2910 440 49.0 35.0 none c,o none 9.35 22.25 
80 SIDS M 1m 1w 38w, normal 3120 4542 532 54.0 38.0 
gross 
myelination none t,e 8.35 7.50 
 
81 SIDS M 1m 2w 40w, induced 3743 5000 570 56.0 35.0 
some 
congestion c,o none 4.20 40.50 
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Table: Infant clinical and autopsy data continued… 
 
 
 
 
Case # Diagnosis Gender AGE 
Gestational 
age, birth 
method 
Birth 
weight 
(g) 
Body 
weight 
(g) 
Brain 
weight 
(g) 
Length 
(cm) 
Head 
circumference 
(cm) 
Neurological 
findings 
Pulmonary- 
o,a,c 
Petechiae 
(t,p,e,th)
Fixation 
time (w)
Post 
Mortem 
Interval (h) 
82 SIDS M 1m 2w 
premature, 
caesarean 
(one of 
twins) 2495 5162 542 56.0 37.5 
leptomeningeal 
congestion, 
inflammation 
necrosis a,c,o t,e 11.50 19.70 
83 SIDS M 1m 2w 
38w, 
caesarean no data 4100 484 54.0 38.0 none none p no data 25.32 
84 SIDS M 2m 1w 40w, normal 3350 4550 1570 57.0 39.0 none c,o p,t,e no data 7.27 
85 SIDS M 2m 2w 40w, normal 3922 5184 634 56.0 40.0 none c,o p,e 8.00 11.08 
86 SIDS M 2m 3w 40w, normal 2980 5420 620 66.0 39.0 none none p,t,e 3.00 17.00 
87 SIDS M 2m 3w 37w no data 4542 616 54.7 39.0 none o,c p 10.70 8.16 
88 SIDS M 2m 3w 39w, normal 3237 6090 666 66.5 46.0 none none p 13.00 25.00 
89 SIDS M 2m 3w 40w, normal 3687 5080 690 58.0 41.0 
congested 
hippocampus c,o p,t,e no data 25.25 
90 SIDS M 3m no data no data 5210 670 59.0 41.0 none none t,e,th no data 26.50 
91  SIDS M 3m 40w, normal 3744 7200 738 59.5 42.5 
congestion & 
gliosis of 
brainstem c,o t 10.60 11.00 
92 SIDS M 3m 40w, normal 3605 5850 742 62.5 39.5 none none p,t 10.35 22.16 
93 SIDS M 3m 40w, normal 2777 5530 720 59.5 40.5 none none p,t no data 23.88 
94 SIDS M 3m 2w 40w, normal 3670 7420 776 67.0 43.0 none none none 9.35 15.00 
95 SIDS M 4m 40w, induced 2270 6640 720 64.0 42.2 none none e 2.50 74.50 
96 SIDS M 4m 
premature, 
caesarean 1923 6900 660 60.0 39.0 
some 
congestion, 
immature brain c,o p,t,e 3.70 10.25 
97 SIDS M 4m no data no data 7980 908 65.0 44.0 congestion c,o t,e 7.70 5.50 
98 SIDS M 4m premature 2110 4200 610 58.5 38.0 none none t,p,e 7.35 6.50 
99 SIDS M 4m no data no data 7600 775 64.0 42.0 none o t 5.50 22.64 
100 SIDS M 4m term, normal 3265 5626 426 63.0 42.0 none none p,t 10.50 17.25 
101 SIDS  M 4m 36w, normal 3060 5244 700 62.0 40.0 myelination o,c p 10.00 25.40 
102 SIDS M 4m 40w, normal 2700 6740 840 61.5 44.5 
swelling of 
leptomeninges none p,e 9.35 19.50 
103 SIDS M 4m 2w no data no data 6100 710 63.0 47.0 none none p,t,e 5.00 9.56 
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Table: Infant clinical and autopsy data continued… 
Abbreviations: Petechia-t, thymic; p, pulmonary; e, epicardial; th, thoracic; Pulmonary- o, oedema; a,, aspiration, c, congestion; SIDS, sudden infant death syndrome. 
 
 
 
Case # Diagnosis Gender Age 
Gestational 
age, birth 
method 
Birth 
weight 
(g) 
Body 
weight 
(g) 
Brain 
weight 
(g) 
Length 
(cm) 
Head 
circumference 
(cm) 
Neurological 
findings 
Pulmonary- 
o,a,c 
Petechiae 
(t,p,e,th)
Fixation 
time (w)
Post 
Mortem 
Interval (h) 
104 SIDS M 5m 
36w, 
caesarean, 
one of twins 2220 6830 856 63.5 42.0 
white matter 
congestion c,o p,t 7.00 17.25 
105 SIDS M 5m 40w, normal 3630 7575 854 61.5 44.5 some gliosis c,o p,t 10.00 12.50 
106 SIDS M 5m 36w, normal 2150 6440 816 61.0 43.0 none none p,t,e no data 21.80 
107 SIDS M 5m 37w, normal 2455 6435 792 59.0 42.0 none none p,t 6.00 9.16 
108 SIDS M 7m 36w, normal no data 8840 934 68.0 49.0 none none p,t,e no data 24.70 
109 SIDS M 7m 
31w, 
caesarean 920 5980 750 61.0 41.0 none c,o p 9.35 23.25 
110 SIDS M 8m 40w, term 3630 8215 872 69.2 43.3 none none none 9.20 10.00 
111 SIDS M 10m 40w, normal 3293 9235 1056 71.0 48.0 none c,o p 7.50 4.50 
112 SIDS M 10m no data no data 9755 1082 72.0 no data none a,c,o t,th 6.00 11.64 
113 SIDS M 10m 40w, normal 2918 9005 996 69.5 47.0 
white matter 
congestion none t 10.00 58.07 
114 
consistent with 
SIDS F 1m 1w 40w, normal 3580 4622 558 56.0 38.0 soft brain c,o t 3.00 30.00 
115 
consistent with 
SIDS F 3m 40w, normal 2610 4922 628 56.0 38.5 none c,o t,e 6.00 8.00 
116 
consistent with 
SIDS F 3m 
40w, elective 
caesarean 3130 5190 584 54.0 38.5 none a,c,o p,t,e 8.60 6.80 
117 
consistent with 
SIDS F 5m term, normal 3715 7315 785 63.0 40.0 none a,c,o t,e 10.60 14.80 
118 
consistent with 
SIDS F 6m 40w, normal 3800 7475 914 65.0 45.0 none c none 10.00 6.56 
119 
consistent with 
SIDS M 2m premature 2630 3950 460 55.0 35.5 none c t,p 4.35 5.75 
120 
consistent with 
SIDS M 2m 1w 40w, normal 2460 5220 592 58.2 38.3 none a,c,o p,t,e 11.70 50.00 
121 
consistent with 
SIDS M 2m 2w no data no data 5532 520 57.0 39.5 
hypoxic 
encephalopathy a,c,o none 11.00 49.50 
 
122 
consistent with 
SIDS M 3m 
40w, 
caesarean 3300 6000 630 62.0 37.0 none c,o none 10.35 20.88 
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Table: Infant clinical and autopsy data continued… 
Abbreviations: Petechia-t, thymic; p, pulmonary; e, epicardial; th, thoracic; Pulmonary- o, oedema; a,, aspiration, c, congestion; SIDS, sudden infant death syndrome. 
 
 
 
Case # Diagnosis Gender AGE 
Gestational 
age, birth 
method 
Birth 
weight 
(g) 
Body 
weight 
(g) 
Brain 
weight 
(g) 
Length 
(cm) 
Head 
circumference 
(cm) 
Neurological 
findings 
Pulmonary- 
o,a,c 
Petechiae 
(t,p,e,th)
Fixation 
time (w)
Post 
Mortem 
Interval (h) 
123 
consistent with 
SIDS M 3m 2w 40w, normal 3280 6935 638 62.0 41.0 none c 
t,p,e & 
kidney 10.35 15.50 
124 
consistent with 
SIDS M 4m no data no data
3260 
(small) 556 46.5 38.5 
gliosis of 
hippocampus 
and cortex c,o e 6.00 11.13 
125 
consistent with 
SIDS M 4m no data no data 6525 626 61.0 41.5 none c e,t,th no data 97.88 
126 
consistent with 
SIDS M 5m 
38w, 2nd 
twin 
caesarean 2862 7500 860 67.0 42.0 none none p,t,e 9.20 30.50 
127 probable SIDS F 3m 2w premature 3320 4542 540 59.0 38.5 none none t,p,e 11.00 23.00 
128 probable SIDS M 3m 3w 40w, normal 3464 7070 758 65.5 42.0 none c,o none no data 5.50 
129 unascertained F 3m 
34w, 
caesarean 2100 3028 529 52.0 37.0 
congested 
vessels none none 2.50 7.00 
130 undetermined M 10m no data no data 8800 1070 70.0 46.5 none c none 9.00 8.64 
131 undetermined M 1m 40w, normal 3305 4278 550 64.0 37.0 none c none 8.00 31.64 
132 undetermined M 2m 36w, normal 2720 3832 628 53.4 38.5 none none t,p,e 8.00 21.00 
133 undetermined M 2m 36w, normal 1952 4360 455 51.0 36.0 none none none 10.70 25.50 
134 undetermined M 2m 40w, normal 2880 4620 590 57.0 37.0 none c,o t,p,th 6.35 20.88 
135 undetermined M 2m 2w 40w, normal 3620 5730 604 59.5 40.8 
reactive 
astrocytosis c,o none 3.00 8.00 
136 
undetermined 
(consistent with 
SIDS) M 1m no data 3460 3490 534 52.0 36.0 none c,o none 3.00 7.32 
137 
undetermined 
(hypoxia) F 4m 3w 
premature, 
normal 1810 3586 456 50.0 35.5 
neuronal 
heterotopias, 
hypoxia none none no data 21.50 
138 
undetermined 
(SIDS or sleeping 
accident) M 4m 2w 
premature, 
caesarean  3170 6360 802 66.0 42.0 none c t,e 7.00 10.50 
139 
undetermined 
(smothering, 
hypoxia) F 6m term, normal no data 8580 682 63.0 49.0 
hypoxic 
ischemic 
changes c,o,a t,e 11.00 53.50 
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Table: Infant clinical and autopsy data continued… 
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Appendix 4 
 Infant clinical and autopsy data 
(Past history and risk factors) 
 
 
 
Case # Diagnosis Immunisation URTI 
Month of 
death 
Bed 
share 
Usual sleep 
position Position found
Maternal Age 
(y,m) Family history Smoking 
 
Drugs 
1 
aspiration of gastric 
contents no data no March no prone prone 31y, 7m none yes yes 
2 
aspiration of gastric 
contents no data no July no no data no data 36y none no no 
3 
aspiration of gastric 
contents 
yes, all shots 
for age yes, asthma May no supine 
prone, face 
down 16y, 1m 
cousin of mother 
died at 6m 
(possible SIDS) yes no 
4 
bronchopulmonary 
dysplasia & sleeping 
accident no data no December yes supine supine no data no data 
yes, both 
parents no data 
5 
brompheniramine 
toxicity  & RTI yes, 1m prior 
yes, previous 
24h  June no right side face down 21y, 9m none no no 
6 bronchopneumonia yes, 3w prior yes August no no data no data 17y, 9m none yes no 
7 bronchopneumonia no yes, 24h prior September no 
prone, head 
left prone 22y, 7m asthma yes no 
8 bronchopneumonia no data yes, 2-3d prior May no data no data no data no data no data no data no data 
9 bronchopneumonia no yes, past week July no side/back side/back 23y, 6m diabetes no no 
10 bronchopneumonia no data yes June no no data no data no data no data no data no data 
11 bronchopneumonia yes yes January no right side right side 21y, 7m asthma yes no 
12 bronchopneumonia yes, 4m &6m yes, bronchitis November yes no data no data no data no data no data no data 
13 
cardiac arrythmia, 
hypoxic insults no 
yes, respiratory 
distress 1d prior June no data no data no data no data none yes, mother no 
14 cardiomyopathy yes no March no no data no data 19y, 3m 
 muscular 
dystrophy yes no 
15 
congenital heart 
disease no data no September no data supine no data no data no data no data no data 
16 diaphragmatic hernia no data no July no side side 35y, 1m diabetes no no 
17 drowning no data no January no data no data no data no data 
mother- epilepsy 
and postnatal 
depression no data no data 
18 drowning no data no November no data no data no data no data no data no data no data 
19 gastroenteritis no data no August no data no data no data no data no data no data no data 
 
20 genetic chromosomal yes, Hep B yes, 2d prior May yes prone prone 20y, 1m 
aunts’ daughter 
SIDS yes, father no 
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Table: Infant clinical and autopsy data (Past history and risk factors) 
Abbreviations: d, days; Hep, Hepatitis;  m, months; SIDS, Sudden Infant death Syndrome; URTI, upper respiratory tract infection;  w, weeks; y, years. 
 
 
Case # Diagnosis Immunisation URTI 
Month of 
death 
Bed 
share 
Usual sleep 
position Position found
Maternal Age 
(y,m) Family history Smoking 
 
Drugs 
21 head injury no data no August no data no data no data no data no data no data no data 
22 head injury no data no December no data no data no data no data no data no data no data 
23 head injury no data no November no data no data no data no data no data no data no data 
24 head injury no data no August no data no data no data no data no data no data no data 
25 head injury no data yes, 1d prior October no data supine no data no data no data no data 
yes, mother 
IV drug use 
26 head injury no data no February no data no data no data no data no data no data no data 
27 
intraabdominal 
tetratoma no data no June no data no data no data no data no data no data no data 
28 leukaemia no data 
yes, several 
weeks September no data no data no data no data no data no data no data 
29 lower RTI no data yes August no no data no data no data no data no data no data 
30 multiple injuries yes, 1d prior no February no no data no data no data no data no data no data 
31 myocarditis no data no December no data no data no data no data no data no data no data 
32 
necrotising 
enterocolitis no data no May no data no data no data no data no data no data no data 
33 
pneumococcal 
meningitis no data no October no data no data no data no data no data no data no data 
34 Pneumonia no data yes October no data no data no data no data no data no data no data 
35 Pneumonia no data yes August no data no data no data no data no data no data no data 
36 positional asphyxia yes no July yes right side right side 23y 
grandmother-
SIDS infant; 
mother-death of 
preterm male  
yes, both 
parents no 
37 positional asphyxia yes 
yes, at 4m had 
bronchitis November no left side 
between bed 
and wall 26y, 9m no 
yes, both 
parents no data 
38 positional asphyxia yes yes, 24h prior November no supine prone 23y, 8m 
 diabetes on 
mothers side no no 
39 septiceamia yes, 1m prior 
yes, had a cold 
the day before June no supine supine 21y, 1m 
sister of mother 
had near SIDS, 
6y ago yes no 
 
40 
shaking impact 
syndrome no data no February no data no data no data no data no data no data 
mother- 
amphetamines 
and cannabis 
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Table: Infant clinical and autopsy data (Past history and risk factors) continued… 
Abbreviations: d, days; IV, intravenous;  m, months; SIDS, Sudden Infant death Syndrome; URTI, upper respiratory tract infection;  w, weeks;  y, years. 
 
 
 
Case # Diagnosis Immunisation URTI 
Month of 
death 
Bed 
share 
Usual sleep 
position Position found
Maternal Age 
(y,m) Family history Smoking 
 
Drugs 
41 sleeping accident yes no April yes side side 23y none 
yes, both 
parents 
yes, parents- 
marijuana  
42 sleeping accident unknown yes, 2w prior July yes left side 
left side, bent 
over 19y, 3m 
both 
grandmothers 
lost infants 
yes, both 
parents no 
43 sleeping accident yes, 3d prior 
yes, inflamed 
trachea August yes left side head down 20y, 5m 
High blood 
pressure yes no 
44 sleeping accident 
unknown, 
possibly Hep  no September yes supine right side 19y, 1m 
mother- 
Dystrophia 
Myotonica yes no 
45 sleeping accident no data yes December yes no data side no data no data yes 
yes, parents 
on methadone 
46 sleeping accident 
yes, 3d prior, 
TA & Polio no July yes side side 31y, 9m none no no 
47 sleeping accident no data no August yes side side 25y, 2m no 
yes, both 
parents no 
48 
tracheobronchitis & 
pneumonia yes yes August yes side 
prone, head 
right 22y, 8m no yes no 
49 valvular heart disease no data no November no data no data no data no data no data no data no data 
50 
ventricular septal 
defect no data 
yes, 3d prior 
(bronchiolitis) November no data no data no data no data no data no data no data 
51 
Waterhouse 
Friderichsen 
syndrome yes, 6w prior no January yes supine side right 37y, 11m none yes no 
52 SIDS no 
yes, previous 
24h  April no data prone prone 16y, 11m none no data no data 
53 SIDS no no July yes side side 31y, 7m  heart condition yes, mother no 
54 SIDS yes yes, 1w prior September yes supine supine 23y, 4m mother- diabetes yes no  
55 SIDS no no September yes side prone 23y, 1m no yes no 
56 SIDS yes yes, 2d prior February yes left side left side 28y, 9m bronchial asthma yes 
yes,  parents 
on methadone 
57 SIDS yes, 4d prior no December yes no data supine no data 
fetal growth 
retardation no data 
mother-drug 
dependent  
58 SIDS no data no December yes side, face left head to left 24y, 3m no data no no 
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Table: Infant clinical and autopsy data (Past history and risk factors) continued… 
Abbreviations: d, days; Hep, Hepatitis; m, months; SIDS, Sudden Infant death Syndrome; TA, Triple Antigen;  URTI, upper respiratory tract infection;  w, weeks;  y, years. 
 
 
 
Case # Diagnosis Immunisation URTI 
Month of 
death 
Bed 
share 
Usual sleep 
position Position found
Maternal Age 
(y,m) Family history Smoking 
 
Drugs 
59 SIDS 
yes, 3d prior, 
Sabin & TA yes, 1w prior May no prone prone no data none no no 
60 SIDS yes, 2w prior yes, last 5d July no supine supine 31y, 10m none yes no 
61 SIDS no no April yes  right side right side 18y, 2m none 
yes, both 
parents no 
62 SIDS no data yes August no prone prone 32y, 4m no no no 
63 SIDS 
none, due to 
have one yes, 1-2d prior May yes left side left side no data none yes, mother no 
64 SIDS no data yes, 24h prior April yes no data no data no data no data no data no data 
65 SIDS no data yes November yes supine supine 30y, 4m no data yes no data 
66 SIDS yes yes, 4w prior  March yes supine prone 18y, 8m 
maternal 
grandmother 
3 stillborns 
yes, both 
parents no 
67 SIDS no data yes, 1w prior July no no data prone no data no data no data no data 
68 SIDS 
yes, 2m 
vaccination no April no supine side 23y, 5m none no no 
69 SIDS yes no April yes side side 21y, 10m none yes no 
70 SIDS no 
yes, since birth. 
well for last 2w February no supine prone 36y, 3m no no data no 
71 SIDS yes, 2w prior no December no supine prone 49y, 7m 
high blood 
pressure- fathers 
side yes no 
72 SIDS yes no February no supine prone, face left 34y, 3m no data no data no data 
73 SIDS yes  yes, 1w prior June no supine supine 27y, 11m none yes no 
74 SIDS yes, up to date yes, 24h prior June no no data 
prone, head 
right 18y, 8m none 
yes, both 
parents no 
75 SIDS 
yes, due for 
2nd set yes April no supine supine 31y, 6m none yes no 
76 SIDS yes no April no left side prone 19y no no data no 
77 SIDS no 
yes, past few 
days May yes right side right side 25y, 11m none no no 
78 SIDS none no June no side side 24y, 2m none yes no 
79 SIDS no no May yes side face down 19y, 6m none yes no 
80 SIDS no no October yes back or side supine 25y, 2m no no data no 
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Table: Infant clinical and autopsy data (Past history and risk factors) continued… 
Abbreviations: d, days; m, months; SIDS, Sudden Infant death Syndrome; TA, Triple Antigen; URTI, upper respiratory tract infection;  w, weeks;  y, years. 
 
 
 
Case # Diagnosis Immunisation URTI 
Month of 
death 
Bed 
share 
Usual sleep 
position Position found
Maternal Age 
(y,m) Family history Smoking 
 
Drugs 
81 SIDS no no May no right side right side 25y, 7m 
mother - Crohns 
disease no no 
82 SIDS no no February no prone no data 39y, 9m none no no 
83 SIDS no data no January yes no data no data no data no data no data no data 
84 SIDS yes, 1w prior no August yes side supine, face left 42y, 1m no yes no 
85 SIDS yes no July no  right side face down no data 
cousin of mother-
SIDS death yes no 
86 SIDS yes, Hep B no February yes supine supine 24y none yes no 
87 SIDS no data no November no left side face down no data no data no data no data 
88 SIDS yes, 1w prior 
yes, few weeks 
prior January yes supine supine 24y, 9m 
stillborn sibling 
6y ago yes no 
89 SIDS yes, 3w prior no August yes left side supine 43y, 9m no yes, father no 
90 SIDS no data yes, 2w prior April yes  side supine no data no data no data no data 
91  SIDS 
yes, 1m prior-
influenza no February no 
supine, head 
left 
supine, head 
left 22y, 10m no 
yes, both 
parents no 
92 SIDS none 
yes, 3w prior 
had bronchitis January no 
prone, head 
right prone 23y, 4m asthma -mum yes no data 
93 SIDS 
yes, TA & 
polio yes, bronchitis July yes right side supine 28y, 1m none yes, mother no 
94 SIDS no yes, past week July no right side supine 27y, 2m none yes no 
95 SIDS yes, 2m TA no March yes 
side, head 
left 
prone, face 
down 22y, 11m none yes no 
96 SIDS 
yes, 1/2 does 
adult Hep B no April yes prone 
supine 
(unusual) 37y, 9m 
mother- Hep C 
positive yes no 
97 SIDS no data no May no data no data no data no data no data yes, mother no data 
98 SIDS no no September no side side 21y, 3m no yes no 
99 SIDS no data no May no left side 
left side, face 
slightly down no data no data no data no data 
100 SIDS yes yes, 2d prior March no right side prone, head left 29y, 6m none no no 
101 SIDS  yes no October no side supine 25y, 5m 
possible SIDS 
case 20y ago 
with relative; 
asthma yes no 
102 SIDS yes yes, a cold March no supine prone 34y, 6m no yes no 
Appendices                                                                                                                                          152
Table: Infant clinical and autopsy data (Past history and risk factors) continued… 
Abbreviations: d, days; Hep, Hepatitis;  m, months; SIDS, Sudden Infant death Syndrome; TA, Triple Antigen;  URTI, upper respiratory tract infection;  w, weeks;  y, years. 
 
 
 
Case # Diagnosis Immunisation URTI 
Month of 
death 
Bed 
share 
Usual sleep 
position Position found
Maternal Age 
(y,m) Family history Smoking 
 
Drugs 
103 SIDS no data yes, 24h prior July yes supine 
body/face to 
side 26y, 2m diabetes yes no 
104 SIDS yes, 2m prior 
yes, 4w prior 
(bronchitis) June no 
supine, head 
right 
prone, head 
down 21y, 10m no yes no 
105 SIDS 
yes, TA & 
polio yes, 1w prior January no supine prone 32y, 1m none no no 
106 SIDS 
yes, due for 
6m no June no supine prone 30y, 7m 
asthma, 
bronchitis 
yes, both 
parents 
cannabis, both 
parents 
107 SIDS yes no December no supine prone 34y, 3m no 
yes, both 
parents no 
108 SIDS yes yes, recent January no left side prone 20y, 8m 
grandmother had 
a stillborn 
yes, both 
parents no 
109 SIDS 
yes, HIB, 
Polio, & TA yes April no right side prone 18y 
mother suffered 
hypertension yes no 
110 SIDS no yes, 1w prior May yes side prone 39y, 58m 
paternal aunt had 
SIDS baby 17y 
ago yes no 
111 SIDS no data no July no supine 
side, doona 
over head no data none no data no data 
112 SIDS no data no April no data no data face down no data no data no data no data 
113 SIDS yes yes November no supine supine 39y, 11m no yes no 
114 consistent  with SIDS no no June yes supine supine no data none yes no 
115 consistent with SIDS no yes, unknown July no left side prone 22y, 6m no yes no 
116 consistent with SIDS yes no July no unknown prone 35y, 10m none yes no 
117 consistent with SIDS 
yes, TA, HIB, 
& Hep B yes March no supine prone 39y, 7m 
asthma (mother 
and brother) no no 
118 consistent with SIDS yes 
yes, bronchitis 
2d prior February no supine supine 19y, 1m no no data no data 
119 consistent with SIDS yes, 1w prior no October no right side face down 26y, 4m 
SIDS sibling, 7y 
ago yes no 
120 consistent with SIDS yes no September yes side side 23y, 2m no yes, mother no 
121 consistent with SIDS no y October yes supine prone no data no no 
yes, mother 
on methadone 
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Table: Infant clinical and autopsy data (Past history and risk factors) continued… 
Abbreviations: d, days; Hep, Hepatitis;  HIB, Haemophylus influenza B;  m, months; SIDS, Sudden Infant death Syndrome; TA, Triple Antigen; URTI, upper respiratory tract 
infection;  w, weeks; y, years. 
 
Case # Diagnosis Immunisation URTI 
Month of 
death 
Bed 
share 
Usual sleep 
position Position found
Maternal Age 
 (y,m) Family history Smoking 
Drugs 
 
122 consistent with SIDS yes no January yes supine prone 27y, 3m 
asthma, 
bronchitus yes, mother yes 
123 consistent with SIDS yes yes, 2w prior January no prone prone 18y, 1m no yes no 
124 consistent with SIDS no data no April yes no data no data no data no data no data no data 
125 consistent with SIDS no data yes April no data right side no data no data 
brother of father 
died as infant no data no data 
126 consistent with SIDS yes, up to date yes, 2w prior May no supine 
prone, head 
covered, face 
down 30y, 6m none yes no 
127 probable SIDS yes, up to date no December yes prone 
prone, face 
right 20y heart disease yes no 
128 probable SIDS yes no December yes supine supine 42y, 1m no 
yes, both 
parents no 
129 unascertained yes no January no data no data supine 26y, 1m 
diabetes and 
asthma no no 
130 undetermined no data no January no supine prone 15y, 3m no data yes 
yes, both 
parents  
131 undetermined no no May yes right side  right side unknown 
SIDS sibling 7y 
ago yes no 
132 undetermined no yes, 2w prior September no left side face down 25y, 6m 
1 SIDS sibling, 1 
sibling drowned
yes, both 
parents no 
133 undetermined no no October yes 
side, head 
left prone, head left unknown no yes no 
134 undetermined yes no June yes left side side 26y, 7m no yes no 
135 undetermined 
yes, 2m prior 
Hep B no January no   prone no data 31y, 1m diabetes  no data no data 
136 
undetermined 
(consistent with 
SIDS) no data no June yes no data right side unknown no data no data no data 
137 
undetermined 
(hypoxia) yes yes, 2d prior August no supine 
supine, face 
side 15y, 2m asthma yes no 
138 
undetermined (SIDS 
or sleeping accident) yes no December yes supine supine 29y, 5m 
sister- parvo 
virus  yes no 
139 
undetermined 
(smothering,hypoxia) yes no February yes prone prone 25y none yes no 
 Abbreviations: d, days; Hep, Hepatitis;  m, months; SIDS, Sudden Infant death Syndrome; URTI, upper respiratory tract infection;  w, weeks; y, years. 
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